data_2k3b_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k3b _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo . . . . . 0 CA--C 1.515 -0.431 0 N-CA-C 109.614 -0.956 . . . . 1.0 109.614 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.37 165.44 12.71 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.795 0.807 . . . . 1.0 109.696 169.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.74 164.12 31.37 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.256 -0.884 . . . . 1.0 111.537 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.5 p -104.05 162.2 13.36 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.77 109.77 21.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.103 0.954 . . . . 1.0 110.459 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -70.84 -42.3 70.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.192 -0.913 . . . . 1.0 111.6 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -137.72 155.89 48.59 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 106.744 -1.576 . . . . 1.0 106.744 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -67.03 133.58 50.2 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 175.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -127.45 124.42 38.37 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.777 -1.194 . . . . 1.0 107.777 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -103.25 118.78 37.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.04 -0.982 . . . . 1.0 110.647 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.508 ' H ' ' HG1' ' A' ' 19' ' ' THR . . . -62.31 136.5 57.95 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.146 -1.022 . . . . 1.0 111.012 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.28 5.96 22.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.361 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -140.29 159.96 41.04 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -63.36 -33.84 76.41 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 113.849 1.055 . . . . 1.0 113.849 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -88.08 6.63 35.37 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.415 1.265 . . . . 1.0 114.415 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -103.27 139.57 38.54 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.328 0.585 . . . . 1.0 112.51 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.07 145.1 36.03 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.697 0.76 . . . . 1.0 110.367 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.508 ' HG1' ' H ' ' A' ' 12' ' ' ALA . 89.9 m -112.83 130.37 56.11 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 105.92 -1.882 . . . . 1.0 105.92 175.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -156.21 169.3 24.85 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.112 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.7 m -120.34 160.8 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 O-C-N 123.694 0.621 . . . . 1.0 109.874 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.36 136.88 6.87 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 80.39 -8.92 1.44 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.757 2.132 . . . . 1.0 116.757 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.04 147.62 52.96 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.259 -0.976 . . . . 1.0 109.038 170.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.72 139.54 32.63 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.048 0.451 . . . . 1.0 111.596 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.53 125.0 73.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 103.83 -2.656 . . . . 1.0 103.83 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 pt -115.66 165.84 10.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-O 121.618 0.723 . . . . 1.0 111.972 -172.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.08 50.99 17.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.982 0.896 . . . . 1.0 111.042 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.4 mt -70.69 131.25 34.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.868 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -112.51 132.84 54.89 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 107.092 -1.447 . . . . 1.0 107.092 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.471 ' HA ' ' CD1' ' A' ' 37' ' ' TRP . 90.1 m-85 -78.85 68.68 4.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.632 0.73 . . . . 1.0 109.174 -176.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.5 t -66.56 -43.85 90.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 113.872 1.064 . . . . 1.0 113.872 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -143.24 162.03 36.72 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.799 -1.556 . . . . 1.0 106.799 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -64.64 -33.13 75.22 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 120.948 0.404 . . . . 1.0 111.575 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -96.56 -39.61 9.45 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 115.076 1.51 . . . . 1.0 115.076 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 43.5 m95 -117.76 141.3 48.56 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.668 -1.234 . . . . 1.0 107.668 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.471 ' CD1' ' HA ' ' A' ' 31' ' ' PHE . 17.5 m0 -126.57 154.88 43.3 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.165 -1.05 . . . . 1.0 108.165 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.5 tp -99.43 128.83 45.57 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.374 -0.973 . . . . 1.0 108.374 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.59 -162.54 9.55 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 119.78 -1.2 . . . . 1.0 111.819 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.441 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 77.1 tt0 -141.92 138.52 32.07 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 123.837 0.855 . . . . 1.0 109.251 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.4 mt -75.3 132.25 40.87 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.287 -0.965 . . . . 1.0 112.256 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.82 -38.52 75.74 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.013 -0.675 . . . . 1.0 110.547 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.84 -21.54 59.21 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 115.884 1.809 . . . . 1.0 115.884 -168.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.87 -0.72 0.8 Allowed 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 116.155 1.909 . . . . 1.0 116.155 -174.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.9 1.76 79.77 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.65 -1.262 . . . . 1.0 115.495 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.04 150.87 46.17 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 119.541 1.67 . . . . 1.0 108.602 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.441 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.25 149.94 51.72 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 109.276 -0.639 . . . . 1.0 109.276 -176.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.42 175.17 36.47 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.579 -0.82 . . . . 1.0 112.825 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.3 mt -72.49 139.45 47.65 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.535 -0.832 . . . . 1.0 111.595 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 49.5 p90 -139.86 149.41 58.99 Favored Pre-proline 0 C--O 1.245 0.837 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -82.11 134.11 7.97 Favored 'Trans proline' 0 CA--C 1.512 -0.589 0 N-CA-C 108.857 -1.247 . . . . 1.0 108.857 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.6 m -63.86 -37.91 89.13 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 114.277 1.214 . . . . 1.0 114.277 -176.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -61.77 -8.54 4.9 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.463 0.912 . . . . 1.0 113.463 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -94.7 -0.24 54.49 Favored 'General case' 0 C--O 1.222 -0.379 0 O-C-N 120.184 -1.572 . . . . 1.0 113.398 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.9 m -137.76 159.01 34.19 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-O 121.606 0.717 . . . . 1.0 111.722 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.6 t -128.8 129.63 45.91 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 108.546 -0.909 . . . . 1.0 108.546 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -59.07 141.67 53.43 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.783 0.801 . . . . 1.0 111.073 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.54 -164.63 54.63 Favored Glycine 0 C--O 1.246 0.876 0 CA-C-N 115.354 -0.839 . . . . 1.0 113.453 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.255 1.352 0 CA-C-O 117.59 -1.195 . . . . 1.0 111.43 -176.984 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 CA--C 1.515 -0.447 0 N-CA-C 109.673 -0.933 . . . . 1.0 109.673 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -114.38 165.38 12.78 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.788 0.804 . . . . 1.0 109.679 169.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.75 164.08 31.5 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.273 -0.876 . . . . 1.0 111.478 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.8 p -114.8 132.48 56.46 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.25 133.95 50.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.989 0.9 . . . . 1.0 110.402 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -99.24 -28.48 13.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.141 -0.936 . . . . 1.0 111.543 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -137.68 150.07 47.04 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 106.707 -1.59 . . . . 1.0 106.707 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -65.9 134.07 52.24 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -126.68 124.21 39.31 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 107.781 -1.192 . . . . 1.0 107.781 177.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -101.03 116.1 32.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.089 -0.96 . . . . 1.0 110.694 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.98 137.65 58.33 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.194 -1.003 . . . . 1.0 111.035 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -113.36 5.66 16.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.207 -0.906 . . . . 1.0 110.34 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -137.27 159.69 41.2 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.218 -1.03 . . . . 1.0 108.218 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -64.49 -33.92 77.02 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 113.866 1.062 . . . . 1.0 113.866 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -88.71 5.5 42.98 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.482 1.29 . . . . 1.0 114.482 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -100.7 136.9 39.84 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.313 0.578 . . . . 1.0 112.538 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.25 142.49 41.39 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.778 0.799 . . . . 1.0 110.336 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.2 m -110.0 131.2 55.28 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 105.969 -1.863 . . . . 1.0 105.969 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -155.68 169.26 24.74 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 120.402 -0.519 . . . . 1.0 110.129 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.4 m -120.37 160.77 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.694 0.621 . . . . 1.0 109.817 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.28 136.86 6.75 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 80.39 -8.92 1.44 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.757 2.132 . . . . 1.0 116.757 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.05 147.64 52.92 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.245 -0.982 . . . . 1.0 109.051 170.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.68 139.5 32.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.018 0.437 . . . . 1.0 111.627 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.56 125.0 73.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 103.745 -2.687 . . . . 1.0 103.745 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 pt -115.7 165.88 10.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.667 0.746 . . . . 1.0 111.931 -172.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 51.1 50.94 18.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.978 0.894 . . . . 1.0 111.058 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.0 mt -68.02 128.8 31.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.934 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -113.0 121.74 45.53 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.051 -1.463 . . . . 1.0 107.051 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -76.19 72.21 2.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.57 0.7 . . . . 1.0 109.204 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.4 t -66.91 -43.82 89.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 113.94 1.089 . . . . 1.0 113.94 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -139.83 164.51 29.78 Favored 'General case' 0 C--O 1.22 -0.494 0 N-CA-C 106.716 -1.587 . . . . 1.0 106.716 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -64.93 -35.45 81.21 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 120.986 0.422 . . . . 1.0 111.648 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -97.49 -33.49 11.35 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 114.986 1.476 . . . . 1.0 114.986 -176.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.407 ' CH2' ' HG3' ' A' ' 51' ' ' PRO . 54.3 m95 -114.28 133.43 55.66 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.731 -1.211 . . . . 1.0 107.731 -178.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 53.0 m0 -116.52 151.0 37.03 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.09 -1.078 . . . . 1.0 108.09 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.9 tp -104.55 124.19 48.86 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.412 -0.958 . . . . 1.0 108.412 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.12 -165.77 11.09 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 119.609 -1.282 . . . . 1.0 111.834 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -140.15 139.7 35.82 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 123.73 0.812 . . . . 1.0 109.284 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.2 mt -76.15 132.25 39.88 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.096 -1.042 . . . . 1.0 112.256 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.76 -38.61 75.72 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.097 -0.641 . . . . 1.0 110.494 172.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.79 -21.6 59.23 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 115.929 1.825 . . . . 1.0 115.929 -168.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.83 -0.71 0.8 Allowed 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 116.084 1.883 . . . . 1.0 116.084 -174.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.87 1.76 79.64 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.673 -1.251 . . . . 1.0 115.43 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.0 p -70.06 150.86 46.15 Favored 'General case' 0 C--O 1.213 -0.851 0 CA-C-N 119.572 1.686 . . . . 1.0 108.577 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -130.23 149.96 51.69 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 109.276 -0.639 . . . . 1.0 109.276 -176.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.56 172.46 34.69 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.57 -0.824 . . . . 1.0 112.806 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.3 mt -75.54 140.36 42.69 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.586 -0.807 . . . . 1.0 111.62 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -144.12 139.55 16.01 Favored Pre-proline 0 C--O 1.246 0.875 0 N-CA-C 108.06 -1.089 . . . . 1.0 108.06 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HG3' ' CH2' ' A' ' 36' ' ' TRP . 31.2 Cg_exo -62.9 133.83 43.54 Favored 'Trans proline' 0 CA--C 1.512 -0.6 0 N-CA-C 108.762 -1.284 . . . . 1.0 108.762 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 81.5 p -66.84 -17.95 65.14 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 114.368 1.247 . . . . 1.0 114.368 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -81.55 -1.26 45.62 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.435 0.902 . . . . 1.0 113.435 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -95.58 -0.99 51.33 Favored 'General case' 0 C--O 1.222 -0.375 0 O-C-N 120.171 -1.58 . . . . 1.0 113.5 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.8 m -136.54 162.13 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.582 0.706 . . . . 1.0 111.734 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 65.0 p -128.28 130.52 47.99 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 123.944 0.898 . . . . 1.0 108.589 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.5 mt -60.46 141.72 56.05 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.893 0.854 . . . . 1.0 111.017 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.44 -164.61 54.56 Favored Glycine 0 C--O 1.246 0.876 0 CA-C-N 115.34 -0.845 . . . . 1.0 113.549 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.329 0 CA-C-O 117.564 -1.208 . . . . 1.0 111.404 -176.966 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 CA--C 1.516 -0.398 0 N-CA-C 109.574 -0.971 . . . . 1.0 109.574 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.28 165.45 12.68 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.816 0.817 . . . . 1.0 109.668 169.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.77 164.15 31.32 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.234 -0.893 . . . . 1.0 111.453 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.5 p -115.35 132.9 56.47 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.161 -1.051 . . . . 1.0 108.161 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.46 136.72 55.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.987 0.899 . . . . 1.0 110.518 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -100.73 -26.34 13.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.204 -0.907 . . . . 1.0 111.533 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -140.33 149.82 43.21 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 106.722 -1.585 . . . . 1.0 106.722 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -63.6 132.8 52.33 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.922 -0.769 . . . . 1.0 108.922 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -128.04 125.85 40.14 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.667 -1.234 . . . . 1.0 107.667 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -106.35 119.65 39.8 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 124.29 0.994 . . . . 1.0 110.789 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.39 136.33 58.01 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 119.195 -1.002 . . . . 1.0 111.114 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.25 2.8 27.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.229 -0.896 . . . . 1.0 110.298 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -142.53 163.85 31.72 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -65.85 -32.65 74.29 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 113.824 1.046 . . . . 1.0 113.824 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -85.99 5.92 31.09 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.544 1.313 . . . . 1.0 114.544 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -104.61 139.75 39.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.318 0.58 . . . . 1.0 112.537 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.6 mt -76.91 142.8 39.97 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.785 0.802 . . . . 1.0 110.321 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.2 m -111.06 129.13 56.01 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 105.953 -1.869 . . . . 1.0 105.953 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -156.17 169.28 24.89 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 120.288 -0.565 . . . . 1.0 110.056 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.31 160.79 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 O-C-N 123.628 0.58 . . . . 1.0 109.89 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -46.21 136.78 6.69 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.698 -0.853 . . . . 1.0 108.698 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 80.42 -8.92 1.44 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.757 2.132 . . . . 1.0 116.757 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -66.99 147.59 53.03 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.266 -0.974 . . . . 1.0 109.084 170.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.69 139.59 32.52 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.037 0.446 . . . . 1.0 111.582 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.61 124.98 73.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 103.756 -2.683 . . . . 1.0 103.756 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.1 pt -115.72 165.78 10.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-O 121.659 0.742 . . . . 1.0 111.958 -172.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.14 51.02 17.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.013 0.911 . . . . 1.0 111.042 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.1 mt -71.38 131.13 34.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.934 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -114.84 135.73 53.87 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.995 -1.483 . . . . 1.0 106.995 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -78.31 67.53 4.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.646 0.736 . . . . 1.0 109.164 -176.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.47 -40.86 89.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.885 1.068 . . . . 1.0 113.885 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -144.49 160.06 41.72 Favored 'General case' 0 C--O 1.219 -0.536 0 N-CA-C 106.763 -1.569 . . . . 1.0 106.763 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -63.68 -33.02 74.7 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 120.902 0.382 . . . . 1.0 111.612 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -100.29 -34.53 9.95 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 115.09 1.515 . . . . 1.0 115.09 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 52.2 m95 -111.24 135.29 51.98 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.598 -1.26 . . . . 1.0 107.598 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.404 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . 10.7 m0 -110.36 151.59 27.26 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.147 -1.057 . . . . 1.0 108.147 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.3 tp -108.58 125.95 52.4 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.419 -0.956 . . . . 1.0 108.419 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.99 -165.84 13.5 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 119.767 -1.206 . . . . 1.0 111.884 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.429 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 75.1 tt0 -135.59 141.94 45.22 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 123.75 0.82 . . . . 1.0 109.195 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.9 mt -75.16 132.21 41.0 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.159 -1.016 . . . . 1.0 112.282 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.82 -38.52 75.74 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.013 -0.675 . . . . 1.0 110.547 172.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.75 -21.58 59.27 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 115.912 1.819 . . . . 1.0 115.912 -168.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.94 -0.7 0.79 Allowed 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 116.091 1.886 . . . . 1.0 116.091 -174.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.82 1.79 79.45 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.658 -1.258 . . . . 1.0 115.51 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.0 p -70.04 150.92 46.12 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 119.541 1.67 . . . . 1.0 108.602 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.429 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.31 149.95 51.77 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 109.241 -0.652 . . . . 1.0 109.241 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.11 176.31 37.91 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.568 -0.825 . . . . 1.0 112.776 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -77.51 137.06 38.42 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.516 -0.842 . . . . 1.0 111.613 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.404 ' CE2' ' HB2' ' A' ' 37' ' ' TRP . 50.1 p90 -138.34 150.83 67.94 Favored Pre-proline 0 C--O 1.243 0.743 0 N-CA-C 107.943 -1.132 . . . . 1.0 107.943 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -80.36 129.19 7.46 Favored 'Trans proline' 0 CA--C 1.513 -0.54 0 N-CA-C 108.839 -1.254 . . . . 1.0 108.839 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.8 m -59.9 -34.84 73.72 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 114.344 1.239 . . . . 1.0 114.344 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -61.99 -9.23 6.59 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.489 0.922 . . . . 1.0 113.489 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -94.74 1.15 55.45 Favored 'General case' 0 C--O 1.222 -0.356 0 O-C-N 120.243 -1.536 . . . . 1.0 113.405 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.7 m -138.01 162.28 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.482 0.658 . . . . 1.0 111.778 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.2 p -133.34 131.59 40.28 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 176.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -60.63 141.72 56.4 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.836 0.827 . . . . 1.0 111.052 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.41 -164.67 54.54 Favored Glycine 0 C--O 1.247 0.933 0 CA-C-N 115.36 -0.836 . . . . 1.0 113.57 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.255 1.352 0 CA-C-O 117.59 -1.195 . . . . 1.0 111.43 -176.981 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 CA--C 1.515 -0.464 0 N-CA-C 109.634 -0.948 . . . . 1.0 109.634 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.39 165.41 12.74 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.766 0.794 . . . . 1.0 109.74 169.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.7 164.05 31.54 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.348 -0.842 . . . . 1.0 111.549 -176.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.6 m -117.8 128.67 55.09 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.11 -1.07 . . . . 1.0 108.11 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.45 136.74 56.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.995 0.902 . . . . 1.0 110.49 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -101.71 -21.05 14.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.16 -0.927 . . . . 1.0 111.584 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -138.73 151.39 47.08 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 106.818 -1.549 . . . . 1.0 106.818 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -67.22 132.42 47.73 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.847 -0.797 . . . . 1.0 108.847 176.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.473 ' HB2' ' CD2' ' A' ' 54' ' ' TYR . 81.8 t80 -135.34 130.53 35.15 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 107.781 -1.192 . . . . 1.0 107.781 177.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -114.16 134.4 54.93 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.049 -0.978 . . . . 1.0 110.658 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.66 139.05 56.77 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.138 -1.025 . . . . 1.0 111.095 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.94 -4.87 18.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.254 -0.885 . . . . 1.0 110.273 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -131.14 166.78 20.36 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 108.26 -1.015 . . . . 1.0 108.26 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -66.81 -34.04 76.93 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 113.876 1.065 . . . . 1.0 113.876 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -87.95 7.56 30.42 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.458 1.281 . . . . 1.0 114.458 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -103.84 149.49 25.0 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.27 0.557 . . . . 1.0 112.448 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 75.6 mt -90.24 142.72 27.44 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.63 0.729 . . . . 1.0 110.349 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.1 t -109.86 132.19 54.38 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 105.882 -1.896 . . . . 1.0 105.882 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -156.12 169.19 25.07 Favored 'General case' 0 CA--C 1.503 -0.855 0 O-C-N 123.33 0.394 . . . . 1.0 110.13 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.8 m -120.31 160.85 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.683 0.614 . . . . 1.0 109.86 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -46.43 136.81 7.06 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.655 -0.869 . . . . 1.0 108.655 176.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 80.5 -8.92 1.43 Allowed 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 116.783 2.142 . . . . 1.0 116.783 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -66.97 147.6 53.02 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.266 -0.974 . . . . 1.0 109.103 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.7 139.51 32.66 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.996 0.427 . . . . 1.0 111.615 175.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.59 124.94 73.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.81 -2.663 . . . . 1.0 103.81 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 pt -115.68 165.91 10.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-O 121.673 0.749 . . . . 1.0 111.994 -172.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.08 51.02 17.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.013 0.911 . . . . 1.0 111.042 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.93 128.75 32.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.918 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -112.92 123.35 50.12 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.093 -1.447 . . . . 1.0 107.093 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -75.71 72.26 2.63 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.691 0.757 . . . . 1.0 109.127 -175.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 68.3 t -66.94 -44.64 88.52 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 N-CA-C 113.947 1.092 . . . . 1.0 113.947 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -141.22 163.09 33.9 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 106.745 -1.576 . . . . 1.0 106.745 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -66.1 -34.63 78.5 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.031 0.443 . . . . 1.0 111.508 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -93.2 -37.73 11.94 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 115.031 1.493 . . . . 1.0 115.031 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 33.3 m95 -114.29 135.23 54.29 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.705 -1.22 . . . . 1.0 107.705 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 50.7 m0 -114.19 148.72 36.85 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.233 -1.025 . . . . 1.0 108.233 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.0 tp -103.46 133.78 47.94 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.359 -0.978 . . . . 1.0 108.359 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.67 -166.64 17.42 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 119.746 -1.216 . . . . 1.0 111.884 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.453 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 77.4 tt0 -136.6 140.18 42.65 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.901 0.88 . . . . 1.0 109.327 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.6 mt -75.58 132.25 40.55 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.724 -0.791 . . . . 1.0 112.242 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.76 -38.62 75.72 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.097 -0.641 . . . . 1.0 110.494 172.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.74 -21.7 59.21 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 115.851 1.797 . . . . 1.0 115.851 -168.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 51.0 p30 -145.83 -0.71 0.8 Allowed 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 116.096 1.887 . . . . 1.0 116.096 -174.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.92 1.76 79.92 Favored Glycine 0 C--O 1.222 -0.631 0 C-N-CA 119.699 -1.239 . . . . 1.0 115.43 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.05 150.86 46.17 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 119.572 1.686 . . . . 1.0 108.584 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.453 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.2 149.87 51.71 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 -176.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.84 174.37 35.28 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.554 -0.831 . . . . 1.0 112.797 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.5 145.44 43.52 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.598 -0.801 . . . . 1.0 111.544 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -149.52 140.17 13.92 Favored Pre-proline 0 N--CA 1.443 -0.823 0 N-CA-C 108.025 -1.102 . . . . 1.0 108.025 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -63.47 133.65 40.99 Favored 'Trans proline' 0 CA--C 1.513 -0.529 0 N-CA-C 108.904 -1.229 . . . . 1.0 108.904 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.4 p -67.8 -18.22 64.78 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 114.274 1.212 . . . . 1.0 114.274 -176.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -80.18 -2.1 43.29 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.436 0.902 . . . . 1.0 113.436 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.473 ' CD2' ' HB2' ' A' ' 10' ' ' TYR . 32.2 m-85 -95.4 0.58 53.61 Favored 'General case' 0 C--O 1.223 -0.326 0 O-C-N 120.157 -1.589 . . . . 1.0 113.317 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 m -138.57 163.03 28.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 118.698 0.681 . . . . 1.0 111.813 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.3 p -129.92 130.76 45.54 Favored 'General case' 0 C--O 1.213 -0.818 0 C-N-CA 123.985 0.914 . . . . 1.0 108.562 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -59.33 141.67 53.94 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 119.628 -0.829 . . . . 1.0 111.073 -177.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.53 -164.68 54.62 Favored Glycine 0 C--O 1.247 0.914 0 CA-C-N 115.336 -0.847 . . . . 1.0 113.455 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.296 0 CA-C-O 117.563 -1.208 . . . . 1.0 111.342 -176.902 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 CA--C 1.515 -0.464 0 N-CA-C 109.635 -0.948 . . . . 1.0 109.635 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.36 165.5 12.65 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.809 0.814 . . . . 1.0 109.712 169.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.77 164.08 31.52 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.292 -0.867 . . . . 1.0 111.487 -176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.5 p -114.97 134.34 55.26 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.0 137.61 51.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.98 0.895 . . . . 1.0 110.532 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -104.25 -25.17 13.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.263 -0.88 . . . . 1.0 111.538 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -138.95 148.27 43.31 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 106.775 -1.565 . . . . 1.0 106.775 -178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -68.55 137.75 54.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -127.04 123.83 37.92 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.744 -1.206 . . . . 1.0 107.744 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -99.52 113.54 25.99 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 124.306 1.004 . . . . 1.0 110.651 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.438 ' H ' ' HG1' ' A' ' 19' ' ' THR . . . -60.34 136.97 58.2 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.226 -0.99 . . . . 1.0 111.001 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.95 -4.94 20.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.187 -0.915 . . . . 1.0 110.343 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -132.35 162.34 31.31 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.268 -1.012 . . . . 1.0 108.268 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -66.86 -31.76 72.59 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 113.885 1.068 . . . . 1.0 113.885 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -88.22 8.01 29.22 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 12' ' ' ALA . 96.3 mt-10 -100.67 139.59 36.14 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 112.567 0.58 . . . . 1.0 112.567 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.7 tp -74.78 134.93 41.73 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.682 0.753 . . . . 1.0 110.403 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.438 ' HG1' ' H ' ' A' ' 12' ' ' ALA . 99.5 m -110.5 128.63 55.71 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 105.939 -1.874 . . . . 1.0 105.939 176.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -155.78 169.32 24.64 Favored 'General case' 0 CA--C 1.503 -0.86 0 O-C-N 123.898 0.749 . . . . 1.0 110.112 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.5 m -120.4 160.82 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.687 0.617 . . . . 1.0 109.794 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.39 136.89 6.92 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.62 -0.881 . . . . 1.0 108.62 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 80.39 -8.92 1.44 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.757 2.132 . . . . 1.0 116.757 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.07 147.51 53.08 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.259 -0.976 . . . . 1.0 109.068 170.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.59 139.57 32.48 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.003 0.43 . . . . 1.0 111.642 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.53 124.95 73.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.788 -2.671 . . . . 1.0 103.788 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 pt -115.65 165.86 10.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.648 0.737 . . . . 1.0 112.015 -172.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.1 50.94 18.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.947 0.879 . . . . 1.0 111.058 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.11 130.56 34.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.882 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -117.36 122.83 44.94 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.094 -1.447 . . . . 1.0 107.094 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -77.3 77.01 3.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.554 0.692 . . . . 1.0 109.152 -175.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.2 t -65.12 -45.27 94.64 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 N-CA-C 113.818 1.044 . . . . 1.0 113.818 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -135.35 177.1 8.08 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 106.759 -1.571 . . . . 1.0 106.759 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -71.05 -29.96 65.99 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 121.037 0.446 . . . . 1.0 111.626 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -111.23 -28.18 8.37 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 114.957 1.466 . . . . 1.0 114.957 -176.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 51.5 m95 -111.97 128.24 56.11 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.625 -1.25 . . . . 1.0 107.625 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -117.14 156.1 28.21 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.161 -1.051 . . . . 1.0 108.161 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.4 tp -106.2 128.22 53.78 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.361 -0.977 . . . . 1.0 108.361 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -150.24 172.51 30.05 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 119.788 -1.196 . . . . 1.0 111.904 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.415 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 77.7 tt0 -120.72 139.35 53.19 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.873 0.869 . . . . 1.0 109.302 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.6 mt -75.2 132.24 40.98 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.203 -0.999 . . . . 1.0 112.267 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.82 -38.56 75.82 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.013 -0.675 . . . . 1.0 110.547 172.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -74.73 -21.64 59.26 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 115.91 1.818 . . . . 1.0 115.91 -168.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.85 -0.62 0.81 Allowed 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 116.146 1.906 . . . . 1.0 116.146 -174.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.85 1.7 79.34 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.65 -1.262 . . . . 1.0 115.461 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.0 p -70.04 150.92 46.12 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 119.589 1.695 . . . . 1.0 108.602 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.415 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.31 149.95 51.77 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 109.241 -0.652 . . . . 1.0 109.241 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.43 172.69 34.02 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.559 -0.829 . . . . 1.0 112.749 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.0 mt -73.13 142.17 47.48 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 114.636 -0.782 . . . . 1.0 111.588 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -143.94 142.31 20.1 Favored Pre-proline 0 C--O 1.245 0.862 0 N-CA-C 108.015 -1.106 . . . . 1.0 108.015 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -65.14 133.65 36.29 Favored 'Trans proline' 0 CA--C 1.513 -0.564 0 N-CA-C 108.855 -1.248 . . . . 1.0 108.855 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.4 p -67.94 -14.81 63.26 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 114.264 1.209 . . . . 1.0 114.264 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -88.78 6.05 40.66 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.402 0.89 . . . . 1.0 113.402 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -101.53 -0.94 34.13 Favored 'General case' 0 C--O 1.221 -0.4 0 O-C-N 120.186 -1.571 . . . . 1.0 113.361 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.3 m -137.81 164.96 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.532 0.682 . . . . 1.0 111.733 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.0 p -129.43 130.85 46.46 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 108.565 -0.902 . . . . 1.0 108.565 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -59.14 141.74 53.38 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.779 0.8 . . . . 1.0 111.13 -177.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.5 -164.7 54.6 Favored Glycine 0 C--O 1.246 0.904 0 CA-C-N 115.359 -0.837 . . . . 1.0 113.491 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.253 1.262 0 CA-C-O 117.581 -1.199 . . . . 1.0 111.43 -176.989 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo . . . . . 0 CA--C 1.515 -0.431 0 N-CA-C 109.614 -0.956 . . . . 1.0 109.614 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.39 165.41 12.75 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.743 0.782 . . . . 1.0 109.724 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.77 164.06 31.57 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.354 -0.839 . . . . 1.0 111.526 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.4 m -115.93 128.03 55.44 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.262 -1.014 . . . . 1.0 108.262 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.17 135.69 55.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.992 0.901 . . . . 1.0 110.501 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -99.37 -24.87 14.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.185 -0.916 . . . . 1.0 111.531 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -140.29 149.81 43.26 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 106.787 -1.56 . . . . 1.0 106.787 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -66.11 136.21 55.65 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.904 -0.776 . . . . 1.0 108.904 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -128.85 123.47 32.83 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 107.757 -1.201 . . . . 1.0 107.757 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -102.28 119.47 38.86 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 124.279 0.987 . . . . 1.0 110.748 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 17' ' ' GLU . . . -60.62 136.29 58.01 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.216 -0.994 . . . . 1.0 111.088 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.75 -3.37 22.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.269 -0.878 . . . . 1.0 110.307 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -136.11 164.6 27.65 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.212 -1.033 . . . . 1.0 108.212 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -65.02 -32.48 74.22 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 113.863 1.06 . . . . 1.0 113.863 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -87.34 4.88 41.2 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.556 1.317 . . . . 1.0 114.556 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 80.7 mm-40 -101.73 137.08 40.51 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 112.525 0.565 . . . . 1.0 112.525 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.0 mt -75.58 147.02 39.95 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.729 0.776 . . . . 1.0 110.39 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.5 m -115.43 129.47 56.58 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 105.853 -1.906 . . . . 1.0 105.853 175.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -153.9 169.29 23.8 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 123.353 0.408 . . . . 1.0 110.09 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.33 160.79 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.681 0.613 . . . . 1.0 109.86 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.24 136.81 6.73 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.605 -0.887 . . . . 1.0 108.605 176.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 80.43 -8.94 1.43 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.745 2.128 . . . . 1.0 116.745 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -67.07 147.63 52.92 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.245 -0.982 . . . . 1.0 109.038 170.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.7 139.54 32.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.06 0.457 . . . . 1.0 111.609 175.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.56 124.99 73.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.782 -2.673 . . . . 1.0 103.782 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.4 pt -115.69 165.9 10.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.642 0.734 . . . . 1.0 112.021 -172.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 51.03 50.97 18.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.928 0.87 . . . . 1.0 111.154 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 97.1 mt -69.22 130.19 34.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.48 -0.782 . . . . 1.0 110.865 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -113.86 128.2 56.31 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.114 -1.439 . . . . 1.0 107.114 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -77.68 70.45 4.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.651 0.739 . . . . 1.0 109.163 -175.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 65.2 t -68.1 -43.83 84.93 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 N-CA-C 113.889 1.07 . . . . 1.0 113.889 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -139.08 161.4 37.47 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.765 -1.569 . . . . 1.0 106.765 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -64.47 -34.51 78.38 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 121.101 0.477 . . . . 1.0 111.668 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -99.19 -33.18 10.87 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 114.991 1.478 . . . . 1.0 114.991 -176.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.478 ' CH2' ' HG3' ' A' ' 51' ' ' PRO . 30.2 m95 -119.4 132.7 55.88 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.655 -1.239 . . . . 1.0 107.655 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 30.7 m0 -115.99 155.59 27.78 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.105 -1.072 . . . . 1.0 108.105 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.82 128.2 53.58 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.398 -0.964 . . . . 1.0 108.398 178.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.1 -162.82 9.77 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 119.698 -1.239 . . . . 1.0 111.795 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.468 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 76.4 tt0 -140.41 139.35 35.25 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 123.847 0.859 . . . . 1.0 109.298 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.9 mt -75.73 132.25 40.37 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.62 -0.832 . . . . 1.0 112.256 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -57.82 -38.6 75.87 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 119.996 -0.682 . . . . 1.0 110.508 172.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.66 -21.62 59.33 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 115.911 1.819 . . . . 1.0 115.911 -168.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -145.91 -0.63 0.8 Allowed 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 116.105 1.891 . . . . 1.0 116.105 -174.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.93 1.74 79.87 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.649 -1.263 . . . . 1.0 115.428 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.1 150.86 46.12 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 119.589 1.694 . . . . 1.0 108.553 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.468 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.9 mttt -130.2 149.87 51.71 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 -176.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.88 175.97 36.81 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.64 -0.79 . . . . 1.0 112.826 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.7 mt -72.97 147.87 44.78 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.517 -0.841 . . . . 1.0 111.633 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 52.5 p90 -151.34 136.33 10.33 Favored Pre-proline 0 C--O 1.244 0.804 0 N-CA-C 107.952 -1.129 . . . . 1.0 107.952 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.478 ' HG3' ' CH2' ' A' ' 36' ' ' TRP . 30.2 Cg_exo -64.63 130.72 27.23 Favored 'Trans proline' 0 CA--C 1.512 -0.595 0 N-CA-C 108.837 -1.255 . . . . 1.0 108.837 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.2 p -67.35 -17.58 64.8 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.364 1.246 . . . . 1.0 114.364 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.3 p30 -77.51 -3.44 40.53 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.428 0.899 . . . . 1.0 113.428 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -100.85 6.01 43.6 Favored 'General case' 0 C--O 1.221 -0.446 0 O-C-N 120.204 -1.56 . . . . 1.0 113.416 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.1 m -138.61 161.93 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.626 0.727 . . . . 1.0 111.681 -177.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.3 t -132.69 130.62 40.31 Favored 'General case' 0 C--O 1.215 -0.729 0 C-N-CA 123.92 0.888 . . . . 1.0 108.609 176.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.6 mt -59.78 141.65 54.85 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.855 0.836 . . . . 1.0 111.073 -177.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.62 -164.66 54.68 Favored Glycine 0 C--O 1.246 0.876 0 CA-C-N 115.332 -0.849 . . . . 1.0 113.512 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.255 1.352 0 CA-C-O 117.59 -1.195 . . . . 1.0 111.43 -177.03 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 CA--C 1.515 -0.447 0 N-CA-C 109.717 -0.917 . . . . 1.0 109.717 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.3 165.38 12.76 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.757 0.789 . . . . 1.0 109.771 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.7 164.1 31.4 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.318 -0.856 . . . . 1.0 111.537 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.2 m -117.88 126.83 53.13 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.48 135.32 52.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 122.057 0.932 . . . . 1.0 110.45 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -102.11 -19.55 15.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.073 -0.967 . . . . 1.0 111.583 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -138.21 148.74 45.11 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 106.732 -1.581 . . . . 1.0 106.732 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.98 133.49 50.06 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -128.13 123.45 34.46 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.729 -1.211 . . . . 1.0 107.729 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -103.18 119.31 38.63 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 124.252 0.97 . . . . 1.0 110.841 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.439 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -62.67 135.98 57.65 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.215 -0.994 . . . . 1.0 110.983 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.09 -3.2 21.79 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.22 -0.9 . . . . 1.0 110.337 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -133.05 161.41 34.44 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 108.312 -0.996 . . . . 1.0 108.312 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -64.88 -34.05 77.46 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 113.889 1.07 . . . . 1.0 113.889 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 p30 -86.39 7.12 27.0 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.552 1.316 . . . . 1.0 114.552 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.439 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 97.8 mt-10 -103.74 138.48 40.3 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 112.542 0.571 . . . . 1.0 112.542 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 97.2 mt -73.75 142.22 46.29 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.741 0.782 . . . . 1.0 110.411 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.7 m -111.7 128.3 56.03 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 105.942 -1.873 . . . . 1.0 105.942 175.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -155.57 169.32 24.57 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 120.156 -0.618 . . . . 1.0 110.056 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.1 m -120.34 160.75 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 O-C-N 123.606 0.566 . . . . 1.0 109.881 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.31 136.89 6.78 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.655 -0.868 . . . . 1.0 108.655 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 80.31 -8.85 1.46 Allowed 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 116.824 2.157 . . . . 1.0 116.824 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -67.12 147.63 52.88 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.238 -0.985 . . . . 1.0 109.038 170.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.65 139.56 32.55 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.01 0.433 . . . . 1.0 111.588 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.6 124.91 73.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 103.779 -2.674 . . . . 1.0 103.779 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 pt -115.58 165.84 10.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.685 0.755 . . . . 1.0 112.066 -172.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 51.07 51.01 17.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.973 0.892 . . . . 1.0 111.114 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.3 mt -68.0 128.4 31.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.902 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -113.36 120.03 39.71 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.166 -1.42 . . . . 1.0 107.166 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -75.05 72.35 2.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.654 0.74 . . . . 1.0 109.141 -175.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.56 -37.07 78.8 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.644 0 N-CA-C 113.864 1.061 . . . . 1.0 113.864 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -145.06 167.37 22.85 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.806 -1.553 . . . . 1.0 106.806 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -67.29 -34.23 76.96 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 121.005 0.431 . . . . 1.0 111.673 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -98.18 -39.41 8.89 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 115.03 1.492 . . . . 1.0 115.03 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -110.71 133.25 53.5 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.678 -1.231 . . . . 1.0 107.678 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 52.6 m0 -117.59 153.33 33.43 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 108.242 -1.021 . . . . 1.0 108.242 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.7 tp -100.28 133.27 44.93 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.42 -0.956 . . . . 1.0 108.42 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.8 178.29 31.61 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 119.723 -1.227 . . . . 1.0 111.737 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.448 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 78.9 tt0 -125.62 140.27 52.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.512 -0.844 . . . . 1.0 109.375 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.6 mt -75.48 132.32 40.71 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 119.398 -0.921 . . . . 1.0 112.238 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.86 -38.61 76.01 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.093 -0.643 . . . . 1.0 110.473 172.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.82 -21.51 59.25 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 115.888 1.81 . . . . 1.0 115.888 -168.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.8 p30 -145.95 -0.72 0.79 Allowed 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 116.072 1.879 . . . . 1.0 116.072 -174.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.94 1.71 79.81 Favored Glycine 0 C--O 1.222 -0.636 0 C-N-CA 119.661 -1.257 . . . . 1.0 115.427 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.1 p -70.04 150.87 46.16 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-N 119.589 1.695 . . . . 1.0 108.59 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.448 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.26 149.95 51.72 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 -176.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.98 174.75 36.48 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.568 -0.825 . . . . 1.0 112.751 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.6 mt -73.65 139.36 45.38 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.463 -0.869 . . . . 1.0 111.721 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 51.3 p90 -140.31 150.14 60.27 Favored Pre-proline 0 C--O 1.245 0.854 0 N-CA-C 108.01 -1.108 . . . . 1.0 108.01 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.75 133.86 10.55 Favored 'Trans proline' 0 CA--C 1.513 -0.571 0 N-CA-C 108.836 -1.255 . . . . 1.0 108.836 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.7 m -62.83 -34.95 78.4 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 114.409 1.263 . . . . 1.0 114.409 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -66.44 -7.36 18.97 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.403 0.89 . . . . 1.0 113.403 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -93.53 -0.02 56.47 Favored 'General case' 0 C--O 1.222 -0.344 0 O-C-N 120.211 -1.556 . . . . 1.0 113.337 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.3 m -138.15 163.29 29.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.613 0.721 . . . . 1.0 111.698 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.9 p -132.77 131.17 40.83 Favored 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.6 mt -60.72 141.71 56.59 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.857 0.837 . . . . 1.0 111.039 -176.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.47 -164.65 54.58 Favored Glycine 0 C--O 1.246 0.904 0 CA-C-N 115.337 -0.847 . . . . 1.0 113.473 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.296 0 CA-C-O 117.593 -1.194 . . . . 1.0 111.44 -176.986 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 CA--C 1.515 -0.43 0 N-CA-C 109.604 -0.96 . . . . 1.0 109.604 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.45 165.41 12.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.834 0.826 . . . . 1.0 109.704 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.71 164.09 31.46 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.323 -0.853 . . . . 1.0 111.543 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.5 p -114.64 129.26 56.66 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.159 -1.052 . . . . 1.0 108.159 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.76 134.04 52.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.03 0.919 . . . . 1.0 110.336 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -98.27 -25.46 14.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.144 -0.935 . . . . 1.0 111.525 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -140.19 151.72 45.45 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 106.719 -1.586 . . . . 1.0 106.719 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -67.42 134.87 52.22 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.89 -0.781 . . . . 1.0 108.89 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -127.32 121.87 32.23 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 107.884 -1.154 . . . . 1.0 107.884 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -100.97 116.34 32.6 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.099 -0.955 . . . . 1.0 110.642 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.84 136.82 58.12 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.222 -0.991 . . . . 1.0 111.018 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.74 -4.57 20.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.164 -0.925 . . . . 1.0 110.214 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -134.22 164.74 26.7 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.2 -1.037 . . . . 1.0 108.2 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -66.62 -29.44 69.48 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 113.884 1.068 . . . . 1.0 113.884 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -88.73 5.89 41.25 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.499 1.296 . . . . 1.0 114.499 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -104.45 136.61 43.69 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.321 0.581 . . . . 1.0 112.481 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.9 mt -74.83 145.13 43.1 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.642 0.734 . . . . 1.0 110.418 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.0 m -112.45 129.64 56.26 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 105.921 -1.881 . . . . 1.0 105.921 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -154.92 169.26 24.45 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 120.191 -0.603 . . . . 1.0 110.129 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.7 m -120.35 160.79 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.694 0.621 . . . . 1.0 109.845 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.3 136.85 6.79 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 80.38 -8.93 1.44 Allowed 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 116.82 2.156 . . . . 1.0 116.82 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -67.02 147.55 53.06 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.252 -0.979 . . . . 1.0 109.127 170.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.67 139.58 32.53 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.011 0.434 . . . . 1.0 111.603 175.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.52 124.86 73.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.876 -2.639 . . . . 1.0 103.876 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.1 pt -115.54 165.85 10.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.649 0.738 . . . . 1.0 112.027 -172.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.03 51.03 17.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.994 0.902 . . . . 1.0 111.103 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.6 mt -72.38 129.99 35.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.499 -0.773 . . . . 1.0 110.832 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -112.01 132.38 54.84 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.134 -1.432 . . . . 1.0 107.134 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.458 ' HA ' ' CD1' ' A' ' 37' ' ' TRP . 94.0 m-85 -78.88 69.1 4.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.598 0.713 . . . . 1.0 109.195 -176.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 80.2 t -65.86 -44.56 92.7 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 N-CA-C 113.97 1.1 . . . . 1.0 113.97 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -143.16 162.24 36.11 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 106.781 -1.562 . . . . 1.0 106.781 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -63.95 -34.69 78.54 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 120.942 0.401 . . . . 1.0 111.612 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -94.72 -40.28 9.87 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 115.048 1.499 . . . . 1.0 115.048 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -116.01 139.21 50.5 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.73 -1.211 . . . . 1.0 107.73 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.458 ' CD1' ' HA ' ' A' ' 31' ' ' PHE . 21.6 m0 -122.88 153.24 39.9 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.1 tp -99.21 131.59 45.13 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.78 -168.78 14.89 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 119.644 -1.265 . . . . 1.0 111.717 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.459 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 78.9 tt0 -138.47 139.2 38.72 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.839 0.856 . . . . 1.0 109.289 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.4 mt -76.04 132.26 40.01 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 119.237 -0.985 . . . . 1.0 112.297 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.76 -38.57 75.63 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 120.041 -0.664 . . . . 1.0 110.54 172.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.85 -21.54 59.21 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 115.884 1.809 . . . . 1.0 115.884 -168.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.8 p30 -145.82 -0.8 0.8 Allowed 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 116.119 1.896 . . . . 1.0 116.119 -174.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.87 1.79 79.74 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.715 -1.231 . . . . 1.0 115.445 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.7 p -70.05 150.91 46.12 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 119.572 1.686 . . . . 1.0 108.584 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.459 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.23 149.88 51.73 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.69 174.76 36.28 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.574 -0.822 . . . . 1.0 112.824 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.3 mt -73.09 139.24 46.35 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.579 -0.811 . . . . 1.0 111.554 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -139.16 149.12 59.91 Favored Pre-proline 0 N--CA 1.443 -0.778 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -79.85 129.66 8.2 Favored 'Trans proline' 0 CA--C 1.512 -0.606 0 N-CA-C 108.808 -1.266 . . . . 1.0 108.808 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.7 m -60.42 -34.74 74.4 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 -176.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -66.44 -6.57 15.07 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.54 0.941 . . . . 1.0 113.54 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -94.14 -0.12 55.46 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 120.078 -1.638 . . . . 1.0 113.4 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.0 m -138.4 162.97 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.7 0.762 . . . . 1.0 111.732 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.5 t -131.42 130.81 43.02 Favored 'General case' 0 C--O 1.214 -0.782 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -60.28 141.62 55.86 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.816 0.817 . . . . 1.0 111.086 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.55 -164.63 54.64 Favored Glycine 0 C--O 1.248 0.988 0 CA-C-N 115.371 -0.831 . . . . 1.0 113.501 177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.255 1.363 0 CA-C-O 117.496 -1.24 . . . . 1.0 111.395 -176.977 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 CA--C 1.515 -0.431 0 N-CA-C 109.614 -0.956 . . . . 1.0 109.614 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -114.42 165.36 12.81 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.788 0.804 . . . . 1.0 109.66 169.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.7 164.11 31.38 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.273 -0.876 . . . . 1.0 111.481 -176.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.9 m -119.59 128.61 54.06 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.205 -1.035 . . . . 1.0 108.205 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.39 140.27 50.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.069 0.937 . . . . 1.0 110.431 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -102.89 -16.68 15.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.053 -0.976 . . . . 1.0 111.539 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -141.54 151.53 43.31 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 106.732 -1.581 . . . . 1.0 106.732 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -68.81 137.43 53.95 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -129.02 125.03 36.46 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.723 -1.214 . . . . 1.0 107.723 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -104.1 117.13 33.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.059 -0.973 . . . . 1.0 110.64 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.57 ' H ' ' HG1' ' A' ' 19' ' ' THR . . . -58.17 134.54 56.58 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 119.181 -1.008 . . . . 1.0 110.984 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.07 -5.05 26.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.079 -0.964 . . . . 1.0 110.313 176.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -137.2 165.2 26.67 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.266 -1.013 . . . . 1.0 108.266 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -65.95 -32.39 73.85 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 113.884 1.068 . . . . 1.0 113.884 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -84.98 7.1 22.45 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 114.481 1.289 . . . . 1.0 114.481 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.403 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 98.8 mt-10 -106.42 138.9 41.77 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.376 0.608 . . . . 1.0 112.495 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.61 140.49 42.65 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.687 0.756 . . . . 1.0 110.411 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.57 ' HG1' ' H ' ' A' ' 12' ' ' ALA . 94.0 m -107.51 128.39 54.46 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 105.859 -1.904 . . . . 1.0 105.859 175.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -154.63 169.27 24.28 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.074 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.1 m -120.28 160.78 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 O-C-N 123.626 0.579 . . . . 1.0 109.874 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.39 136.85 6.95 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.62 -0.881 . . . . 1.0 108.62 176.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 80.45 -8.92 1.43 Allowed 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 116.783 2.142 . . . . 1.0 116.783 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.04 147.61 52.97 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.259 -0.976 . . . . 1.0 109.038 170.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.65 139.59 32.5 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.047 0.451 . . . . 1.0 111.594 175.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.59 124.94 73.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 103.841 -2.651 . . . . 1.0 103.841 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 pt -115.64 165.81 10.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-O 121.625 0.726 . . . . 1.0 112.027 -172.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 51.14 50.97 17.96 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.982 0.896 . . . . 1.0 111.022 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.8 mt -71.75 131.07 35.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.96 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -112.65 133.53 54.63 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.065 -1.457 . . . . 1.0 107.065 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -79.34 68.67 5.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.66 0.743 . . . . 1.0 109.145 -176.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.9 t -64.86 -44.3 96.28 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 N-CA-C 113.873 1.064 . . . . 1.0 113.873 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -143.49 163.84 32.02 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.762 -1.57 . . . . 1.0 106.762 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -64.34 -32.57 74.23 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 120.976 0.417 . . . . 1.0 111.585 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -102.11 -36.28 8.61 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 114.946 1.462 . . . . 1.0 114.946 -177.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -111.76 133.56 53.91 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 16.3 m0 -117.95 158.05 25.61 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.199 -1.037 . . . . 1.0 108.199 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.1 tp -110.44 126.5 54.38 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.51 -170.0 14.7 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 119.694 -1.241 . . . . 1.0 111.853 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -133.05 139.26 47.09 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 123.733 0.813 . . . . 1.0 109.345 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.9 mt -74.87 132.28 41.38 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 118.801 -1.159 . . . . 1.0 112.308 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -57.82 -38.59 75.84 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 120.081 -0.648 . . . . 1.0 110.543 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.84 -21.53 59.21 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 115.849 1.796 . . . . 1.0 115.849 -168.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.86 -0.75 0.8 Allowed 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 116.023 1.86 . . . . 1.0 116.023 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.91 1.77 79.84 Favored Glycine 0 C--O 1.223 -0.566 0 C-N-CA 119.657 -1.259 . . . . 1.0 115.449 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.07 150.87 46.13 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 119.598 1.699 . . . . 1.0 108.602 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -130.21 149.97 51.67 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 -176.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.37 175.22 36.48 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.607 -0.806 . . . . 1.0 112.789 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.29 137.39 46.68 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.52 -0.84 . . . . 1.0 111.599 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 39.3 p90 -138.41 146.8 52.73 Favored Pre-proline 0 C--O 1.244 0.804 0 N-CA-C 108.088 -1.079 . . . . 1.0 108.088 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.516 ' HG2' ' CD1' ' A' ' 54' ' ' TYR . 57.8 Cg_endo -77.78 129.26 9.83 Favored 'Trans proline' 0 CA--C 1.512 -0.597 0 N-CA-C 108.83 -1.258 . . . . 1.0 108.83 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.5 m -61.8 -36.18 80.37 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 114.36 1.244 . . . . 1.0 114.36 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -64.3 -7.51 9.73 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.477 0.917 . . . . 1.0 113.477 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.516 ' CD1' ' HG2' ' A' ' 51' ' ' PRO . 15.5 m-85 -94.12 -0.14 55.48 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 120.198 -1.563 . . . . 1.0 113.316 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.36 161.66 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.605 0.717 . . . . 1.0 111.847 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.7 t -129.4 129.82 45.21 Favored 'General case' 0 C--O 1.214 -0.806 0 C-N-CA 124.054 0.941 . . . . 1.0 108.553 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.8 mt -58.85 141.71 52.52 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.762 0.791 . . . . 1.0 111.108 -177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.53 -164.64 54.62 Favored Glycine 0 C--O 1.246 0.876 0 CA-C-N 115.377 -0.828 . . . . 1.0 113.547 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.318 0 CA-C-O 117.624 -1.179 . . . . 1.0 111.411 -176.998 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 CA--C 1.515 -0.431 0 N-CA-C 109.637 -0.947 . . . . 1.0 109.637 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.38 165.38 12.78 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.788 0.804 . . . . 1.0 109.679 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.73 164.09 31.45 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.273 -0.876 . . . . 1.0 111.515 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.4 p -115.37 131.1 57.04 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.132 -1.062 . . . . 1.0 108.132 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.69 136.83 56.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.947 0.88 . . . . 1.0 110.49 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -101.19 -25.38 14.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.167 -0.924 . . . . 1.0 111.578 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -139.77 153.21 47.1 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 106.741 -1.578 . . . . 1.0 106.741 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -69.17 133.72 48.34 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.928 -0.768 . . . . 1.0 108.928 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -129.14 121.0 26.84 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -101.08 119.96 39.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.048 -0.978 . . . . 1.0 110.62 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.25 135.65 57.79 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 119.204 -0.999 . . . . 1.0 110.929 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.87 -2.58 19.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.135 -0.939 . . . . 1.0 110.277 176.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -136.58 164.66 27.67 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.295 -1.002 . . . . 1.0 108.295 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -65.24 -33.97 77.24 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 113.904 1.075 . . . . 1.0 113.904 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.6 p-10 -85.86 2.35 46.22 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 114.496 1.295 . . . . 1.0 114.496 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -100.12 137.68 38.24 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.331 0.586 . . . . 1.0 112.466 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.8 mt -76.29 147.22 38.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.715 0.769 . . . . 1.0 110.423 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.0 m -114.91 127.47 55.72 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 105.924 -1.88 . . . . 1.0 105.924 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -154.09 169.28 23.93 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 123.477 0.485 . . . . 1.0 110.056 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.8 m -120.31 160.85 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 O-C-N 123.67 0.606 . . . . 1.0 109.89 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -46.39 136.92 6.9 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 80.41 -8.96 1.43 Allowed 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 116.783 2.142 . . . . 1.0 116.783 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -67.04 147.64 52.93 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.258 -0.977 . . . . 1.0 109.051 170.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.66 139.61 32.49 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.019 0.438 . . . . 1.0 111.588 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.64 124.96 73.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 103.792 -2.67 . . . . 1.0 103.792 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 pt -115.64 165.86 10.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.655 0.741 . . . . 1.0 112.031 -172.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 51.08 51.02 17.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.013 0.911 . . . . 1.0 111.042 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.5 mt -72.75 131.29 35.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.873 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -112.8 134.29 54.39 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.036 -1.468 . . . . 1.0 107.036 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.416 ' HA ' ' CD1' ' A' ' 37' ' ' TRP . 94.0 m-85 -78.68 68.04 4.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.701 0.762 . . . . 1.0 109.246 -176.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.6 t -65.27 -44.32 95.01 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.703 0 N-CA-C 113.946 1.091 . . . . 1.0 113.946 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -143.42 162.99 34.32 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.702 -1.592 . . . . 1.0 106.702 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -64.56 -35.68 81.77 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 120.922 0.391 . . . . 1.0 111.594 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -96.28 -42.02 8.37 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.959 1.466 . . . . 1.0 114.959 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -113.26 136.89 52.25 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.633 -1.247 . . . . 1.0 107.633 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 17.6 m0 -120.52 160.02 24.01 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.139 -1.06 . . . . 1.0 108.139 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.0 tp -107.68 131.06 54.81 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.72 -170.8 16.87 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 119.65 -1.262 . . . . 1.0 111.836 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.44 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 78.3 tt0 -133.67 139.3 46.36 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 123.797 0.839 . . . . 1.0 109.374 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.7 mt -75.81 132.22 40.26 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 119.311 -0.956 . . . . 1.0 112.266 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -57.77 -38.62 75.74 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 120.072 -0.651 . . . . 1.0 110.556 172.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.81 -21.55 59.23 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 115.898 1.814 . . . . 1.0 115.898 -168.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.9 -0.66 0.8 Allowed 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 116.082 1.882 . . . . 1.0 116.082 -174.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.93 1.71 79.81 Favored Glycine 0 C--O 1.223 -0.566 0 C-N-CA 119.588 -1.292 . . . . 1.0 115.446 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.05 150.84 46.19 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 119.615 1.708 . . . . 1.0 108.546 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.22 149.9 51.71 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 109.373 -0.602 . . . . 1.0 109.373 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.47 178.99 39.5 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.582 -0.818 . . . . 1.0 112.772 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.9 mp -73.33 146.03 45.55 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.551 -0.825 . . . . 1.0 111.608 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 44.0 p90 -146.57 150.48 40.37 Favored Pre-proline 0 C--O 1.245 0.827 0 N-CA-C 108.053 -1.091 . . . . 1.0 108.053 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.413 ' HG2' ' CD1' ' A' ' 54' ' ' TYR . 61.4 Cg_endo -82.62 127.08 4.86 Favored 'Trans proline' 0 CA--C 1.513 -0.572 0 N-CA-C 108.784 -1.275 . . . . 1.0 108.784 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.6 m -59.05 -36.9 75.83 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 114.383 1.253 . . . . 1.0 114.383 -177.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -65.32 -6.5 10.08 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.403 0.89 . . . . 1.0 113.403 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.413 ' CD1' ' HG2' ' A' ' 51' ' ' PRO . 16.3 m-85 -92.63 -2.83 55.8 Favored 'General case' 0 C--O 1.222 -0.374 0 O-C-N 120.275 -1.516 . . . . 1.0 113.434 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.1 m -138.3 162.11 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.617 0.722 . . . . 1.0 111.774 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 56.3 m -127.63 130.36 48.83 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 123.995 0.918 . . . . 1.0 108.596 177.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.8 mt -58.36 141.76 50.27 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.836 0.827 . . . . 1.0 111.074 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.42 -164.61 54.55 Favored Glycine 0 C--O 1.246 0.904 0 CA-C-N 115.401 -0.818 . . . . 1.0 113.546 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.318 0 CA-C-O 117.619 -1.181 . . . . 1.0 111.44 -177.023 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.366 0.127 . . . . 1.0 111.05 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -76.94 171.0 18.75 Favored 'Trans proline' 0 C--N 1.317 -1.109 1 C-N-CA 127.273 5.316 . . . . 1.0 109.614 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.37 165.44 12.71 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.795 0.807 . . . . 1.0 109.696 169.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.74 164.12 31.37 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.256 -0.884 . . . . 1.0 111.537 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.5 p -104.05 162.2 13.36 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.77 109.77 21.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.103 0.954 . . . . 1.0 110.459 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -70.84 -42.3 70.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.192 -0.913 . . . . 1.0 111.6 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -137.72 155.89 48.59 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 106.744 -1.576 . . . . 1.0 106.744 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -67.03 133.58 50.2 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 175.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -127.45 124.42 38.37 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.777 -1.194 . . . . 1.0 107.777 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -103.25 118.78 37.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.04 -0.982 . . . . 1.0 110.647 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.508 ' H ' ' HG1' ' A' ' 19' ' ' THR . . . -62.31 136.5 57.95 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.146 -1.022 . . . . 1.0 111.012 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.28 5.96 22.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.361 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -140.29 159.96 41.04 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -63.36 -33.84 76.41 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 113.849 1.055 . . . . 1.0 113.849 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -88.08 6.63 35.37 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.415 1.265 . . . . 1.0 114.415 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -103.27 139.57 38.54 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.328 0.585 . . . . 1.0 112.51 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.07 145.1 36.03 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.697 0.76 . . . . 1.0 110.367 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.508 ' HG1' ' H ' ' A' ' 12' ' ' ALA . 89.9 m -112.83 130.37 56.11 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 105.92 -1.882 . . . . 1.0 105.92 175.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -156.21 169.3 24.85 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.112 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.7 m -120.34 160.8 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 O-C-N 123.694 0.621 . . . . 1.0 109.874 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.36 136.88 6.87 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 80.39 -8.92 1.44 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.757 2.132 . . . . 1.0 116.757 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.04 147.62 52.96 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.259 -0.976 . . . . 1.0 109.038 170.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.72 139.54 32.63 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.048 0.451 . . . . 1.0 111.596 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.53 125.0 73.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 103.83 -2.656 . . . . 1.0 103.83 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 pt -115.66 165.84 10.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-O 121.618 0.723 . . . . 1.0 111.972 -172.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.08 50.99 17.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.982 0.896 . . . . 1.0 111.042 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.4 mt -70.69 131.25 34.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.868 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -112.51 132.84 54.89 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 107.092 -1.447 . . . . 1.0 107.092 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.471 ' HA ' ' CD1' ' A' ' 37' ' ' TRP . 90.1 m-85 -78.85 68.68 4.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.632 0.73 . . . . 1.0 109.174 -176.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.5 t -66.56 -43.85 90.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 113.872 1.064 . . . . 1.0 113.872 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -143.24 162.03 36.72 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.799 -1.556 . . . . 1.0 106.799 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -64.64 -33.13 75.22 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 120.948 0.404 . . . . 1.0 111.575 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -96.56 -39.61 9.45 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 115.076 1.51 . . . . 1.0 115.076 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 43.5 m95 -117.76 141.3 48.56 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.668 -1.234 . . . . 1.0 107.668 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.471 ' CD1' ' HA ' ' A' ' 31' ' ' PHE . 17.5 m0 -126.57 154.88 43.3 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.165 -1.05 . . . . 1.0 108.165 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.5 tp -99.43 128.83 45.57 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.374 -0.973 . . . . 1.0 108.374 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.59 -162.54 9.55 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 119.78 -1.2 . . . . 1.0 111.819 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.441 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 77.1 tt0 -141.92 138.52 32.07 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 123.837 0.855 . . . . 1.0 109.251 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.4 mt -75.3 132.25 40.87 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.287 -0.965 . . . . 1.0 112.256 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.82 -38.52 75.74 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.013 -0.675 . . . . 1.0 110.547 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.84 -21.54 59.21 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 115.884 1.809 . . . . 1.0 115.884 -168.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.87 -0.72 0.8 Allowed 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 116.155 1.909 . . . . 1.0 116.155 -174.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.9 1.76 79.77 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.65 -1.262 . . . . 1.0 115.495 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.04 150.87 46.17 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 119.541 1.67 . . . . 1.0 108.602 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.441 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.25 149.94 51.72 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 109.276 -0.639 . . . . 1.0 109.276 -176.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.42 175.17 36.47 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.579 -0.82 . . . . 1.0 112.825 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.3 mt -72.49 139.45 47.65 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.535 -0.832 . . . . 1.0 111.595 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 49.5 p90 -139.86 149.41 58.99 Favored Pre-proline 0 C--O 1.245 0.837 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -82.11 134.11 7.97 Favored 'Trans proline' 0 CA--C 1.512 -0.589 0 N-CA-C 108.857 -1.247 . . . . 1.0 108.857 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.6 m -63.86 -37.91 89.13 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 114.277 1.214 . . . . 1.0 114.277 -176.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -61.77 -8.54 4.9 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.463 0.912 . . . . 1.0 113.463 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -94.7 -0.24 54.49 Favored 'General case' 0 C--O 1.222 -0.379 0 O-C-N 120.184 -1.572 . . . . 1.0 113.398 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.9 m -137.76 159.01 34.19 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-O 121.606 0.717 . . . . 1.0 111.722 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.6 t -128.8 129.63 45.91 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 108.546 -0.909 . . . . 1.0 108.546 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -59.07 141.67 53.43 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.783 0.801 . . . . 1.0 111.073 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.54 -164.63 54.63 Favored Glycine 0 C--O 1.246 0.876 0 CA-C-N 115.354 -0.839 . . . . 1.0 113.453 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.255 1.352 0 CA-C-O 117.59 -1.195 . . . . 1.0 111.43 -176.984 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.34 0.114 . . . . 1.0 111.015 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.93 171.0 18.75 Favored 'Trans proline' 0 C--N 1.317 -1.109 1 C-N-CA 127.261 5.308 . . . . 1.0 109.673 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -114.38 165.38 12.78 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.788 0.804 . . . . 1.0 109.679 169.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.75 164.08 31.5 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.273 -0.876 . . . . 1.0 111.478 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.8 p -114.8 132.48 56.46 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.25 133.95 50.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.989 0.9 . . . . 1.0 110.402 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -99.24 -28.48 13.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.141 -0.936 . . . . 1.0 111.543 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -137.68 150.07 47.04 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 106.707 -1.59 . . . . 1.0 106.707 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -65.9 134.07 52.24 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -126.68 124.21 39.31 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 107.781 -1.192 . . . . 1.0 107.781 177.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -101.03 116.1 32.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.089 -0.96 . . . . 1.0 110.694 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.98 137.65 58.33 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.194 -1.003 . . . . 1.0 111.035 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -113.36 5.66 16.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.207 -0.906 . . . . 1.0 110.34 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -137.27 159.69 41.2 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.218 -1.03 . . . . 1.0 108.218 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -64.49 -33.92 77.02 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 113.866 1.062 . . . . 1.0 113.866 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -88.71 5.5 42.98 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.482 1.29 . . . . 1.0 114.482 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -100.7 136.9 39.84 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.313 0.578 . . . . 1.0 112.538 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.25 142.49 41.39 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.778 0.799 . . . . 1.0 110.336 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.2 m -110.0 131.2 55.28 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 105.969 -1.863 . . . . 1.0 105.969 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -155.68 169.26 24.74 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 120.402 -0.519 . . . . 1.0 110.129 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.4 m -120.37 160.77 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.694 0.621 . . . . 1.0 109.817 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.28 136.86 6.75 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 80.39 -8.92 1.44 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.757 2.132 . . . . 1.0 116.757 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.05 147.64 52.92 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.245 -0.982 . . . . 1.0 109.051 170.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.68 139.5 32.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.018 0.437 . . . . 1.0 111.627 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.56 125.0 73.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 103.745 -2.687 . . . . 1.0 103.745 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 pt -115.7 165.88 10.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.667 0.746 . . . . 1.0 111.931 -172.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 51.1 50.94 18.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.978 0.894 . . . . 1.0 111.058 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.0 mt -68.02 128.8 31.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.934 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -113.0 121.74 45.53 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.051 -1.463 . . . . 1.0 107.051 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -76.19 72.21 2.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.57 0.7 . . . . 1.0 109.204 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.4 t -66.91 -43.82 89.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 113.94 1.089 . . . . 1.0 113.94 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -139.83 164.51 29.78 Favored 'General case' 0 C--O 1.22 -0.494 0 N-CA-C 106.716 -1.587 . . . . 1.0 106.716 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -64.93 -35.45 81.21 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 120.986 0.422 . . . . 1.0 111.648 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -97.49 -33.49 11.35 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 114.986 1.476 . . . . 1.0 114.986 -176.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.407 ' CH2' ' HG3' ' A' ' 51' ' ' PRO . 54.3 m95 -114.28 133.43 55.66 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.731 -1.211 . . . . 1.0 107.731 -178.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 53.0 m0 -116.52 151.0 37.03 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.09 -1.078 . . . . 1.0 108.09 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.9 tp -104.55 124.19 48.86 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.412 -0.958 . . . . 1.0 108.412 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.12 -165.77 11.09 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 119.609 -1.282 . . . . 1.0 111.834 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -140.15 139.7 35.82 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 123.73 0.812 . . . . 1.0 109.284 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.2 mt -76.15 132.25 39.88 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.096 -1.042 . . . . 1.0 112.256 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.76 -38.61 75.72 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.097 -0.641 . . . . 1.0 110.494 172.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.79 -21.6 59.23 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 115.929 1.825 . . . . 1.0 115.929 -168.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.83 -0.71 0.8 Allowed 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 116.084 1.883 . . . . 1.0 116.084 -174.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.87 1.76 79.64 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.673 -1.251 . . . . 1.0 115.43 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.0 p -70.06 150.86 46.15 Favored 'General case' 0 C--O 1.213 -0.851 0 CA-C-N 119.572 1.686 . . . . 1.0 108.577 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -130.23 149.96 51.69 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 109.276 -0.639 . . . . 1.0 109.276 -176.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.56 172.46 34.69 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.57 -0.824 . . . . 1.0 112.806 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.3 mt -75.54 140.36 42.69 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.586 -0.807 . . . . 1.0 111.62 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -144.12 139.55 16.01 Favored Pre-proline 0 C--O 1.246 0.875 0 N-CA-C 108.06 -1.089 . . . . 1.0 108.06 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HG3' ' CH2' ' A' ' 36' ' ' TRP . 31.2 Cg_exo -62.9 133.83 43.54 Favored 'Trans proline' 0 CA--C 1.512 -0.6 0 N-CA-C 108.762 -1.284 . . . . 1.0 108.762 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 81.5 p -66.84 -17.95 65.14 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 114.368 1.247 . . . . 1.0 114.368 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -81.55 -1.26 45.62 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.435 0.902 . . . . 1.0 113.435 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -95.58 -0.99 51.33 Favored 'General case' 0 C--O 1.222 -0.375 0 O-C-N 120.171 -1.58 . . . . 1.0 113.5 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.8 m -136.54 162.13 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.582 0.706 . . . . 1.0 111.734 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 65.0 p -128.28 130.52 47.99 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 123.944 0.898 . . . . 1.0 108.589 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.5 mt -60.46 141.72 56.05 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.893 0.854 . . . . 1.0 111.017 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.44 -164.61 54.56 Favored Glycine 0 C--O 1.246 0.876 0 CA-C-N 115.34 -0.845 . . . . 1.0 113.549 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.329 0 CA-C-O 117.564 -1.208 . . . . 1.0 111.404 -176.966 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.348 0.118 . . . . 1.0 110.978 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -77.02 170.95 18.82 Favored 'Trans proline' 0 C--N 1.317 -1.122 1 C-N-CA 127.318 5.345 . . . . 1.0 109.574 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.28 165.45 12.68 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.816 0.817 . . . . 1.0 109.668 169.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.77 164.15 31.32 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.234 -0.893 . . . . 1.0 111.453 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.5 p -115.35 132.9 56.47 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.161 -1.051 . . . . 1.0 108.161 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.46 136.72 55.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.987 0.899 . . . . 1.0 110.518 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -100.73 -26.34 13.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.204 -0.907 . . . . 1.0 111.533 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -140.33 149.82 43.21 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 106.722 -1.585 . . . . 1.0 106.722 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -63.6 132.8 52.33 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.922 -0.769 . . . . 1.0 108.922 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -128.04 125.85 40.14 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.667 -1.234 . . . . 1.0 107.667 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -106.35 119.65 39.8 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 124.29 0.994 . . . . 1.0 110.789 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.39 136.33 58.01 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 119.195 -1.002 . . . . 1.0 111.114 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.25 2.8 27.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.229 -0.896 . . . . 1.0 110.298 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -142.53 163.85 31.72 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -65.85 -32.65 74.29 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 113.824 1.046 . . . . 1.0 113.824 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -85.99 5.92 31.09 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.544 1.313 . . . . 1.0 114.544 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -104.61 139.75 39.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.318 0.58 . . . . 1.0 112.537 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.6 mt -76.91 142.8 39.97 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.785 0.802 . . . . 1.0 110.321 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.2 m -111.06 129.13 56.01 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 105.953 -1.869 . . . . 1.0 105.953 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -156.17 169.28 24.89 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 120.288 -0.565 . . . . 1.0 110.056 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.31 160.79 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 O-C-N 123.628 0.58 . . . . 1.0 109.89 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -46.21 136.78 6.69 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.698 -0.853 . . . . 1.0 108.698 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 80.42 -8.92 1.44 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.757 2.132 . . . . 1.0 116.757 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -66.99 147.59 53.03 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.266 -0.974 . . . . 1.0 109.084 170.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.69 139.59 32.52 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.037 0.446 . . . . 1.0 111.582 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.61 124.98 73.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 103.756 -2.683 . . . . 1.0 103.756 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.1 pt -115.72 165.78 10.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-O 121.659 0.742 . . . . 1.0 111.958 -172.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.14 51.02 17.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.013 0.911 . . . . 1.0 111.042 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.1 mt -71.38 131.13 34.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.934 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -114.84 135.73 53.87 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.995 -1.483 . . . . 1.0 106.995 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -78.31 67.53 4.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.646 0.736 . . . . 1.0 109.164 -176.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.47 -40.86 89.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.885 1.068 . . . . 1.0 113.885 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -144.49 160.06 41.72 Favored 'General case' 0 C--O 1.219 -0.536 0 N-CA-C 106.763 -1.569 . . . . 1.0 106.763 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -63.68 -33.02 74.7 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 120.902 0.382 . . . . 1.0 111.612 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -100.29 -34.53 9.95 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 115.09 1.515 . . . . 1.0 115.09 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 52.2 m95 -111.24 135.29 51.98 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.598 -1.26 . . . . 1.0 107.598 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.404 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . 10.7 m0 -110.36 151.59 27.26 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.147 -1.057 . . . . 1.0 108.147 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.3 tp -108.58 125.95 52.4 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.419 -0.956 . . . . 1.0 108.419 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.99 -165.84 13.5 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 119.767 -1.206 . . . . 1.0 111.884 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.429 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 75.1 tt0 -135.59 141.94 45.22 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 123.75 0.82 . . . . 1.0 109.195 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.9 mt -75.16 132.21 41.0 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.159 -1.016 . . . . 1.0 112.282 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.82 -38.52 75.74 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.013 -0.675 . . . . 1.0 110.547 172.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.75 -21.58 59.27 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 115.912 1.819 . . . . 1.0 115.912 -168.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.94 -0.7 0.79 Allowed 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 116.091 1.886 . . . . 1.0 116.091 -174.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.82 1.79 79.45 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.658 -1.258 . . . . 1.0 115.51 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.0 p -70.04 150.92 46.12 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 119.541 1.67 . . . . 1.0 108.602 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.429 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.31 149.95 51.77 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 109.241 -0.652 . . . . 1.0 109.241 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.11 176.31 37.91 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.568 -0.825 . . . . 1.0 112.776 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -77.51 137.06 38.42 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.516 -0.842 . . . . 1.0 111.613 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.404 ' CE2' ' HB2' ' A' ' 37' ' ' TRP . 50.1 p90 -138.34 150.83 67.94 Favored Pre-proline 0 C--O 1.243 0.743 0 N-CA-C 107.943 -1.132 . . . . 1.0 107.943 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -80.36 129.19 7.46 Favored 'Trans proline' 0 CA--C 1.513 -0.54 0 N-CA-C 108.839 -1.254 . . . . 1.0 108.839 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.8 m -59.9 -34.84 73.72 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 114.344 1.239 . . . . 1.0 114.344 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -61.99 -9.23 6.59 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.489 0.922 . . . . 1.0 113.489 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -94.74 1.15 55.45 Favored 'General case' 0 C--O 1.222 -0.356 0 O-C-N 120.243 -1.536 . . . . 1.0 113.405 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.7 m -138.01 162.28 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.482 0.658 . . . . 1.0 111.778 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.2 p -133.34 131.59 40.28 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 176.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -60.63 141.72 56.4 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.836 0.827 . . . . 1.0 111.052 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.41 -164.67 54.54 Favored Glycine 0 C--O 1.247 0.933 0 CA-C-N 115.36 -0.836 . . . . 1.0 113.57 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.255 1.352 0 CA-C-O 117.59 -1.195 . . . . 1.0 111.43 -176.981 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.302 0.096 . . . . 1.0 110.998 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -76.79 170.98 18.82 Favored 'Trans proline' 0 C--N 1.316 -1.178 1 C-N-CA 127.307 5.338 . . . . 1.0 109.634 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.39 165.41 12.74 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.766 0.794 . . . . 1.0 109.74 169.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.7 164.05 31.54 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.348 -0.842 . . . . 1.0 111.549 -176.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.6 m -117.8 128.67 55.09 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.11 -1.07 . . . . 1.0 108.11 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.45 136.74 56.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.995 0.902 . . . . 1.0 110.49 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -101.71 -21.05 14.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.16 -0.927 . . . . 1.0 111.584 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -138.73 151.39 47.08 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 106.818 -1.549 . . . . 1.0 106.818 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -67.22 132.42 47.73 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.847 -0.797 . . . . 1.0 108.847 176.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.473 ' HB2' ' CD2' ' A' ' 54' ' ' TYR . 81.8 t80 -135.34 130.53 35.15 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 107.781 -1.192 . . . . 1.0 107.781 177.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -114.16 134.4 54.93 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.049 -0.978 . . . . 1.0 110.658 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.66 139.05 56.77 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.138 -1.025 . . . . 1.0 111.095 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.94 -4.87 18.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.254 -0.885 . . . . 1.0 110.273 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -131.14 166.78 20.36 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 108.26 -1.015 . . . . 1.0 108.26 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -66.81 -34.04 76.93 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 113.876 1.065 . . . . 1.0 113.876 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -87.95 7.56 30.42 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.458 1.281 . . . . 1.0 114.458 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -103.84 149.49 25.0 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.27 0.557 . . . . 1.0 112.448 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 75.6 mt -90.24 142.72 27.44 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.63 0.729 . . . . 1.0 110.349 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.1 t -109.86 132.19 54.38 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 105.882 -1.896 . . . . 1.0 105.882 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -156.12 169.19 25.07 Favored 'General case' 0 CA--C 1.503 -0.855 0 O-C-N 123.33 0.394 . . . . 1.0 110.13 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.8 m -120.31 160.85 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.683 0.614 . . . . 1.0 109.86 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -46.43 136.81 7.06 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.655 -0.869 . . . . 1.0 108.655 176.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 80.5 -8.92 1.43 Allowed 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 116.783 2.142 . . . . 1.0 116.783 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -66.97 147.6 53.02 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.266 -0.974 . . . . 1.0 109.103 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.7 139.51 32.66 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.996 0.427 . . . . 1.0 111.615 175.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.59 124.94 73.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.81 -2.663 . . . . 1.0 103.81 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 pt -115.68 165.91 10.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-O 121.673 0.749 . . . . 1.0 111.994 -172.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.08 51.02 17.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.013 0.911 . . . . 1.0 111.042 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.93 128.75 32.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.918 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -112.92 123.35 50.12 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.093 -1.447 . . . . 1.0 107.093 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -75.71 72.26 2.63 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.691 0.757 . . . . 1.0 109.127 -175.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 68.3 t -66.94 -44.64 88.52 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 N-CA-C 113.947 1.092 . . . . 1.0 113.947 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -141.22 163.09 33.9 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 106.745 -1.576 . . . . 1.0 106.745 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -66.1 -34.63 78.5 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.031 0.443 . . . . 1.0 111.508 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -93.2 -37.73 11.94 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 115.031 1.493 . . . . 1.0 115.031 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 33.3 m95 -114.29 135.23 54.29 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.705 -1.22 . . . . 1.0 107.705 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 50.7 m0 -114.19 148.72 36.85 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.233 -1.025 . . . . 1.0 108.233 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.0 tp -103.46 133.78 47.94 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.359 -0.978 . . . . 1.0 108.359 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.67 -166.64 17.42 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 119.746 -1.216 . . . . 1.0 111.884 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.453 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 77.4 tt0 -136.6 140.18 42.65 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.901 0.88 . . . . 1.0 109.327 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.6 mt -75.58 132.25 40.55 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.724 -0.791 . . . . 1.0 112.242 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.76 -38.62 75.72 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.097 -0.641 . . . . 1.0 110.494 172.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.74 -21.7 59.21 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 115.851 1.797 . . . . 1.0 115.851 -168.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 51.0 p30 -145.83 -0.71 0.8 Allowed 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 116.096 1.887 . . . . 1.0 116.096 -174.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.92 1.76 79.92 Favored Glycine 0 C--O 1.222 -0.631 0 C-N-CA 119.699 -1.239 . . . . 1.0 115.43 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.05 150.86 46.17 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 119.572 1.686 . . . . 1.0 108.584 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.453 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.2 149.87 51.71 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 -176.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.84 174.37 35.28 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.554 -0.831 . . . . 1.0 112.797 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.5 145.44 43.52 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.598 -0.801 . . . . 1.0 111.544 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -149.52 140.17 13.92 Favored Pre-proline 0 N--CA 1.443 -0.823 0 N-CA-C 108.025 -1.102 . . . . 1.0 108.025 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -63.47 133.65 40.99 Favored 'Trans proline' 0 CA--C 1.513 -0.529 0 N-CA-C 108.904 -1.229 . . . . 1.0 108.904 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.4 p -67.8 -18.22 64.78 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 114.274 1.212 . . . . 1.0 114.274 -176.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -80.18 -2.1 43.29 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.436 0.902 . . . . 1.0 113.436 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.473 ' CD2' ' HB2' ' A' ' 10' ' ' TYR . 32.2 m-85 -95.4 0.58 53.61 Favored 'General case' 0 C--O 1.223 -0.326 0 O-C-N 120.157 -1.589 . . . . 1.0 113.317 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 m -138.57 163.03 28.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 118.698 0.681 . . . . 1.0 111.813 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.3 p -129.92 130.76 45.54 Favored 'General case' 0 C--O 1.213 -0.818 0 C-N-CA 123.985 0.914 . . . . 1.0 108.562 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -59.33 141.67 53.94 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 119.628 -0.829 . . . . 1.0 111.073 -177.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.53 -164.68 54.62 Favored Glycine 0 C--O 1.247 0.914 0 CA-C-N 115.336 -0.847 . . . . 1.0 113.455 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.296 0 CA-C-O 117.563 -1.208 . . . . 1.0 111.342 -176.902 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.373 0.13 . . . . 1.0 111.002 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -76.82 171.02 18.75 Favored 'Trans proline' 0 C--N 1.317 -1.106 1 C-N-CA 127.285 5.323 . . . . 1.0 109.635 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.36 165.5 12.65 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.809 0.814 . . . . 1.0 109.712 169.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.77 164.08 31.52 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.292 -0.867 . . . . 1.0 111.487 -176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.5 p -114.97 134.34 55.26 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.0 137.61 51.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.98 0.895 . . . . 1.0 110.532 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -104.25 -25.17 13.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.263 -0.88 . . . . 1.0 111.538 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -138.95 148.27 43.31 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 106.775 -1.565 . . . . 1.0 106.775 -178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -68.55 137.75 54.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -127.04 123.83 37.92 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.744 -1.206 . . . . 1.0 107.744 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -99.52 113.54 25.99 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 124.306 1.004 . . . . 1.0 110.651 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.438 ' H ' ' HG1' ' A' ' 19' ' ' THR . . . -60.34 136.97 58.2 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.226 -0.99 . . . . 1.0 111.001 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.95 -4.94 20.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.187 -0.915 . . . . 1.0 110.343 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -132.35 162.34 31.31 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.268 -1.012 . . . . 1.0 108.268 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -66.86 -31.76 72.59 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 113.885 1.068 . . . . 1.0 113.885 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -88.22 8.01 29.22 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 12' ' ' ALA . 96.3 mt-10 -100.67 139.59 36.14 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 112.567 0.58 . . . . 1.0 112.567 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.7 tp -74.78 134.93 41.73 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.682 0.753 . . . . 1.0 110.403 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.438 ' HG1' ' H ' ' A' ' 12' ' ' ALA . 99.5 m -110.5 128.63 55.71 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 105.939 -1.874 . . . . 1.0 105.939 176.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -155.78 169.32 24.64 Favored 'General case' 0 CA--C 1.503 -0.86 0 O-C-N 123.898 0.749 . . . . 1.0 110.112 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.5 m -120.4 160.82 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.687 0.617 . . . . 1.0 109.794 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.39 136.89 6.92 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.62 -0.881 . . . . 1.0 108.62 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 80.39 -8.92 1.44 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.757 2.132 . . . . 1.0 116.757 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.07 147.51 53.08 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.259 -0.976 . . . . 1.0 109.068 170.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.59 139.57 32.48 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.003 0.43 . . . . 1.0 111.642 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.53 124.95 73.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.788 -2.671 . . . . 1.0 103.788 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 pt -115.65 165.86 10.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.648 0.737 . . . . 1.0 112.015 -172.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.1 50.94 18.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.947 0.879 . . . . 1.0 111.058 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.11 130.56 34.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.882 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -117.36 122.83 44.94 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.094 -1.447 . . . . 1.0 107.094 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -77.3 77.01 3.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.554 0.692 . . . . 1.0 109.152 -175.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.2 t -65.12 -45.27 94.64 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 N-CA-C 113.818 1.044 . . . . 1.0 113.818 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -135.35 177.1 8.08 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 106.759 -1.571 . . . . 1.0 106.759 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -71.05 -29.96 65.99 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 121.037 0.446 . . . . 1.0 111.626 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -111.23 -28.18 8.37 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 114.957 1.466 . . . . 1.0 114.957 -176.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 51.5 m95 -111.97 128.24 56.11 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.625 -1.25 . . . . 1.0 107.625 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -117.14 156.1 28.21 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.161 -1.051 . . . . 1.0 108.161 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.4 tp -106.2 128.22 53.78 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.361 -0.977 . . . . 1.0 108.361 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -150.24 172.51 30.05 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 119.788 -1.196 . . . . 1.0 111.904 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.415 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 77.7 tt0 -120.72 139.35 53.19 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.873 0.869 . . . . 1.0 109.302 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.6 mt -75.2 132.24 40.98 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.203 -0.999 . . . . 1.0 112.267 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.82 -38.56 75.82 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.013 -0.675 . . . . 1.0 110.547 172.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -74.73 -21.64 59.26 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 115.91 1.818 . . . . 1.0 115.91 -168.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.85 -0.62 0.81 Allowed 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 116.146 1.906 . . . . 1.0 116.146 -174.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.85 1.7 79.34 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.65 -1.262 . . . . 1.0 115.461 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.0 p -70.04 150.92 46.12 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 119.589 1.695 . . . . 1.0 108.602 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.415 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.31 149.95 51.77 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 109.241 -0.652 . . . . 1.0 109.241 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.43 172.69 34.02 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.559 -0.829 . . . . 1.0 112.749 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.0 mt -73.13 142.17 47.48 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 114.636 -0.782 . . . . 1.0 111.588 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -143.94 142.31 20.1 Favored Pre-proline 0 C--O 1.245 0.862 0 N-CA-C 108.015 -1.106 . . . . 1.0 108.015 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -65.14 133.65 36.29 Favored 'Trans proline' 0 CA--C 1.513 -0.564 0 N-CA-C 108.855 -1.248 . . . . 1.0 108.855 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.4 p -67.94 -14.81 63.26 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 114.264 1.209 . . . . 1.0 114.264 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -88.78 6.05 40.66 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.402 0.89 . . . . 1.0 113.402 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -101.53 -0.94 34.13 Favored 'General case' 0 C--O 1.221 -0.4 0 O-C-N 120.186 -1.571 . . . . 1.0 113.361 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.3 m -137.81 164.96 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.532 0.682 . . . . 1.0 111.733 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.0 p -129.43 130.85 46.46 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 108.565 -0.902 . . . . 1.0 108.565 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -59.14 141.74 53.38 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.779 0.8 . . . . 1.0 111.13 -177.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.5 -164.7 54.6 Favored Glycine 0 C--O 1.246 0.904 0 CA-C-N 115.359 -0.837 . . . . 1.0 113.491 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.253 1.262 0 CA-C-O 117.581 -1.199 . . . . 1.0 111.43 -176.989 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 120.367 0.127 . . . . 1.0 111.02 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -76.94 171.0 18.75 Favored 'Trans proline' 0 C--N 1.317 -1.109 1 C-N-CA 127.273 5.316 . . . . 1.0 109.614 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.39 165.41 12.75 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.743 0.782 . . . . 1.0 109.724 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.77 164.06 31.57 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.354 -0.839 . . . . 1.0 111.526 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.4 m -115.93 128.03 55.44 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.262 -1.014 . . . . 1.0 108.262 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.17 135.69 55.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.992 0.901 . . . . 1.0 110.501 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -99.37 -24.87 14.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.185 -0.916 . . . . 1.0 111.531 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -140.29 149.81 43.26 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 106.787 -1.56 . . . . 1.0 106.787 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -66.11 136.21 55.65 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.904 -0.776 . . . . 1.0 108.904 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -128.85 123.47 32.83 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 107.757 -1.201 . . . . 1.0 107.757 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -102.28 119.47 38.86 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 124.279 0.987 . . . . 1.0 110.748 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 17' ' ' GLU . . . -60.62 136.29 58.01 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.216 -0.994 . . . . 1.0 111.088 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.75 -3.37 22.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.269 -0.878 . . . . 1.0 110.307 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -136.11 164.6 27.65 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.212 -1.033 . . . . 1.0 108.212 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -65.02 -32.48 74.22 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 113.863 1.06 . . . . 1.0 113.863 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -87.34 4.88 41.2 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.556 1.317 . . . . 1.0 114.556 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 80.7 mm-40 -101.73 137.08 40.51 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 112.525 0.565 . . . . 1.0 112.525 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.0 mt -75.58 147.02 39.95 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.729 0.776 . . . . 1.0 110.39 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.5 m -115.43 129.47 56.58 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 105.853 -1.906 . . . . 1.0 105.853 175.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -153.9 169.29 23.8 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 123.353 0.408 . . . . 1.0 110.09 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.33 160.79 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.681 0.613 . . . . 1.0 109.86 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.24 136.81 6.73 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.605 -0.887 . . . . 1.0 108.605 176.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 80.43 -8.94 1.43 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.745 2.128 . . . . 1.0 116.745 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -67.07 147.63 52.92 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.245 -0.982 . . . . 1.0 109.038 170.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.7 139.54 32.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.06 0.457 . . . . 1.0 111.609 175.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.56 124.99 73.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.782 -2.673 . . . . 1.0 103.782 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.4 pt -115.69 165.9 10.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.642 0.734 . . . . 1.0 112.021 -172.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 51.03 50.97 18.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.928 0.87 . . . . 1.0 111.154 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 97.1 mt -69.22 130.19 34.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.48 -0.782 . . . . 1.0 110.865 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -113.86 128.2 56.31 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.114 -1.439 . . . . 1.0 107.114 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -77.68 70.45 4.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.651 0.739 . . . . 1.0 109.163 -175.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 65.2 t -68.1 -43.83 84.93 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 N-CA-C 113.889 1.07 . . . . 1.0 113.889 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -139.08 161.4 37.47 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.765 -1.569 . . . . 1.0 106.765 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -64.47 -34.51 78.38 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 121.101 0.477 . . . . 1.0 111.668 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -99.19 -33.18 10.87 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 114.991 1.478 . . . . 1.0 114.991 -176.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.478 ' CH2' ' HG3' ' A' ' 51' ' ' PRO . 30.2 m95 -119.4 132.7 55.88 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.655 -1.239 . . . . 1.0 107.655 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 30.7 m0 -115.99 155.59 27.78 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.105 -1.072 . . . . 1.0 108.105 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.82 128.2 53.58 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.398 -0.964 . . . . 1.0 108.398 178.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.1 -162.82 9.77 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 119.698 -1.239 . . . . 1.0 111.795 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.468 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 76.4 tt0 -140.41 139.35 35.25 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 123.847 0.859 . . . . 1.0 109.298 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.9 mt -75.73 132.25 40.37 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.62 -0.832 . . . . 1.0 112.256 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -57.82 -38.6 75.87 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 119.996 -0.682 . . . . 1.0 110.508 172.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.66 -21.62 59.33 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 115.911 1.819 . . . . 1.0 115.911 -168.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -145.91 -0.63 0.8 Allowed 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 116.105 1.891 . . . . 1.0 116.105 -174.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.93 1.74 79.87 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.649 -1.263 . . . . 1.0 115.428 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.1 150.86 46.12 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 119.589 1.694 . . . . 1.0 108.553 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.468 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.9 mttt -130.2 149.87 51.71 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 -176.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.88 175.97 36.81 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.64 -0.79 . . . . 1.0 112.826 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.7 mt -72.97 147.87 44.78 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.517 -0.841 . . . . 1.0 111.633 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 52.5 p90 -151.34 136.33 10.33 Favored Pre-proline 0 C--O 1.244 0.804 0 N-CA-C 107.952 -1.129 . . . . 1.0 107.952 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.478 ' HG3' ' CH2' ' A' ' 36' ' ' TRP . 30.2 Cg_exo -64.63 130.72 27.23 Favored 'Trans proline' 0 CA--C 1.512 -0.595 0 N-CA-C 108.837 -1.255 . . . . 1.0 108.837 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.2 p -67.35 -17.58 64.8 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.364 1.246 . . . . 1.0 114.364 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.3 p30 -77.51 -3.44 40.53 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.428 0.899 . . . . 1.0 113.428 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -100.85 6.01 43.6 Favored 'General case' 0 C--O 1.221 -0.446 0 O-C-N 120.204 -1.56 . . . . 1.0 113.416 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.1 m -138.61 161.93 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.626 0.727 . . . . 1.0 111.681 -177.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.3 t -132.69 130.62 40.31 Favored 'General case' 0 C--O 1.215 -0.729 0 C-N-CA 123.92 0.888 . . . . 1.0 108.609 176.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.6 mt -59.78 141.65 54.85 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.855 0.836 . . . . 1.0 111.073 -177.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.62 -164.66 54.68 Favored Glycine 0 C--O 1.246 0.876 0 CA-C-N 115.332 -0.849 . . . . 1.0 113.512 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.255 1.352 0 CA-C-O 117.59 -1.195 . . . . 1.0 111.43 -177.03 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.316 0.103 . . . . 1.0 111.077 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.79 170.96 18.87 Favored 'Trans proline' 0 C--N 1.316 -1.165 1 C-N-CA 127.227 5.284 . . . . 1.0 109.717 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.3 165.38 12.76 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.757 0.789 . . . . 1.0 109.771 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.7 164.1 31.4 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.318 -0.856 . . . . 1.0 111.537 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.2 m -117.88 126.83 53.13 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.48 135.32 52.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 122.057 0.932 . . . . 1.0 110.45 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -102.11 -19.55 15.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.073 -0.967 . . . . 1.0 111.583 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -138.21 148.74 45.11 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 106.732 -1.581 . . . . 1.0 106.732 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.98 133.49 50.06 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -128.13 123.45 34.46 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.729 -1.211 . . . . 1.0 107.729 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -103.18 119.31 38.63 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 124.252 0.97 . . . . 1.0 110.841 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.439 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -62.67 135.98 57.65 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.215 -0.994 . . . . 1.0 110.983 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.09 -3.2 21.79 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.22 -0.9 . . . . 1.0 110.337 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -133.05 161.41 34.44 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 108.312 -0.996 . . . . 1.0 108.312 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -64.88 -34.05 77.46 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 113.889 1.07 . . . . 1.0 113.889 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 p30 -86.39 7.12 27.0 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.552 1.316 . . . . 1.0 114.552 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.439 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 97.8 mt-10 -103.74 138.48 40.3 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 112.542 0.571 . . . . 1.0 112.542 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 97.2 mt -73.75 142.22 46.29 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.741 0.782 . . . . 1.0 110.411 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.7 m -111.7 128.3 56.03 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 105.942 -1.873 . . . . 1.0 105.942 175.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -155.57 169.32 24.57 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 120.156 -0.618 . . . . 1.0 110.056 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.1 m -120.34 160.75 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 O-C-N 123.606 0.566 . . . . 1.0 109.881 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.31 136.89 6.78 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.655 -0.868 . . . . 1.0 108.655 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 80.31 -8.85 1.46 Allowed 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 116.824 2.157 . . . . 1.0 116.824 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -67.12 147.63 52.88 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.238 -0.985 . . . . 1.0 109.038 170.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.65 139.56 32.55 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.01 0.433 . . . . 1.0 111.588 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.6 124.91 73.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 103.779 -2.674 . . . . 1.0 103.779 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 pt -115.58 165.84 10.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.685 0.755 . . . . 1.0 112.066 -172.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 51.07 51.01 17.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.973 0.892 . . . . 1.0 111.114 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.3 mt -68.0 128.4 31.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.902 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -113.36 120.03 39.71 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.166 -1.42 . . . . 1.0 107.166 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -75.05 72.35 2.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.654 0.74 . . . . 1.0 109.141 -175.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.56 -37.07 78.8 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.644 0 N-CA-C 113.864 1.061 . . . . 1.0 113.864 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -145.06 167.37 22.85 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.806 -1.553 . . . . 1.0 106.806 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -67.29 -34.23 76.96 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 121.005 0.431 . . . . 1.0 111.673 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -98.18 -39.41 8.89 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 115.03 1.492 . . . . 1.0 115.03 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -110.71 133.25 53.5 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.678 -1.231 . . . . 1.0 107.678 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 52.6 m0 -117.59 153.33 33.43 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 108.242 -1.021 . . . . 1.0 108.242 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.7 tp -100.28 133.27 44.93 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.42 -0.956 . . . . 1.0 108.42 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.8 178.29 31.61 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 119.723 -1.227 . . . . 1.0 111.737 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.448 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 78.9 tt0 -125.62 140.27 52.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.512 -0.844 . . . . 1.0 109.375 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.6 mt -75.48 132.32 40.71 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 119.398 -0.921 . . . . 1.0 112.238 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.86 -38.61 76.01 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.093 -0.643 . . . . 1.0 110.473 172.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.82 -21.51 59.25 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 115.888 1.81 . . . . 1.0 115.888 -168.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.8 p30 -145.95 -0.72 0.79 Allowed 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 116.072 1.879 . . . . 1.0 116.072 -174.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.94 1.71 79.81 Favored Glycine 0 C--O 1.222 -0.636 0 C-N-CA 119.661 -1.257 . . . . 1.0 115.427 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.1 p -70.04 150.87 46.16 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-N 119.589 1.695 . . . . 1.0 108.59 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.448 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.26 149.95 51.72 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 -176.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.98 174.75 36.48 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.568 -0.825 . . . . 1.0 112.751 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.6 mt -73.65 139.36 45.38 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.463 -0.869 . . . . 1.0 111.721 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 51.3 p90 -140.31 150.14 60.27 Favored Pre-proline 0 C--O 1.245 0.854 0 N-CA-C 108.01 -1.108 . . . . 1.0 108.01 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.75 133.86 10.55 Favored 'Trans proline' 0 CA--C 1.513 -0.571 0 N-CA-C 108.836 -1.255 . . . . 1.0 108.836 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.7 m -62.83 -34.95 78.4 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 114.409 1.263 . . . . 1.0 114.409 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -66.44 -7.36 18.97 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.403 0.89 . . . . 1.0 113.403 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -93.53 -0.02 56.47 Favored 'General case' 0 C--O 1.222 -0.344 0 O-C-N 120.211 -1.556 . . . . 1.0 113.337 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.3 m -138.15 163.29 29.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.613 0.721 . . . . 1.0 111.698 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.9 p -132.77 131.17 40.83 Favored 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.6 mt -60.72 141.71 56.59 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.857 0.837 . . . . 1.0 111.039 -176.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.47 -164.65 54.58 Favored Glycine 0 C--O 1.246 0.904 0 CA-C-N 115.337 -0.847 . . . . 1.0 113.473 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.296 0 CA-C-O 117.593 -1.194 . . . . 1.0 111.44 -176.986 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.356 0.122 . . . . 1.0 110.986 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -76.88 171.02 18.74 Favored 'Trans proline' 0 C--N 1.317 -1.109 1 C-N-CA 127.302 5.335 . . . . 1.0 109.604 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.45 165.41 12.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.834 0.826 . . . . 1.0 109.704 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.71 164.09 31.46 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.323 -0.853 . . . . 1.0 111.543 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.5 p -114.64 129.26 56.66 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.159 -1.052 . . . . 1.0 108.159 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.76 134.04 52.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.03 0.919 . . . . 1.0 110.336 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -98.27 -25.46 14.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.144 -0.935 . . . . 1.0 111.525 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -140.19 151.72 45.45 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 106.719 -1.586 . . . . 1.0 106.719 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -67.42 134.87 52.22 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.89 -0.781 . . . . 1.0 108.89 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -127.32 121.87 32.23 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 107.884 -1.154 . . . . 1.0 107.884 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -100.97 116.34 32.6 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.099 -0.955 . . . . 1.0 110.642 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.84 136.82 58.12 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.222 -0.991 . . . . 1.0 111.018 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.74 -4.57 20.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.164 -0.925 . . . . 1.0 110.214 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -134.22 164.74 26.7 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.2 -1.037 . . . . 1.0 108.2 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -66.62 -29.44 69.48 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 113.884 1.068 . . . . 1.0 113.884 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -88.73 5.89 41.25 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.499 1.296 . . . . 1.0 114.499 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -104.45 136.61 43.69 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.321 0.581 . . . . 1.0 112.481 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.9 mt -74.83 145.13 43.1 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.642 0.734 . . . . 1.0 110.418 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.0 m -112.45 129.64 56.26 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 105.921 -1.881 . . . . 1.0 105.921 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -154.92 169.26 24.45 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 120.191 -0.603 . . . . 1.0 110.129 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.7 m -120.35 160.79 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.694 0.621 . . . . 1.0 109.845 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.3 136.85 6.79 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 80.38 -8.93 1.44 Allowed 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 116.82 2.156 . . . . 1.0 116.82 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -67.02 147.55 53.06 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.252 -0.979 . . . . 1.0 109.127 170.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.67 139.58 32.53 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.011 0.434 . . . . 1.0 111.603 175.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.52 124.86 73.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.876 -2.639 . . . . 1.0 103.876 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.1 pt -115.54 165.85 10.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.649 0.738 . . . . 1.0 112.027 -172.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.03 51.03 17.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.994 0.902 . . . . 1.0 111.103 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.6 mt -72.38 129.99 35.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.499 -0.773 . . . . 1.0 110.832 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -112.01 132.38 54.84 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.134 -1.432 . . . . 1.0 107.134 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.458 ' HA ' ' CD1' ' A' ' 37' ' ' TRP . 94.0 m-85 -78.88 69.1 4.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.598 0.713 . . . . 1.0 109.195 -176.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 80.2 t -65.86 -44.56 92.7 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 N-CA-C 113.97 1.1 . . . . 1.0 113.97 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -143.16 162.24 36.11 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 106.781 -1.562 . . . . 1.0 106.781 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -63.95 -34.69 78.54 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 120.942 0.401 . . . . 1.0 111.612 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -94.72 -40.28 9.87 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 115.048 1.499 . . . . 1.0 115.048 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -116.01 139.21 50.5 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.73 -1.211 . . . . 1.0 107.73 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.458 ' CD1' ' HA ' ' A' ' 31' ' ' PHE . 21.6 m0 -122.88 153.24 39.9 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.1 tp -99.21 131.59 45.13 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.78 -168.78 14.89 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 119.644 -1.265 . . . . 1.0 111.717 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.459 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 78.9 tt0 -138.47 139.2 38.72 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.839 0.856 . . . . 1.0 109.289 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.4 mt -76.04 132.26 40.01 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 119.237 -0.985 . . . . 1.0 112.297 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.76 -38.57 75.63 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 120.041 -0.664 . . . . 1.0 110.54 172.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.85 -21.54 59.21 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 115.884 1.809 . . . . 1.0 115.884 -168.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.8 p30 -145.82 -0.8 0.8 Allowed 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 116.119 1.896 . . . . 1.0 116.119 -174.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.87 1.79 79.74 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.715 -1.231 . . . . 1.0 115.445 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.7 p -70.05 150.91 46.12 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 119.572 1.686 . . . . 1.0 108.584 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.459 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.23 149.88 51.73 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.69 174.76 36.28 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.574 -0.822 . . . . 1.0 112.824 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.3 mt -73.09 139.24 46.35 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.579 -0.811 . . . . 1.0 111.554 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -139.16 149.12 59.91 Favored Pre-proline 0 N--CA 1.443 -0.778 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -79.85 129.66 8.2 Favored 'Trans proline' 0 CA--C 1.512 -0.606 0 N-CA-C 108.808 -1.266 . . . . 1.0 108.808 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.7 m -60.42 -34.74 74.4 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 -176.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -66.44 -6.57 15.07 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.54 0.941 . . . . 1.0 113.54 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -94.14 -0.12 55.46 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 120.078 -1.638 . . . . 1.0 113.4 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.0 m -138.4 162.97 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.7 0.762 . . . . 1.0 111.732 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.5 t -131.42 130.81 43.02 Favored 'General case' 0 C--O 1.214 -0.782 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -60.28 141.62 55.86 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.816 0.817 . . . . 1.0 111.086 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.55 -164.63 54.64 Favored Glycine 0 C--O 1.248 0.988 0 CA-C-N 115.371 -0.831 . . . . 1.0 113.501 177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.255 1.363 0 CA-C-O 117.496 -1.24 . . . . 1.0 111.395 -176.977 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.329 0.109 . . . . 1.0 110.955 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -76.94 171.04 18.69 Favored 'Trans proline' 0 C--N 1.317 -1.109 1 C-N-CA 127.273 5.316 . . . . 1.0 109.614 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -114.42 165.36 12.81 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.788 0.804 . . . . 1.0 109.66 169.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.7 164.11 31.38 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.273 -0.876 . . . . 1.0 111.481 -176.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.9 m -119.59 128.61 54.06 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.205 -1.035 . . . . 1.0 108.205 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.39 140.27 50.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.069 0.937 . . . . 1.0 110.431 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -102.89 -16.68 15.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.053 -0.976 . . . . 1.0 111.539 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -141.54 151.53 43.31 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 106.732 -1.581 . . . . 1.0 106.732 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -68.81 137.43 53.95 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -129.02 125.03 36.46 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.723 -1.214 . . . . 1.0 107.723 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -104.1 117.13 33.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.059 -0.973 . . . . 1.0 110.64 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.57 ' H ' ' HG1' ' A' ' 19' ' ' THR . . . -58.17 134.54 56.58 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 119.181 -1.008 . . . . 1.0 110.984 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.07 -5.05 26.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.079 -0.964 . . . . 1.0 110.313 176.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -137.2 165.2 26.67 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.266 -1.013 . . . . 1.0 108.266 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -65.95 -32.39 73.85 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 113.884 1.068 . . . . 1.0 113.884 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -84.98 7.1 22.45 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 114.481 1.289 . . . . 1.0 114.481 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.403 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 98.8 mt-10 -106.42 138.9 41.77 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.376 0.608 . . . . 1.0 112.495 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.61 140.49 42.65 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.687 0.756 . . . . 1.0 110.411 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.57 ' HG1' ' H ' ' A' ' 12' ' ' ALA . 94.0 m -107.51 128.39 54.46 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 105.859 -1.904 . . . . 1.0 105.859 175.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -154.63 169.27 24.28 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.074 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.1 m -120.28 160.78 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 O-C-N 123.626 0.579 . . . . 1.0 109.874 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.39 136.85 6.95 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.62 -0.881 . . . . 1.0 108.62 176.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 80.45 -8.92 1.43 Allowed 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 116.783 2.142 . . . . 1.0 116.783 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.04 147.61 52.97 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.259 -0.976 . . . . 1.0 109.038 170.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.65 139.59 32.5 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.047 0.451 . . . . 1.0 111.594 175.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.59 124.94 73.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 103.841 -2.651 . . . . 1.0 103.841 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 pt -115.64 165.81 10.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-O 121.625 0.726 . . . . 1.0 112.027 -172.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 51.14 50.97 17.96 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.982 0.896 . . . . 1.0 111.022 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.8 mt -71.75 131.07 35.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.96 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -112.65 133.53 54.63 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.065 -1.457 . . . . 1.0 107.065 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -79.34 68.67 5.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.66 0.743 . . . . 1.0 109.145 -176.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.9 t -64.86 -44.3 96.28 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 N-CA-C 113.873 1.064 . . . . 1.0 113.873 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -143.49 163.84 32.02 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.762 -1.57 . . . . 1.0 106.762 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -64.34 -32.57 74.23 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 120.976 0.417 . . . . 1.0 111.585 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -102.11 -36.28 8.61 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 114.946 1.462 . . . . 1.0 114.946 -177.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -111.76 133.56 53.91 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 16.3 m0 -117.95 158.05 25.61 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.199 -1.037 . . . . 1.0 108.199 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.1 tp -110.44 126.5 54.38 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.51 -170.0 14.7 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 119.694 -1.241 . . . . 1.0 111.853 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -133.05 139.26 47.09 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 123.733 0.813 . . . . 1.0 109.345 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.9 mt -74.87 132.28 41.38 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 118.801 -1.159 . . . . 1.0 112.308 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -57.82 -38.59 75.84 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 120.081 -0.648 . . . . 1.0 110.543 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.84 -21.53 59.21 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 115.849 1.796 . . . . 1.0 115.849 -168.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.86 -0.75 0.8 Allowed 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 116.023 1.86 . . . . 1.0 116.023 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.91 1.77 79.84 Favored Glycine 0 C--O 1.223 -0.566 0 C-N-CA 119.657 -1.259 . . . . 1.0 115.449 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.07 150.87 46.13 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 119.598 1.699 . . . . 1.0 108.602 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -130.21 149.97 51.67 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 -176.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.37 175.22 36.48 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.607 -0.806 . . . . 1.0 112.789 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.29 137.39 46.68 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.52 -0.84 . . . . 1.0 111.599 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 39.3 p90 -138.41 146.8 52.73 Favored Pre-proline 0 C--O 1.244 0.804 0 N-CA-C 108.088 -1.079 . . . . 1.0 108.088 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.516 ' HG2' ' CD1' ' A' ' 54' ' ' TYR . 57.8 Cg_endo -77.78 129.26 9.83 Favored 'Trans proline' 0 CA--C 1.512 -0.597 0 N-CA-C 108.83 -1.258 . . . . 1.0 108.83 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.5 m -61.8 -36.18 80.37 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 114.36 1.244 . . . . 1.0 114.36 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -64.3 -7.51 9.73 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.477 0.917 . . . . 1.0 113.477 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.516 ' CD1' ' HG2' ' A' ' 51' ' ' PRO . 15.5 m-85 -94.12 -0.14 55.48 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 120.198 -1.563 . . . . 1.0 113.316 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.36 161.66 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.605 0.717 . . . . 1.0 111.847 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.7 t -129.4 129.82 45.21 Favored 'General case' 0 C--O 1.214 -0.806 0 C-N-CA 124.054 0.941 . . . . 1.0 108.553 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.8 mt -58.85 141.71 52.52 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.762 0.791 . . . . 1.0 111.108 -177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.53 -164.64 54.62 Favored Glycine 0 C--O 1.246 0.876 0 CA-C-N 115.377 -0.828 . . . . 1.0 113.547 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.318 0 CA-C-O 117.624 -1.179 . . . . 1.0 111.411 -176.998 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.329 0.109 . . . . 1.0 110.979 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -76.86 170.97 18.83 Favored 'Trans proline' 0 C--N 1.316 -1.144 1 C-N-CA 127.302 5.334 . . . . 1.0 109.637 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.38 165.38 12.78 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.788 0.804 . . . . 1.0 109.679 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.73 164.09 31.45 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.273 -0.876 . . . . 1.0 111.515 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.4 p -115.37 131.1 57.04 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.132 -1.062 . . . . 1.0 108.132 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.69 136.83 56.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.947 0.88 . . . . 1.0 110.49 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -101.19 -25.38 14.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.167 -0.924 . . . . 1.0 111.578 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -139.77 153.21 47.1 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 106.741 -1.578 . . . . 1.0 106.741 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -69.17 133.72 48.34 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.928 -0.768 . . . . 1.0 108.928 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -129.14 121.0 26.84 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -101.08 119.96 39.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.048 -0.978 . . . . 1.0 110.62 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.25 135.65 57.79 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 119.204 -0.999 . . . . 1.0 110.929 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.87 -2.58 19.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.135 -0.939 . . . . 1.0 110.277 176.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -136.58 164.66 27.67 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.295 -1.002 . . . . 1.0 108.295 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -65.24 -33.97 77.24 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 113.904 1.075 . . . . 1.0 113.904 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.6 p-10 -85.86 2.35 46.22 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 114.496 1.295 . . . . 1.0 114.496 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -100.12 137.68 38.24 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.331 0.586 . . . . 1.0 112.466 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.8 mt -76.29 147.22 38.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.715 0.769 . . . . 1.0 110.423 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.0 m -114.91 127.47 55.72 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 105.924 -1.88 . . . . 1.0 105.924 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -154.09 169.28 23.93 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 123.477 0.485 . . . . 1.0 110.056 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.8 m -120.31 160.85 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 O-C-N 123.67 0.606 . . . . 1.0 109.89 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -46.39 136.92 6.9 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 80.41 -8.96 1.43 Allowed 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 116.783 2.142 . . . . 1.0 116.783 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -67.04 147.64 52.93 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.258 -0.977 . . . . 1.0 109.051 170.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.66 139.61 32.49 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.019 0.438 . . . . 1.0 111.588 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.64 124.96 73.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 103.792 -2.67 . . . . 1.0 103.792 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 pt -115.64 165.86 10.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.655 0.741 . . . . 1.0 112.031 -172.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 51.08 51.02 17.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.013 0.911 . . . . 1.0 111.042 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.5 mt -72.75 131.29 35.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.873 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -112.8 134.29 54.39 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.036 -1.468 . . . . 1.0 107.036 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.416 ' HA ' ' CD1' ' A' ' 37' ' ' TRP . 94.0 m-85 -78.68 68.04 4.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.701 0.762 . . . . 1.0 109.246 -176.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.6 t -65.27 -44.32 95.01 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.703 0 N-CA-C 113.946 1.091 . . . . 1.0 113.946 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -143.42 162.99 34.32 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.702 -1.592 . . . . 1.0 106.702 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -64.56 -35.68 81.77 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 120.922 0.391 . . . . 1.0 111.594 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -96.28 -42.02 8.37 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.959 1.466 . . . . 1.0 114.959 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -113.26 136.89 52.25 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.633 -1.247 . . . . 1.0 107.633 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 17.6 m0 -120.52 160.02 24.01 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.139 -1.06 . . . . 1.0 108.139 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.0 tp -107.68 131.06 54.81 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.72 -170.8 16.87 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 119.65 -1.262 . . . . 1.0 111.836 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.44 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 78.3 tt0 -133.67 139.3 46.36 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 123.797 0.839 . . . . 1.0 109.374 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.7 mt -75.81 132.22 40.26 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 119.311 -0.956 . . . . 1.0 112.266 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -57.77 -38.62 75.74 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 120.072 -0.651 . . . . 1.0 110.556 172.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.81 -21.55 59.23 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 115.898 1.814 . . . . 1.0 115.898 -168.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.9 -0.66 0.8 Allowed 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 116.082 1.882 . . . . 1.0 116.082 -174.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.93 1.71 79.81 Favored Glycine 0 C--O 1.223 -0.566 0 C-N-CA 119.588 -1.292 . . . . 1.0 115.446 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.05 150.84 46.19 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 119.615 1.708 . . . . 1.0 108.546 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.22 149.9 51.71 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 109.373 -0.602 . . . . 1.0 109.373 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.47 178.99 39.5 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.582 -0.818 . . . . 1.0 112.772 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.9 mp -73.33 146.03 45.55 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.551 -0.825 . . . . 1.0 111.608 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 44.0 p90 -146.57 150.48 40.37 Favored Pre-proline 0 C--O 1.245 0.827 0 N-CA-C 108.053 -1.091 . . . . 1.0 108.053 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.413 ' HG2' ' CD1' ' A' ' 54' ' ' TYR . 61.4 Cg_endo -82.62 127.08 4.86 Favored 'Trans proline' 0 CA--C 1.513 -0.572 0 N-CA-C 108.784 -1.275 . . . . 1.0 108.784 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.6 m -59.05 -36.9 75.83 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 114.383 1.253 . . . . 1.0 114.383 -177.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -65.32 -6.5 10.08 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.403 0.89 . . . . 1.0 113.403 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.413 ' CD1' ' HG2' ' A' ' 51' ' ' PRO . 16.3 m-85 -92.63 -2.83 55.8 Favored 'General case' 0 C--O 1.222 -0.374 0 O-C-N 120.275 -1.516 . . . . 1.0 113.434 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.1 m -138.3 162.11 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.617 0.722 . . . . 1.0 111.774 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 56.3 m -127.63 130.36 48.83 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 123.995 0.918 . . . . 1.0 108.596 177.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.8 mt -58.36 141.76 50.27 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.836 0.827 . . . . 1.0 111.074 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.42 -164.61 54.55 Favored Glycine 0 C--O 1.246 0.904 0 CA-C-N 115.401 -0.818 . . . . 1.0 113.546 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.318 0 CA-C-O 117.619 -1.181 . . . . 1.0 111.44 -177.023 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo . . . . . 0 CA--C 1.515 -0.431 0 N-CA-C 109.614 -0.956 . . . . 1.0 109.614 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.37 165.44 12.71 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.795 0.807 . . . . 1.0 109.696 169.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.74 164.12 31.37 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.256 -0.884 . . . . 1.0 111.537 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 58' ' ' GLY . 4.5 p -104.05 162.2 13.36 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 177.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.511 ' HB3' ' N ' ' A' ' 23' ' ' ASN . . . -92.77 109.77 21.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.103 0.954 . . . . 1.0 110.459 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -70.84 -42.3 70.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.192 -0.913 . . . . 1.0 111.6 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -137.72 155.89 48.59 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 106.744 -1.576 . . . . 1.0 106.744 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -67.03 133.58 50.2 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 175.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -127.45 124.42 38.37 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.777 -1.194 . . . . 1.0 107.777 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -103.25 118.78 37.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.04 -0.982 . . . . 1.0 110.647 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -62.31 136.5 57.95 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.146 -1.022 . . . . 1.0 111.012 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.28 5.96 22.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.361 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -140.29 159.96 41.04 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -63.36 -33.84 76.41 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 113.849 1.055 . . . . 1.0 113.849 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -88.08 6.63 35.37 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.415 1.265 . . . . 1.0 114.415 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 99.2 mt-10 -103.27 139.57 38.54 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.328 0.585 . . . . 1.0 112.51 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.07 145.1 36.03 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.697 0.76 . . . . 1.0 110.367 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.9 m -112.83 130.37 56.11 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 105.92 -1.882 . . . . 1.0 105.92 175.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -156.21 169.3 24.85 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.112 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.7 m -120.34 160.8 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 O-C-N 123.694 0.621 . . . . 1.0 109.874 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.36 136.88 6.87 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.511 ' N ' ' HB3' ' A' ' 6' ' ' ALA . 90.6 m-20 80.39 -8.92 1.44 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.757 2.132 . . . . 1.0 116.757 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.04 147.62 52.96 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.259 -0.976 . . . . 1.0 109.038 170.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.72 139.54 32.63 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.048 0.451 . . . . 1.0 111.596 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.53 125.0 73.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 103.83 -2.656 . . . . 1.0 103.83 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 pt -115.66 165.84 10.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-O 121.618 0.723 . . . . 1.0 111.972 -172.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.08 50.99 17.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.982 0.896 . . . . 1.0 111.042 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.4 mt -70.69 131.25 34.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.868 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -112.51 132.84 54.89 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 107.092 -1.447 . . . . 1.0 107.092 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.487 ' HA ' ' CD1' ' A' ' 37' ' ' TRP . 90.1 m-85 -78.85 68.68 4.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.632 0.73 . . . . 1.0 109.174 -176.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.5 t -66.56 -43.85 90.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 113.872 1.064 . . . . 1.0 113.872 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -143.24 162.03 36.72 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.799 -1.556 . . . . 1.0 106.799 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -64.64 -33.13 75.22 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 120.948 0.404 . . . . 1.0 111.575 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -96.56 -39.61 9.45 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 115.076 1.51 . . . . 1.0 115.076 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 43.5 m95 -117.76 141.3 48.56 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.668 -1.234 . . . . 1.0 107.668 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.487 ' CD1' ' HA ' ' A' ' 31' ' ' PHE . 17.5 m0 -126.57 154.88 43.3 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.165 -1.05 . . . . 1.0 108.165 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.5 tp -99.43 128.83 45.57 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.374 -0.973 . . . . 1.0 108.374 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.59 -162.54 9.55 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 119.78 -1.2 . . . . 1.0 111.819 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.456 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 77.1 tt0 -141.92 138.52 32.07 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 123.837 0.855 . . . . 1.0 109.251 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.4 mt -75.3 132.25 40.87 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.287 -0.965 . . . . 1.0 112.256 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.82 -38.52 75.74 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.013 -0.675 . . . . 1.0 110.547 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.84 -21.54 59.21 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 115.884 1.809 . . . . 1.0 115.884 -168.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.87 -0.72 0.8 Allowed 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 116.155 1.909 . . . . 1.0 116.155 -174.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.9 1.76 79.77 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.65 -1.262 . . . . 1.0 115.495 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.04 150.87 46.17 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 119.541 1.67 . . . . 1.0 108.602 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.456 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.25 149.94 51.72 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 109.276 -0.639 . . . . 1.0 109.276 -176.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.42 175.17 36.47 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.579 -0.82 . . . . 1.0 112.825 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.3 mt -72.49 139.45 47.65 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.535 -0.832 . . . . 1.0 111.595 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 49.5 p90 -139.86 149.41 58.99 Favored Pre-proline 0 C--O 1.245 0.837 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.404 ' HG2' ' CD1' ' A' ' 54' ' ' TYR . 61.5 Cg_endo -82.11 134.11 7.97 Favored 'Trans proline' 0 CA--C 1.512 -0.589 0 N-CA-C 108.857 -1.247 . . . . 1.0 108.857 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.6 m -63.86 -37.91 89.13 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 114.277 1.214 . . . . 1.0 114.277 -176.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -61.77 -8.54 4.9 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.463 0.912 . . . . 1.0 113.463 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.404 ' CD1' ' HG2' ' A' ' 51' ' ' PRO . 23.3 m-85 -94.7 -0.24 54.49 Favored 'General case' 0 C--O 1.222 -0.379 0 O-C-N 120.184 -1.572 . . . . 1.0 113.398 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.9 m -137.76 159.01 34.19 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-O 121.606 0.717 . . . . 1.0 111.722 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.6 t -128.8 129.63 45.91 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 108.546 -0.909 . . . . 1.0 108.546 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -59.07 141.67 53.43 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.783 0.801 . . . . 1.0 111.073 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 5' ' ' THR . . . 72.54 -164.63 54.63 Favored Glycine 0 C--O 1.246 0.876 0 CA-C-N 115.354 -0.839 . . . . 1.0 113.453 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.255 1.352 0 CA-C-O 117.59 -1.195 . . . . 1.0 111.43 -176.984 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 CA--C 1.515 -0.447 0 N-CA-C 109.673 -0.933 . . . . 1.0 109.673 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -114.38 165.38 12.78 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.788 0.804 . . . . 1.0 109.679 169.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.75 164.08 31.5 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.273 -0.876 . . . . 1.0 111.478 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.8 p -114.8 132.48 56.46 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.25 133.95 50.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.989 0.9 . . . . 1.0 110.402 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -99.24 -28.48 13.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.141 -0.936 . . . . 1.0 111.543 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -137.68 150.07 47.04 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 106.707 -1.59 . . . . 1.0 106.707 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -65.9 134.07 52.24 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -126.68 124.21 39.31 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 107.781 -1.192 . . . . 1.0 107.781 177.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -101.03 116.1 32.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.089 -0.96 . . . . 1.0 110.694 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.98 137.65 58.33 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.194 -1.003 . . . . 1.0 111.035 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -113.36 5.66 16.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.207 -0.906 . . . . 1.0 110.34 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -137.27 159.69 41.2 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.218 -1.03 . . . . 1.0 108.218 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -64.49 -33.92 77.02 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 113.866 1.062 . . . . 1.0 113.866 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -88.71 5.5 42.98 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.482 1.29 . . . . 1.0 114.482 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -100.7 136.9 39.84 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.313 0.578 . . . . 1.0 112.538 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.25 142.49 41.39 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.778 0.799 . . . . 1.0 110.336 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.2 m -110.0 131.2 55.28 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 105.969 -1.863 . . . . 1.0 105.969 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -155.68 169.26 24.74 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 120.402 -0.519 . . . . 1.0 110.129 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.4 m -120.37 160.77 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.694 0.621 . . . . 1.0 109.817 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.28 136.86 6.75 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 80.39 -8.92 1.44 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.757 2.132 . . . . 1.0 116.757 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.05 147.64 52.92 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.245 -0.982 . . . . 1.0 109.051 170.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.68 139.5 32.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.018 0.437 . . . . 1.0 111.627 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.412 HG21 ' CE1' ' A' ' 50' ' ' PHE . 4.5 mp -117.56 125.0 73.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 103.745 -2.687 . . . . 1.0 103.745 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 pt -115.7 165.88 10.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.667 0.746 . . . . 1.0 111.931 -172.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 51.1 50.94 18.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.978 0.894 . . . . 1.0 111.058 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.0 mt -68.02 128.8 31.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.934 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -113.0 121.74 45.53 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.051 -1.463 . . . . 1.0 107.051 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -76.19 72.21 2.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.57 0.7 . . . . 1.0 109.204 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.4 t -66.91 -43.82 89.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 113.94 1.089 . . . . 1.0 113.94 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -139.83 164.51 29.78 Favored 'General case' 0 C--O 1.22 -0.494 0 N-CA-C 106.716 -1.587 . . . . 1.0 106.716 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -64.93 -35.45 81.21 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 120.986 0.422 . . . . 1.0 111.648 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -97.49 -33.49 11.35 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 114.986 1.476 . . . . 1.0 114.986 -176.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.415 ' CH2' ' HG3' ' A' ' 51' ' ' PRO . 54.3 m95 -114.28 133.43 55.66 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.731 -1.211 . . . . 1.0 107.731 -178.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 53.0 m0 -116.52 151.0 37.03 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.09 -1.078 . . . . 1.0 108.09 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.9 tp -104.55 124.19 48.86 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.412 -0.958 . . . . 1.0 108.412 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.12 -165.77 11.09 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 119.609 -1.282 . . . . 1.0 111.834 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -140.15 139.7 35.82 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 123.73 0.812 . . . . 1.0 109.284 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.2 mt -76.15 132.25 39.88 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.096 -1.042 . . . . 1.0 112.256 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.76 -38.61 75.72 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.097 -0.641 . . . . 1.0 110.494 172.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.79 -21.6 59.23 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 115.929 1.825 . . . . 1.0 115.929 -168.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.83 -0.71 0.8 Allowed 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 116.084 1.883 . . . . 1.0 116.084 -174.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.87 1.76 79.64 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.673 -1.251 . . . . 1.0 115.43 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.0 p -70.06 150.86 46.15 Favored 'General case' 0 C--O 1.213 -0.851 0 CA-C-N 119.572 1.686 . . . . 1.0 108.577 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -130.23 149.96 51.69 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 109.276 -0.639 . . . . 1.0 109.276 -176.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.56 172.46 34.69 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.57 -0.824 . . . . 1.0 112.806 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.3 mt -75.54 140.36 42.69 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.586 -0.807 . . . . 1.0 111.62 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.412 ' CE1' HG21 ' A' ' 26' ' ' ILE . 50.3 p90 -144.12 139.55 16.01 Favored Pre-proline 0 C--O 1.246 0.875 0 N-CA-C 108.06 -1.089 . . . . 1.0 108.06 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.415 ' HG3' ' CH2' ' A' ' 36' ' ' TRP . 31.2 Cg_exo -62.9 133.83 43.54 Favored 'Trans proline' 0 CA--C 1.512 -0.6 0 N-CA-C 108.762 -1.284 . . . . 1.0 108.762 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 81.5 p -66.84 -17.95 65.14 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 114.368 1.247 . . . . 1.0 114.368 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -81.55 -1.26 45.62 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.435 0.902 . . . . 1.0 113.435 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -95.58 -0.99 51.33 Favored 'General case' 0 C--O 1.222 -0.375 0 O-C-N 120.171 -1.58 . . . . 1.0 113.5 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.8 m -136.54 162.13 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.582 0.706 . . . . 1.0 111.734 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 65.0 p -128.28 130.52 47.99 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 123.944 0.898 . . . . 1.0 108.589 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.5 mt -60.46 141.72 56.05 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.893 0.854 . . . . 1.0 111.017 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.44 -164.61 54.56 Favored Glycine 0 C--O 1.246 0.876 0 CA-C-N 115.34 -0.845 . . . . 1.0 113.549 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.329 0 CA-C-O 117.564 -1.208 . . . . 1.0 111.404 -176.966 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 CA--C 1.516 -0.398 0 N-CA-C 109.574 -0.971 . . . . 1.0 109.574 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.28 165.45 12.68 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.816 0.817 . . . . 1.0 109.668 169.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.77 164.15 31.32 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.234 -0.893 . . . . 1.0 111.453 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 58' ' ' GLY . 25.5 p -115.35 132.9 56.47 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.161 -1.051 . . . . 1.0 108.161 178.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.482 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -67.46 136.72 55.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.987 0.899 . . . . 1.0 110.518 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -100.73 -26.34 13.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.204 -0.907 . . . . 1.0 111.533 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.402 ' HB2' ' CD2' ' A' ' 54' ' ' TYR . 91.5 m-85 -140.33 149.82 43.21 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 106.722 -1.585 . . . . 1.0 106.722 -178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -63.6 132.8 52.33 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.922 -0.769 . . . . 1.0 108.922 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -128.04 125.85 40.14 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.667 -1.234 . . . . 1.0 107.667 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -106.35 119.65 39.8 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 124.29 0.994 . . . . 1.0 110.789 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.459 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -60.39 136.33 58.01 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 119.195 -1.002 . . . . 1.0 111.114 178.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.25 2.8 27.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.229 -0.896 . . . . 1.0 110.298 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -142.53 163.85 31.72 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -65.85 -32.65 74.29 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 113.824 1.046 . . . . 1.0 113.824 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -85.99 5.92 31.09 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.544 1.313 . . . . 1.0 114.544 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 96.4 mt-10 -104.61 139.75 39.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.318 0.58 . . . . 1.0 112.537 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.6 mt -76.91 142.8 39.97 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.785 0.802 . . . . 1.0 110.321 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.2 m -111.06 129.13 56.01 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 105.953 -1.869 . . . . 1.0 105.953 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -156.17 169.28 24.89 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 120.288 -0.565 . . . . 1.0 110.056 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.31 160.79 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 O-C-N 123.628 0.58 . . . . 1.0 109.89 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -46.21 136.78 6.69 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.698 -0.853 . . . . 1.0 108.698 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 80.42 -8.92 1.44 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.757 2.132 . . . . 1.0 116.757 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -66.99 147.59 53.03 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.266 -0.974 . . . . 1.0 109.084 170.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.69 139.59 32.52 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.037 0.446 . . . . 1.0 111.582 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.61 124.98 73.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 103.756 -2.683 . . . . 1.0 103.756 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.1 pt -115.72 165.78 10.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-O 121.659 0.742 . . . . 1.0 111.958 -172.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.14 51.02 17.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.013 0.911 . . . . 1.0 111.042 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.1 mt -71.38 131.13 34.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.934 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -114.84 135.73 53.87 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.995 -1.483 . . . . 1.0 106.995 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -78.31 67.53 4.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.646 0.736 . . . . 1.0 109.164 -176.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.47 -40.86 89.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.885 1.068 . . . . 1.0 113.885 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -144.49 160.06 41.72 Favored 'General case' 0 C--O 1.219 -0.536 0 N-CA-C 106.763 -1.569 . . . . 1.0 106.763 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -63.68 -33.02 74.7 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 120.902 0.382 . . . . 1.0 111.612 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -100.29 -34.53 9.95 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 115.09 1.515 . . . . 1.0 115.09 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 52.2 m95 -111.24 135.29 51.98 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.598 -1.26 . . . . 1.0 107.598 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.425 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . 10.7 m0 -110.36 151.59 27.26 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.147 -1.057 . . . . 1.0 108.147 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.3 tp -108.58 125.95 52.4 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.419 -0.956 . . . . 1.0 108.419 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.99 -165.84 13.5 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 119.767 -1.206 . . . . 1.0 111.884 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.444 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 75.1 tt0 -135.59 141.94 45.22 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 123.75 0.82 . . . . 1.0 109.195 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.9 mt -75.16 132.21 41.0 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.159 -1.016 . . . . 1.0 112.282 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.82 -38.52 75.74 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.013 -0.675 . . . . 1.0 110.547 172.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.75 -21.58 59.27 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 115.912 1.819 . . . . 1.0 115.912 -168.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.94 -0.7 0.79 Allowed 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 116.091 1.886 . . . . 1.0 116.091 -174.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.82 1.79 79.45 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.658 -1.258 . . . . 1.0 115.51 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.0 p -70.04 150.92 46.12 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 119.541 1.67 . . . . 1.0 108.602 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.444 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.31 149.95 51.77 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 109.241 -0.652 . . . . 1.0 109.241 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.11 176.31 37.91 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.568 -0.825 . . . . 1.0 112.776 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -77.51 137.06 38.42 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.516 -0.842 . . . . 1.0 111.613 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.425 ' CE2' ' HB2' ' A' ' 37' ' ' TRP . 50.1 p90 -138.34 150.83 67.94 Favored Pre-proline 0 C--O 1.243 0.743 0 N-CA-C 107.943 -1.132 . . . . 1.0 107.943 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -80.36 129.19 7.46 Favored 'Trans proline' 0 CA--C 1.513 -0.54 0 N-CA-C 108.839 -1.254 . . . . 1.0 108.839 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.8 m -59.9 -34.84 73.72 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 114.344 1.239 . . . . 1.0 114.344 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -61.99 -9.23 6.59 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.489 0.922 . . . . 1.0 113.489 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.402 ' CD2' ' HB2' ' A' ' 8' ' ' TYR . 22.3 m-85 -94.74 1.15 55.45 Favored 'General case' 0 C--O 1.222 -0.356 0 O-C-N 120.243 -1.536 . . . . 1.0 113.405 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.482 HG12 ' HA ' ' A' ' 6' ' ' ALA . 33.7 m -138.01 162.28 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.482 0.658 . . . . 1.0 111.778 -178.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.2 p -133.34 131.59 40.28 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 176.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -60.63 141.72 56.4 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.836 0.827 . . . . 1.0 111.052 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 5' ' ' THR . . . 72.41 -164.67 54.54 Favored Glycine 0 C--O 1.247 0.933 0 CA-C-N 115.36 -0.836 . . . . 1.0 113.57 177.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.255 1.352 0 CA-C-O 117.59 -1.195 . . . . 1.0 111.43 -176.981 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 CA--C 1.515 -0.464 0 N-CA-C 109.634 -0.948 . . . . 1.0 109.634 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.39 165.41 12.74 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.766 0.794 . . . . 1.0 109.74 169.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.7 164.05 31.54 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.348 -0.842 . . . . 1.0 111.549 -176.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.6 m -117.8 128.67 55.09 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.11 -1.07 . . . . 1.0 108.11 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.45 136.74 56.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.995 0.902 . . . . 1.0 110.49 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -101.71 -21.05 14.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.16 -0.927 . . . . 1.0 111.584 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -138.73 151.39 47.08 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 106.818 -1.549 . . . . 1.0 106.818 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -67.22 132.42 47.73 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.847 -0.797 . . . . 1.0 108.847 176.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.482 ' HB2' ' CD2' ' A' ' 54' ' ' TYR . 81.8 t80 -135.34 130.53 35.15 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 107.781 -1.192 . . . . 1.0 107.781 177.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -114.16 134.4 54.93 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.049 -0.978 . . . . 1.0 110.658 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.575 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -67.66 139.05 56.77 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.138 -1.025 . . . . 1.0 111.095 178.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.94 -4.87 18.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.254 -0.885 . . . . 1.0 110.273 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -131.14 166.78 20.36 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 108.26 -1.015 . . . . 1.0 108.26 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -66.81 -34.04 76.93 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 113.876 1.065 . . . . 1.0 113.876 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -87.95 7.56 30.42 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.458 1.281 . . . . 1.0 114.458 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.575 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 99.5 mt-10 -103.84 149.49 25.0 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.27 0.557 . . . . 1.0 112.448 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.457 HD22 ' HG ' ' A' ' 41' ' ' LEU . 75.6 mt -90.24 142.72 27.44 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.63 0.729 . . . . 1.0 110.349 177.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.1 t -109.86 132.19 54.38 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 105.882 -1.896 . . . . 1.0 105.882 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -156.12 169.19 25.07 Favored 'General case' 0 CA--C 1.503 -0.855 0 O-C-N 123.33 0.394 . . . . 1.0 110.13 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.8 m -120.31 160.85 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.683 0.614 . . . . 1.0 109.86 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -46.43 136.81 7.06 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.655 -0.869 . . . . 1.0 108.655 176.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 80.5 -8.92 1.43 Allowed 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 116.783 2.142 . . . . 1.0 116.783 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -66.97 147.6 53.02 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.266 -0.974 . . . . 1.0 109.103 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.7 139.51 32.66 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.996 0.427 . . . . 1.0 111.615 175.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.59 124.94 73.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.81 -2.663 . . . . 1.0 103.81 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 pt -115.68 165.91 10.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-O 121.673 0.749 . . . . 1.0 111.994 -172.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.08 51.02 17.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.013 0.911 . . . . 1.0 111.042 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.93 128.75 32.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.918 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -112.92 123.35 50.12 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.093 -1.447 . . . . 1.0 107.093 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -75.71 72.26 2.63 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.691 0.757 . . . . 1.0 109.127 -175.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.441 HG21 HD22 ' A' ' 38' ' ' LEU . 68.3 t -66.94 -44.64 88.52 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 N-CA-C 113.947 1.092 . . . . 1.0 113.947 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -141.22 163.09 33.9 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 106.745 -1.576 . . . . 1.0 106.745 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -66.1 -34.63 78.5 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.031 0.443 . . . . 1.0 111.508 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -93.2 -37.73 11.94 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 115.031 1.493 . . . . 1.0 115.031 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 33.3 m95 -114.29 135.23 54.29 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.705 -1.22 . . . . 1.0 107.705 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 50.7 m0 -114.19 148.72 36.85 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.233 -1.025 . . . . 1.0 108.233 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.441 HD22 HG21 ' A' ' 32' ' ' VAL . 38.0 tp -103.46 133.78 47.94 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.359 -0.978 . . . . 1.0 108.359 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.67 -166.64 17.42 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 119.746 -1.216 . . . . 1.0 111.884 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.469 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 77.4 tt0 -136.6 140.18 42.65 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.901 0.88 . . . . 1.0 109.327 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.457 ' HG ' HD22 ' A' ' 18' ' ' LEU . 52.6 mt -75.58 132.25 40.55 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.724 -0.791 . . . . 1.0 112.242 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.76 -38.62 75.72 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.097 -0.641 . . . . 1.0 110.494 172.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.74 -21.7 59.21 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 115.851 1.797 . . . . 1.0 115.851 -168.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 51.0 p30 -145.83 -0.71 0.8 Allowed 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 116.096 1.887 . . . . 1.0 116.096 -174.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.92 1.76 79.92 Favored Glycine 0 C--O 1.222 -0.631 0 C-N-CA 119.699 -1.239 . . . . 1.0 115.43 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.05 150.86 46.17 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 119.572 1.686 . . . . 1.0 108.584 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.469 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.2 149.87 51.71 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 -176.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.84 174.37 35.28 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.554 -0.831 . . . . 1.0 112.797 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.5 145.44 43.52 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.598 -0.801 . . . . 1.0 111.544 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -149.52 140.17 13.92 Favored Pre-proline 0 N--CA 1.443 -0.823 0 N-CA-C 108.025 -1.102 . . . . 1.0 108.025 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -63.47 133.65 40.99 Favored 'Trans proline' 0 CA--C 1.513 -0.529 0 N-CA-C 108.904 -1.229 . . . . 1.0 108.904 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.4 p -67.8 -18.22 64.78 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 114.274 1.212 . . . . 1.0 114.274 -176.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -80.18 -2.1 43.29 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.436 0.902 . . . . 1.0 113.436 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.482 ' CD2' ' HB2' ' A' ' 10' ' ' TYR . 32.2 m-85 -95.4 0.58 53.61 Favored 'General case' 0 C--O 1.223 -0.326 0 O-C-N 120.157 -1.589 . . . . 1.0 113.317 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 m -138.57 163.03 28.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 118.698 0.681 . . . . 1.0 111.813 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.3 p -129.92 130.76 45.54 Favored 'General case' 0 C--O 1.213 -0.818 0 C-N-CA 123.985 0.914 . . . . 1.0 108.562 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -59.33 141.67 53.94 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 119.628 -0.829 . . . . 1.0 111.073 -177.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.53 -164.68 54.62 Favored Glycine 0 C--O 1.247 0.914 0 CA-C-N 115.336 -0.847 . . . . 1.0 113.455 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.296 0 CA-C-O 117.563 -1.208 . . . . 1.0 111.342 -176.902 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 CA--C 1.515 -0.464 0 N-CA-C 109.635 -0.948 . . . . 1.0 109.635 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.36 165.5 12.65 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.809 0.814 . . . . 1.0 109.712 169.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.77 164.08 31.52 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.292 -0.867 . . . . 1.0 111.487 -176.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.5 p -114.97 134.34 55.26 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.71 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -70.0 137.61 51.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.98 0.895 . . . . 1.0 110.532 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -104.25 -25.17 13.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.263 -0.88 . . . . 1.0 111.538 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -138.95 148.27 43.31 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 106.775 -1.565 . . . . 1.0 106.775 -178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -68.55 137.75 54.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -127.04 123.83 37.92 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.744 -1.206 . . . . 1.0 107.744 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -99.52 113.54 25.99 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 124.306 1.004 . . . . 1.0 110.651 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.482 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -60.34 136.97 58.2 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.226 -0.99 . . . . 1.0 111.001 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.95 -4.94 20.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.187 -0.915 . . . . 1.0 110.343 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -132.35 162.34 31.31 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.268 -1.012 . . . . 1.0 108.268 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -66.86 -31.76 72.59 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 113.885 1.068 . . . . 1.0 113.885 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -88.22 8.01 29.22 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.482 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 96.3 mt-10 -100.67 139.59 36.14 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 112.567 0.58 . . . . 1.0 112.567 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.845 HD11 ' HG ' ' A' ' 41' ' ' LEU . 12.7 tp -74.78 134.93 41.73 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.682 0.753 . . . . 1.0 110.403 177.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.5 m -110.5 128.63 55.71 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 105.939 -1.874 . . . . 1.0 105.939 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -155.78 169.32 24.64 Favored 'General case' 0 CA--C 1.503 -0.86 0 O-C-N 123.898 0.749 . . . . 1.0 110.112 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.5 m -120.4 160.82 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.687 0.617 . . . . 1.0 109.794 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.39 136.89 6.92 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.62 -0.881 . . . . 1.0 108.62 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 80.39 -8.92 1.44 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.757 2.132 . . . . 1.0 116.757 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.07 147.51 53.08 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.259 -0.976 . . . . 1.0 109.068 170.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.59 139.57 32.48 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.003 0.43 . . . . 1.0 111.642 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.524 HD13 HG11 ' A' ' 55' ' ' VAL . 4.5 mp -117.53 124.95 73.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.788 -2.671 . . . . 1.0 103.788 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 pt -115.65 165.86 10.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.648 0.737 . . . . 1.0 112.015 -172.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.1 50.94 18.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.947 0.879 . . . . 1.0 111.058 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.11 130.56 34.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.882 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -117.36 122.83 44.94 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.094 -1.447 . . . . 1.0 107.094 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -77.3 77.01 3.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.554 0.692 . . . . 1.0 109.152 -175.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.2 t -65.12 -45.27 94.64 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 N-CA-C 113.818 1.044 . . . . 1.0 113.818 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -135.35 177.1 8.08 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 106.759 -1.571 . . . . 1.0 106.759 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -71.05 -29.96 65.99 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 121.037 0.446 . . . . 1.0 111.626 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -111.23 -28.18 8.37 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 114.957 1.466 . . . . 1.0 114.957 -176.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 51.5 m95 -111.97 128.24 56.11 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.625 -1.25 . . . . 1.0 107.625 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -117.14 156.1 28.21 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.161 -1.051 . . . . 1.0 108.161 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.4 tp -106.2 128.22 53.78 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.361 -0.977 . . . . 1.0 108.361 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -150.24 172.51 30.05 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 119.788 -1.196 . . . . 1.0 111.904 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.43 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 77.7 tt0 -120.72 139.35 53.19 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.873 0.869 . . . . 1.0 109.302 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.845 ' HG ' HD11 ' A' ' 18' ' ' LEU . 52.6 mt -75.2 132.24 40.98 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.203 -0.999 . . . . 1.0 112.267 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.82 -38.56 75.82 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.013 -0.675 . . . . 1.0 110.547 172.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -74.73 -21.64 59.26 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 115.91 1.818 . . . . 1.0 115.91 -168.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.85 -0.62 0.81 Allowed 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 116.146 1.906 . . . . 1.0 116.146 -174.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.85 1.7 79.34 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.65 -1.262 . . . . 1.0 115.461 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.0 p -70.04 150.92 46.12 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 119.589 1.695 . . . . 1.0 108.602 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.43 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.31 149.95 51.77 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 109.241 -0.652 . . . . 1.0 109.241 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.43 172.69 34.02 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.559 -0.829 . . . . 1.0 112.749 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.0 mt -73.13 142.17 47.48 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 114.636 -0.782 . . . . 1.0 111.588 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -143.94 142.31 20.1 Favored Pre-proline 0 C--O 1.245 0.862 0 N-CA-C 108.015 -1.106 . . . . 1.0 108.015 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -65.14 133.65 36.29 Favored 'Trans proline' 0 CA--C 1.513 -0.564 0 N-CA-C 108.855 -1.248 . . . . 1.0 108.855 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.4 p -67.94 -14.81 63.26 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 114.264 1.209 . . . . 1.0 114.264 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -88.78 6.05 40.66 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.402 0.89 . . . . 1.0 113.402 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -101.53 -0.94 34.13 Favored 'General case' 0 C--O 1.221 -0.4 0 O-C-N 120.186 -1.571 . . . . 1.0 113.361 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.71 HG12 ' HA ' ' A' ' 6' ' ' ALA . 33.3 m -137.81 164.96 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.532 0.682 . . . . 1.0 111.733 -178.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.0 p -129.43 130.85 46.46 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 108.565 -0.902 . . . . 1.0 108.565 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -59.14 141.74 53.38 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.779 0.8 . . . . 1.0 111.13 -177.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.5 -164.7 54.6 Favored Glycine 0 C--O 1.246 0.904 0 CA-C-N 115.359 -0.837 . . . . 1.0 113.491 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.253 1.262 0 CA-C-O 117.581 -1.199 . . . . 1.0 111.43 -176.989 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo . . . . . 0 CA--C 1.515 -0.431 0 N-CA-C 109.614 -0.956 . . . . 1.0 109.614 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.39 165.41 12.75 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.743 0.782 . . . . 1.0 109.724 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.77 164.06 31.57 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.354 -0.839 . . . . 1.0 111.526 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.4 m -115.93 128.03 55.44 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.262 -1.014 . . . . 1.0 108.262 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.575 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -65.17 135.69 55.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.992 0.901 . . . . 1.0 110.501 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -99.37 -24.87 14.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.185 -0.916 . . . . 1.0 111.531 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -140.29 149.81 43.26 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 106.787 -1.56 . . . . 1.0 106.787 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -66.11 136.21 55.65 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.904 -0.776 . . . . 1.0 108.904 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -128.85 123.47 32.83 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 107.757 -1.201 . . . . 1.0 107.757 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -102.28 119.47 38.86 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 124.279 0.987 . . . . 1.0 110.748 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -60.62 136.29 58.01 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.216 -0.994 . . . . 1.0 111.088 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.75 -3.37 22.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.269 -0.878 . . . . 1.0 110.307 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -136.11 164.6 27.65 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.212 -1.033 . . . . 1.0 108.212 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -65.02 -32.48 74.22 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 113.863 1.06 . . . . 1.0 113.863 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -87.34 4.88 41.2 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.556 1.317 . . . . 1.0 114.556 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.524 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 80.7 mm-40 -101.73 137.08 40.51 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 112.525 0.565 . . . . 1.0 112.525 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.0 mt -75.58 147.02 39.95 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.729 0.776 . . . . 1.0 110.39 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.5 m -115.43 129.47 56.58 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 105.853 -1.906 . . . . 1.0 105.853 175.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -153.9 169.29 23.8 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 123.353 0.408 . . . . 1.0 110.09 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.33 160.79 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.681 0.613 . . . . 1.0 109.86 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.24 136.81 6.73 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.605 -0.887 . . . . 1.0 108.605 176.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 80.43 -8.94 1.43 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.745 2.128 . . . . 1.0 116.745 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -67.07 147.63 52.92 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.245 -0.982 . . . . 1.0 109.038 170.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.7 139.54 32.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.06 0.457 . . . . 1.0 111.609 175.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.56 124.99 73.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.782 -2.673 . . . . 1.0 103.782 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.4 pt -115.69 165.9 10.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.642 0.734 . . . . 1.0 112.021 -172.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 51.03 50.97 18.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.928 0.87 . . . . 1.0 111.154 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 97.1 mt -69.22 130.19 34.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.48 -0.782 . . . . 1.0 110.865 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -113.86 128.2 56.31 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.114 -1.439 . . . . 1.0 107.114 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -77.68 70.45 4.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.651 0.739 . . . . 1.0 109.163 -175.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 65.2 t -68.1 -43.83 84.93 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 N-CA-C 113.889 1.07 . . . . 1.0 113.889 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -139.08 161.4 37.47 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.765 -1.569 . . . . 1.0 106.765 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -64.47 -34.51 78.38 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 121.101 0.477 . . . . 1.0 111.668 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -99.19 -33.18 10.87 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 114.991 1.478 . . . . 1.0 114.991 -176.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.495 ' CH2' ' HG3' ' A' ' 51' ' ' PRO . 30.2 m95 -119.4 132.7 55.88 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.655 -1.239 . . . . 1.0 107.655 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 30.7 m0 -115.99 155.59 27.78 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.105 -1.072 . . . . 1.0 108.105 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.82 128.2 53.58 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.398 -0.964 . . . . 1.0 108.398 178.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.1 -162.82 9.77 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 119.698 -1.239 . . . . 1.0 111.795 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.484 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 76.4 tt0 -140.41 139.35 35.25 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 123.847 0.859 . . . . 1.0 109.298 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.9 mt -75.73 132.25 40.37 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.62 -0.832 . . . . 1.0 112.256 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -57.82 -38.6 75.87 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 119.996 -0.682 . . . . 1.0 110.508 172.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.66 -21.62 59.33 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 115.911 1.819 . . . . 1.0 115.911 -168.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -145.91 -0.63 0.8 Allowed 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 116.105 1.891 . . . . 1.0 116.105 -174.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.93 1.74 79.87 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.649 -1.263 . . . . 1.0 115.428 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.1 150.86 46.12 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 119.589 1.694 . . . . 1.0 108.553 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.484 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.9 mttt -130.2 149.87 51.71 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 -176.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.88 175.97 36.81 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.64 -0.79 . . . . 1.0 112.826 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.7 mt -72.97 147.87 44.78 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.517 -0.841 . . . . 1.0 111.633 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.477 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 52.5 p90 -151.34 136.33 10.33 Favored Pre-proline 0 C--O 1.244 0.804 0 N-CA-C 107.952 -1.129 . . . . 1.0 107.952 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.495 ' HG3' ' CH2' ' A' ' 36' ' ' TRP . 30.2 Cg_exo -64.63 130.72 27.23 Favored 'Trans proline' 0 CA--C 1.512 -0.595 0 N-CA-C 108.837 -1.255 . . . . 1.0 108.837 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.2 p -67.35 -17.58 64.8 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.364 1.246 . . . . 1.0 114.364 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.3 p30 -77.51 -3.44 40.53 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.428 0.899 . . . . 1.0 113.428 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -100.85 6.01 43.6 Favored 'General case' 0 C--O 1.221 -0.446 0 O-C-N 120.204 -1.56 . . . . 1.0 113.416 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 6' ' ' ALA . 34.1 m -138.61 161.93 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.626 0.727 . . . . 1.0 111.681 -177.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.3 t -132.69 130.62 40.31 Favored 'General case' 0 C--O 1.215 -0.729 0 C-N-CA 123.92 0.888 . . . . 1.0 108.609 176.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.6 mt -59.78 141.65 54.85 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.855 0.836 . . . . 1.0 111.073 -177.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.62 -164.66 54.68 Favored Glycine 0 C--O 1.246 0.876 0 CA-C-N 115.332 -0.849 . . . . 1.0 113.512 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.255 1.352 0 CA-C-O 117.59 -1.195 . . . . 1.0 111.43 -177.03 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 CA--C 1.515 -0.447 0 N-CA-C 109.717 -0.917 . . . . 1.0 109.717 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.3 165.38 12.76 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.757 0.789 . . . . 1.0 109.771 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.7 164.1 31.4 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.318 -0.856 . . . . 1.0 111.537 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.2 m -117.88 126.83 53.13 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.42 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -67.48 135.32 52.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 122.057 0.932 . . . . 1.0 110.45 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -102.11 -19.55 15.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.073 -0.967 . . . . 1.0 111.583 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -138.21 148.74 45.11 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 106.732 -1.581 . . . . 1.0 106.732 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.98 133.49 50.06 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -128.13 123.45 34.46 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.729 -1.211 . . . . 1.0 107.729 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -103.18 119.31 38.63 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 124.252 0.97 . . . . 1.0 110.841 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.455 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -62.67 135.98 57.65 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.215 -0.994 . . . . 1.0 110.983 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.09 -3.2 21.79 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.22 -0.9 . . . . 1.0 110.337 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -133.05 161.41 34.44 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 108.312 -0.996 . . . . 1.0 108.312 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -64.88 -34.05 77.46 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 113.889 1.07 . . . . 1.0 113.889 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 p30 -86.39 7.12 27.0 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.552 1.316 . . . . 1.0 114.552 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 97.8 mt-10 -103.74 138.48 40.3 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 112.542 0.571 . . . . 1.0 112.542 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.459 HD11 ' O ' ' A' ' 39' ' ' GLY . 97.2 mt -73.75 142.22 46.29 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.741 0.782 . . . . 1.0 110.411 176.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.7 m -111.7 128.3 56.03 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 105.942 -1.873 . . . . 1.0 105.942 175.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -155.57 169.32 24.57 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 120.156 -0.618 . . . . 1.0 110.056 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.1 m -120.34 160.75 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 O-C-N 123.606 0.566 . . . . 1.0 109.881 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.31 136.89 6.78 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.655 -0.868 . . . . 1.0 108.655 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 80.31 -8.85 1.46 Allowed 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 116.824 2.157 . . . . 1.0 116.824 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -67.12 147.63 52.88 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.238 -0.985 . . . . 1.0 109.038 170.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.65 139.56 32.55 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.01 0.433 . . . . 1.0 111.588 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.6 124.91 73.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 103.779 -2.674 . . . . 1.0 103.779 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 pt -115.58 165.84 10.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.685 0.755 . . . . 1.0 112.066 -172.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 51.07 51.01 17.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.973 0.892 . . . . 1.0 111.114 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.3 mt -68.0 128.4 31.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.902 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -113.36 120.03 39.71 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.166 -1.42 . . . . 1.0 107.166 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -75.05 72.35 2.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.654 0.74 . . . . 1.0 109.141 -175.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.56 -37.07 78.8 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.644 0 N-CA-C 113.864 1.061 . . . . 1.0 113.864 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -145.06 167.37 22.85 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.806 -1.553 . . . . 1.0 106.806 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -67.29 -34.23 76.96 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 121.005 0.431 . . . . 1.0 111.673 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -98.18 -39.41 8.89 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 115.03 1.492 . . . . 1.0 115.03 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -110.71 133.25 53.5 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.678 -1.231 . . . . 1.0 107.678 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 52.6 m0 -117.59 153.33 33.43 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 108.242 -1.021 . . . . 1.0 108.242 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.7 tp -100.28 133.27 44.93 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.42 -0.956 . . . . 1.0 108.42 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.459 ' O ' HD11 ' A' ' 18' ' ' LEU . . . -154.8 178.29 31.61 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 119.723 -1.227 . . . . 1.0 111.737 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.465 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 78.9 tt0 -125.62 140.27 52.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.512 -0.844 . . . . 1.0 109.375 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.6 mt -75.48 132.32 40.71 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 119.398 -0.921 . . . . 1.0 112.238 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.86 -38.61 76.01 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.093 -0.643 . . . . 1.0 110.473 172.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.82 -21.51 59.25 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 115.888 1.81 . . . . 1.0 115.888 -168.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.8 p30 -145.95 -0.72 0.79 Allowed 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 116.072 1.879 . . . . 1.0 116.072 -174.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.94 1.71 79.81 Favored Glycine 0 C--O 1.222 -0.636 0 C-N-CA 119.661 -1.257 . . . . 1.0 115.427 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.1 p -70.04 150.87 46.16 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-N 119.589 1.695 . . . . 1.0 108.59 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.26 149.95 51.72 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 -176.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.98 174.75 36.48 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.568 -0.825 . . . . 1.0 112.751 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.6 mt -73.65 139.36 45.38 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.463 -0.869 . . . . 1.0 111.721 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 51.3 p90 -140.31 150.14 60.27 Favored Pre-proline 0 C--O 1.245 0.854 0 N-CA-C 108.01 -1.108 . . . . 1.0 108.01 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.4 ' HG2' ' CD1' ' A' ' 54' ' ' TYR . 60.4 Cg_endo -79.75 133.86 10.55 Favored 'Trans proline' 0 CA--C 1.513 -0.571 0 N-CA-C 108.836 -1.255 . . . . 1.0 108.836 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.7 m -62.83 -34.95 78.4 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 114.409 1.263 . . . . 1.0 114.409 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -66.44 -7.36 18.97 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.403 0.89 . . . . 1.0 113.403 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.4 ' CD1' ' HG2' ' A' ' 51' ' ' PRO . 24.6 m-85 -93.53 -0.02 56.47 Favored 'General case' 0 C--O 1.222 -0.344 0 O-C-N 120.211 -1.556 . . . . 1.0 113.337 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 6' ' ' ALA . 33.3 m -138.15 163.29 29.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.613 0.721 . . . . 1.0 111.698 -178.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.9 p -132.77 131.17 40.83 Favored 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.6 mt -60.72 141.71 56.59 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.857 0.837 . . . . 1.0 111.039 -176.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.47 -164.65 54.58 Favored Glycine 0 C--O 1.246 0.904 0 CA-C-N 115.337 -0.847 . . . . 1.0 113.473 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.296 0 CA-C-O 117.593 -1.194 . . . . 1.0 111.44 -176.986 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 CA--C 1.515 -0.43 0 N-CA-C 109.604 -0.96 . . . . 1.0 109.604 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.45 165.41 12.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.834 0.826 . . . . 1.0 109.704 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.71 164.09 31.46 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.323 -0.853 . . . . 1.0 111.543 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.5 p -114.64 129.26 56.66 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.159 -1.052 . . . . 1.0 108.159 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.64 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -65.76 134.04 52.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.03 0.919 . . . . 1.0 110.336 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -98.27 -25.46 14.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.144 -0.935 . . . . 1.0 111.525 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -140.19 151.72 45.45 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 106.719 -1.586 . . . . 1.0 106.719 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -67.42 134.87 52.22 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.89 -0.781 . . . . 1.0 108.89 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -127.32 121.87 32.23 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 107.884 -1.154 . . . . 1.0 107.884 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -100.97 116.34 32.6 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.099 -0.955 . . . . 1.0 110.642 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.476 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -59.84 136.82 58.12 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.222 -0.991 . . . . 1.0 111.018 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.74 -4.57 20.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.164 -0.925 . . . . 1.0 110.214 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -134.22 164.74 26.7 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.2 -1.037 . . . . 1.0 108.2 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -66.62 -29.44 69.48 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 113.884 1.068 . . . . 1.0 113.884 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -88.73 5.89 41.25 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.499 1.296 . . . . 1.0 114.499 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.476 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 98.4 mt-10 -104.45 136.61 43.69 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.321 0.581 . . . . 1.0 112.481 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.9 mt -74.83 145.13 43.1 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.642 0.734 . . . . 1.0 110.418 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.0 m -112.45 129.64 56.26 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 105.921 -1.881 . . . . 1.0 105.921 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -154.92 169.26 24.45 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 120.191 -0.603 . . . . 1.0 110.129 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.7 m -120.35 160.79 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.694 0.621 . . . . 1.0 109.845 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.3 136.85 6.79 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 80.38 -8.93 1.44 Allowed 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 116.82 2.156 . . . . 1.0 116.82 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -67.02 147.55 53.06 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.252 -0.979 . . . . 1.0 109.127 170.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.67 139.58 32.53 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.011 0.434 . . . . 1.0 111.603 175.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.52 124.86 73.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.876 -2.639 . . . . 1.0 103.876 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.1 pt -115.54 165.85 10.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.649 0.738 . . . . 1.0 112.027 -172.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.03 51.03 17.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.994 0.902 . . . . 1.0 111.103 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.6 mt -72.38 129.99 35.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.499 -0.773 . . . . 1.0 110.832 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -112.01 132.38 54.84 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.134 -1.432 . . . . 1.0 107.134 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.473 ' HA ' ' CD1' ' A' ' 37' ' ' TRP . 94.0 m-85 -78.88 69.1 4.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.598 0.713 . . . . 1.0 109.195 -176.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 80.2 t -65.86 -44.56 92.7 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 N-CA-C 113.97 1.1 . . . . 1.0 113.97 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -143.16 162.24 36.11 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 106.781 -1.562 . . . . 1.0 106.781 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -63.95 -34.69 78.54 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 120.942 0.401 . . . . 1.0 111.612 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -94.72 -40.28 9.87 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 115.048 1.499 . . . . 1.0 115.048 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -116.01 139.21 50.5 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.73 -1.211 . . . . 1.0 107.73 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.473 ' CD1' ' HA ' ' A' ' 31' ' ' PHE . 21.6 m0 -122.88 153.24 39.9 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.1 tp -99.21 131.59 45.13 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.78 -168.78 14.89 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 119.644 -1.265 . . . . 1.0 111.717 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.474 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 78.9 tt0 -138.47 139.2 38.72 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.839 0.856 . . . . 1.0 109.289 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.4 mt -76.04 132.26 40.01 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 119.237 -0.985 . . . . 1.0 112.297 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.76 -38.57 75.63 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 120.041 -0.664 . . . . 1.0 110.54 172.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.85 -21.54 59.21 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 115.884 1.809 . . . . 1.0 115.884 -168.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.8 p30 -145.82 -0.8 0.8 Allowed 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 116.119 1.896 . . . . 1.0 116.119 -174.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.87 1.79 79.74 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.715 -1.231 . . . . 1.0 115.445 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.7 p -70.05 150.91 46.12 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 119.572 1.686 . . . . 1.0 108.584 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.23 149.88 51.73 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.69 174.76 36.28 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.574 -0.822 . . . . 1.0 112.824 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.3 mt -73.09 139.24 46.35 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.579 -0.811 . . . . 1.0 111.554 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -139.16 149.12 59.91 Favored Pre-proline 0 N--CA 1.443 -0.778 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -79.85 129.66 8.2 Favored 'Trans proline' 0 CA--C 1.512 -0.606 0 N-CA-C 108.808 -1.266 . . . . 1.0 108.808 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.7 m -60.42 -34.74 74.4 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 -176.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -66.44 -6.57 15.07 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.54 0.941 . . . . 1.0 113.54 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -94.14 -0.12 55.46 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 120.078 -1.638 . . . . 1.0 113.4 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.64 HG12 ' HA ' ' A' ' 6' ' ' ALA . 35.0 m -138.4 162.97 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.7 0.762 . . . . 1.0 111.732 -178.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.5 t -131.42 130.81 43.02 Favored 'General case' 0 C--O 1.214 -0.782 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -60.28 141.62 55.86 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.816 0.817 . . . . 1.0 111.086 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.55 -164.63 54.64 Favored Glycine 0 C--O 1.248 0.988 0 CA-C-N 115.371 -0.831 . . . . 1.0 113.501 177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.255 1.363 0 CA-C-O 117.496 -1.24 . . . . 1.0 111.395 -176.977 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 CA--C 1.515 -0.431 0 N-CA-C 109.614 -0.956 . . . . 1.0 109.614 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -114.42 165.36 12.81 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.788 0.804 . . . . 1.0 109.66 169.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.7 164.11 31.38 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.273 -0.876 . . . . 1.0 111.481 -176.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.9 m -119.59 128.61 54.06 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.205 -1.035 . . . . 1.0 108.205 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.537 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -71.39 140.27 50.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.069 0.937 . . . . 1.0 110.431 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.405 ' C ' ' HG3' ' A' ' 22' ' ' GLU . 97.2 mt-10 -102.89 -16.68 15.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.053 -0.976 . . . . 1.0 111.539 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -141.54 151.53 43.31 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 106.732 -1.581 . . . . 1.0 106.732 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -68.81 137.43 53.95 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -129.02 125.03 36.46 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.723 -1.214 . . . . 1.0 107.723 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -104.1 117.13 33.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.059 -0.973 . . . . 1.0 110.64 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -58.17 134.54 56.58 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 119.181 -1.008 . . . . 1.0 110.984 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.07 -5.05 26.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.079 -0.964 . . . . 1.0 110.313 176.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -137.2 165.2 26.67 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.266 -1.013 . . . . 1.0 108.266 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -65.95 -32.39 73.85 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 113.884 1.068 . . . . 1.0 113.884 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -84.98 7.1 22.45 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 114.481 1.289 . . . . 1.0 114.481 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.501 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 98.8 mt-10 -106.42 138.9 41.77 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.376 0.608 . . . . 1.0 112.495 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.61 140.49 42.65 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.687 0.756 . . . . 1.0 110.411 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.0 m -107.51 128.39 54.46 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 105.859 -1.904 . . . . 1.0 105.859 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -154.63 169.27 24.28 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.074 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.1 m -120.28 160.78 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 O-C-N 123.626 0.579 . . . . 1.0 109.874 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.405 ' HG3' ' C ' ' A' ' 7' ' ' GLU . 74.5 tt0 -46.39 136.85 6.95 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.62 -0.881 . . . . 1.0 108.62 176.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 80.45 -8.92 1.43 Allowed 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 116.783 2.142 . . . . 1.0 116.783 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.04 147.61 52.97 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.259 -0.976 . . . . 1.0 109.038 170.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.65 139.59 32.5 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.047 0.451 . . . . 1.0 111.594 175.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.433 HD13 HG11 ' A' ' 55' ' ' VAL . 4.5 mp -117.59 124.94 73.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 103.841 -2.651 . . . . 1.0 103.841 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 pt -115.64 165.81 10.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-O 121.625 0.726 . . . . 1.0 112.027 -172.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 51.14 50.97 17.96 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.982 0.896 . . . . 1.0 111.022 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.8 mt -71.75 131.07 35.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.96 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -112.65 133.53 54.63 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.065 -1.457 . . . . 1.0 107.065 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -79.34 68.67 5.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.66 0.743 . . . . 1.0 109.145 -176.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.507 HG21 ' HB2' ' A' ' 38' ' ' LEU . 66.9 t -64.86 -44.3 96.28 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 N-CA-C 113.873 1.064 . . . . 1.0 113.873 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -143.49 163.84 32.02 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.762 -1.57 . . . . 1.0 106.762 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -64.34 -32.57 74.23 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 120.976 0.417 . . . . 1.0 111.585 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -102.11 -36.28 8.61 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 114.946 1.462 . . . . 1.0 114.946 -177.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -111.76 133.56 53.91 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 16.3 m0 -117.95 158.05 25.61 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.199 -1.037 . . . . 1.0 108.199 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.507 ' HB2' HG21 ' A' ' 32' ' ' VAL . 47.1 tp -110.44 126.5 54.38 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.51 -170.0 14.7 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 119.694 -1.241 . . . . 1.0 111.853 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.402 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 80.9 tt0 -133.05 139.26 47.09 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 123.733 0.813 . . . . 1.0 109.345 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.9 mt -74.87 132.28 41.38 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 118.801 -1.159 . . . . 1.0 112.308 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -57.82 -38.59 75.84 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 120.081 -0.648 . . . . 1.0 110.543 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.84 -21.53 59.21 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 115.849 1.796 . . . . 1.0 115.849 -168.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.86 -0.75 0.8 Allowed 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 116.023 1.86 . . . . 1.0 116.023 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.91 1.77 79.84 Favored Glycine 0 C--O 1.223 -0.566 0 C-N-CA 119.657 -1.259 . . . . 1.0 115.449 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.07 150.87 46.13 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 119.598 1.699 . . . . 1.0 108.602 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.402 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.21 149.97 51.67 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.37 175.22 36.48 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.607 -0.806 . . . . 1.0 112.789 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.29 137.39 46.68 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.52 -0.84 . . . . 1.0 111.599 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.522 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 39.3 p90 -138.41 146.8 52.73 Favored Pre-proline 0 C--O 1.244 0.804 0 N-CA-C 108.088 -1.079 . . . . 1.0 108.088 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.536 ' HG2' ' CD1' ' A' ' 54' ' ' TYR . 57.8 Cg_endo -77.78 129.26 9.83 Favored 'Trans proline' 0 CA--C 1.512 -0.597 0 N-CA-C 108.83 -1.258 . . . . 1.0 108.83 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.5 m -61.8 -36.18 80.37 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 114.36 1.244 . . . . 1.0 114.36 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -64.3 -7.51 9.73 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.477 0.917 . . . . 1.0 113.477 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.536 ' CD1' ' HG2' ' A' ' 51' ' ' PRO . 15.5 m-85 -94.12 -0.14 55.48 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 120.198 -1.563 . . . . 1.0 113.316 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 6' ' ' ALA . 27.7 m -137.36 161.66 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.605 0.717 . . . . 1.0 111.847 -178.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.7 t -129.4 129.82 45.21 Favored 'General case' 0 C--O 1.214 -0.806 0 C-N-CA 124.054 0.941 . . . . 1.0 108.553 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.8 mt -58.85 141.71 52.52 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.762 0.791 . . . . 1.0 111.108 -177.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.53 -164.64 54.62 Favored Glycine 0 C--O 1.246 0.876 0 CA-C-N 115.377 -0.828 . . . . 1.0 113.547 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.318 0 CA-C-O 117.624 -1.179 . . . . 1.0 111.411 -176.998 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 CA--C 1.515 -0.431 0 N-CA-C 109.637 -0.947 . . . . 1.0 109.637 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.38 165.38 12.78 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.788 0.804 . . . . 1.0 109.679 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.73 164.09 31.45 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.273 -0.876 . . . . 1.0 111.515 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.4 p -115.37 131.1 57.04 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.132 -1.062 . . . . 1.0 108.132 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.69 136.83 56.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.947 0.88 . . . . 1.0 110.49 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -101.19 -25.38 14.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.167 -0.924 . . . . 1.0 111.578 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.405 ' HB2' ' CD2' ' A' ' 54' ' ' TYR . 85.6 m-85 -139.77 153.21 47.1 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 106.741 -1.578 . . . . 1.0 106.741 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -69.17 133.72 48.34 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.928 -0.768 . . . . 1.0 108.928 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -129.14 121.0 26.84 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -101.08 119.96 39.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.048 -0.978 . . . . 1.0 110.62 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.25 135.65 57.79 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 119.204 -0.999 . . . . 1.0 110.929 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.87 -2.58 19.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.135 -0.939 . . . . 1.0 110.277 176.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -136.58 164.66 27.67 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.295 -1.002 . . . . 1.0 108.295 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -65.24 -33.97 77.24 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 113.904 1.075 . . . . 1.0 113.904 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.6 p-10 -85.86 2.35 46.22 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 114.496 1.295 . . . . 1.0 114.496 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -100.12 137.68 38.24 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.331 0.586 . . . . 1.0 112.466 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.8 mt -76.29 147.22 38.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.715 0.769 . . . . 1.0 110.423 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.0 m -114.91 127.47 55.72 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 105.924 -1.88 . . . . 1.0 105.924 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -154.09 169.28 23.93 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 123.477 0.485 . . . . 1.0 110.056 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.8 m -120.31 160.85 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 O-C-N 123.67 0.606 . . . . 1.0 109.89 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -46.39 136.92 6.9 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 80.41 -8.96 1.43 Allowed 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 116.783 2.142 . . . . 1.0 116.783 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -67.04 147.64 52.93 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.258 -0.977 . . . . 1.0 109.051 170.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.66 139.61 32.49 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.019 0.438 . . . . 1.0 111.588 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.64 124.96 73.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 103.792 -2.67 . . . . 1.0 103.792 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 pt -115.64 165.86 10.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.655 0.741 . . . . 1.0 112.031 -172.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 51.08 51.02 17.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.013 0.911 . . . . 1.0 111.042 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.5 mt -72.75 131.29 35.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.873 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -112.8 134.29 54.39 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.036 -1.468 . . . . 1.0 107.036 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.437 ' HA ' ' CD1' ' A' ' 37' ' ' TRP . 94.0 m-85 -78.68 68.04 4.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.701 0.762 . . . . 1.0 109.246 -176.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.423 HG21 ' HB2' ' A' ' 38' ' ' LEU . 92.6 t -65.27 -44.32 95.01 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.703 0 N-CA-C 113.946 1.091 . . . . 1.0 113.946 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -143.42 162.99 34.32 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.702 -1.592 . . . . 1.0 106.702 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -64.56 -35.68 81.77 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 120.922 0.391 . . . . 1.0 111.594 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -96.28 -42.02 8.37 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.959 1.466 . . . . 1.0 114.959 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -113.26 136.89 52.25 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.633 -1.247 . . . . 1.0 107.633 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 17.6 m0 -120.52 160.02 24.01 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.139 -1.06 . . . . 1.0 108.139 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.439 HD12 ' C ' ' A' ' 48' ' ' GLY . 53.0 tp -107.68 131.06 54.81 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.72 -170.8 16.87 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 119.65 -1.262 . . . . 1.0 111.836 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.455 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 78.3 tt0 -133.67 139.3 46.36 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 123.797 0.839 . . . . 1.0 109.374 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.7 mt -75.81 132.22 40.26 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 119.311 -0.956 . . . . 1.0 112.266 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -57.77 -38.62 75.74 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 120.072 -0.651 . . . . 1.0 110.556 172.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.81 -21.55 59.23 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 115.898 1.814 . . . . 1.0 115.898 -168.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.9 -0.66 0.8 Allowed 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 116.082 1.882 . . . . 1.0 116.082 -174.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.93 1.71 79.81 Favored Glycine 0 C--O 1.223 -0.566 0 C-N-CA 119.588 -1.292 . . . . 1.0 115.446 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.05 150.84 46.19 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 119.615 1.708 . . . . 1.0 108.546 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.455 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.22 149.9 51.71 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 109.373 -0.602 . . . . 1.0 109.373 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.439 ' C ' HD12 ' A' ' 38' ' ' LEU . . . 166.47 178.99 39.5 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.582 -0.818 . . . . 1.0 112.772 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.9 mp -73.33 146.03 45.55 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.551 -0.825 . . . . 1.0 111.608 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.533 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 44.0 p90 -146.57 150.48 40.37 Favored Pre-proline 0 C--O 1.245 0.827 0 N-CA-C 108.053 -1.091 . . . . 1.0 108.053 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.432 ' HG2' ' CD1' ' A' ' 54' ' ' TYR . 61.4 Cg_endo -82.62 127.08 4.86 Favored 'Trans proline' 0 CA--C 1.513 -0.572 0 N-CA-C 108.784 -1.275 . . . . 1.0 108.784 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.6 m -59.05 -36.9 75.83 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 114.383 1.253 . . . . 1.0 114.383 -177.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -65.32 -6.5 10.08 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.403 0.89 . . . . 1.0 113.403 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.432 ' CD1' ' HG2' ' A' ' 51' ' ' PRO . 16.3 m-85 -92.63 -2.83 55.8 Favored 'General case' 0 C--O 1.222 -0.374 0 O-C-N 120.275 -1.516 . . . . 1.0 113.434 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.1 m -138.3 162.11 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.617 0.722 . . . . 1.0 111.774 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 56.3 m -127.63 130.36 48.83 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 123.995 0.918 . . . . 1.0 108.596 177.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.8 mt -58.36 141.76 50.27 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.836 0.827 . . . . 1.0 111.074 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.42 -164.61 54.55 Favored Glycine 0 C--O 1.246 0.904 0 CA-C-N 115.401 -0.818 . . . . 1.0 113.546 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.318 0 CA-C-O 117.619 -1.181 . . . . 1.0 111.44 -177.023 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.366 0.127 . . . . 1.0 111.05 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -76.94 171.0 18.75 Favored 'Trans proline' 0 C--N 1.317 -1.109 1 C-N-CA 127.273 5.316 . . . . 1.0 109.614 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.37 165.44 12.71 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.795 0.807 . . . . 1.0 109.696 169.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.74 164.12 31.37 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.256 -0.884 . . . . 1.0 111.537 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 58' ' ' GLY . 4.5 p -104.05 162.2 13.36 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 177.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.511 ' HB3' ' N ' ' A' ' 23' ' ' ASN . . . -92.77 109.77 21.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.103 0.954 . . . . 1.0 110.459 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -70.84 -42.3 70.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.192 -0.913 . . . . 1.0 111.6 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -137.72 155.89 48.59 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 106.744 -1.576 . . . . 1.0 106.744 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -67.03 133.58 50.2 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 175.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -127.45 124.42 38.37 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.777 -1.194 . . . . 1.0 107.777 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -103.25 118.78 37.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.04 -0.982 . . . . 1.0 110.647 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -62.31 136.5 57.95 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.146 -1.022 . . . . 1.0 111.012 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.28 5.96 22.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.361 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -140.29 159.96 41.04 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -63.36 -33.84 76.41 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 113.849 1.055 . . . . 1.0 113.849 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -88.08 6.63 35.37 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.415 1.265 . . . . 1.0 114.415 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 99.2 mt-10 -103.27 139.57 38.54 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.328 0.585 . . . . 1.0 112.51 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.07 145.1 36.03 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.697 0.76 . . . . 1.0 110.367 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.9 m -112.83 130.37 56.11 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 105.92 -1.882 . . . . 1.0 105.92 175.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -156.21 169.3 24.85 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.112 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.7 m -120.34 160.8 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 O-C-N 123.694 0.621 . . . . 1.0 109.874 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.36 136.88 6.87 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.511 ' N ' ' HB3' ' A' ' 6' ' ' ALA . 90.6 m-20 80.39 -8.92 1.44 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.757 2.132 . . . . 1.0 116.757 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.04 147.62 52.96 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.259 -0.976 . . . . 1.0 109.038 170.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.72 139.54 32.63 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.048 0.451 . . . . 1.0 111.596 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.53 125.0 73.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 103.83 -2.656 . . . . 1.0 103.83 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 pt -115.66 165.84 10.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-O 121.618 0.723 . . . . 1.0 111.972 -172.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.08 50.99 17.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.982 0.896 . . . . 1.0 111.042 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.4 mt -70.69 131.25 34.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.868 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -112.51 132.84 54.89 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 107.092 -1.447 . . . . 1.0 107.092 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.487 ' HA ' ' CD1' ' A' ' 37' ' ' TRP . 90.1 m-85 -78.85 68.68 4.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.632 0.73 . . . . 1.0 109.174 -176.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.5 t -66.56 -43.85 90.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 113.872 1.064 . . . . 1.0 113.872 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -143.24 162.03 36.72 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.799 -1.556 . . . . 1.0 106.799 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -64.64 -33.13 75.22 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 120.948 0.404 . . . . 1.0 111.575 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -96.56 -39.61 9.45 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 115.076 1.51 . . . . 1.0 115.076 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 43.5 m95 -117.76 141.3 48.56 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.668 -1.234 . . . . 1.0 107.668 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.487 ' CD1' ' HA ' ' A' ' 31' ' ' PHE . 17.5 m0 -126.57 154.88 43.3 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.165 -1.05 . . . . 1.0 108.165 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.5 tp -99.43 128.83 45.57 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.374 -0.973 . . . . 1.0 108.374 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.59 -162.54 9.55 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 119.78 -1.2 . . . . 1.0 111.819 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.456 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 77.1 tt0 -141.92 138.52 32.07 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 123.837 0.855 . . . . 1.0 109.251 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.4 mt -75.3 132.25 40.87 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.287 -0.965 . . . . 1.0 112.256 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.82 -38.52 75.74 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.013 -0.675 . . . . 1.0 110.547 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.84 -21.54 59.21 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 115.884 1.809 . . . . 1.0 115.884 -168.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.87 -0.72 0.8 Allowed 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 116.155 1.909 . . . . 1.0 116.155 -174.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.9 1.76 79.77 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.65 -1.262 . . . . 1.0 115.495 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.04 150.87 46.17 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 119.541 1.67 . . . . 1.0 108.602 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.456 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.25 149.94 51.72 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 109.276 -0.639 . . . . 1.0 109.276 -176.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.42 175.17 36.47 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.579 -0.82 . . . . 1.0 112.825 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.3 mt -72.49 139.45 47.65 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.535 -0.832 . . . . 1.0 111.595 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 49.5 p90 -139.86 149.41 58.99 Favored Pre-proline 0 C--O 1.245 0.837 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.404 ' HG2' ' CD1' ' A' ' 54' ' ' TYR . 61.5 Cg_endo -82.11 134.11 7.97 Favored 'Trans proline' 0 CA--C 1.512 -0.589 0 N-CA-C 108.857 -1.247 . . . . 1.0 108.857 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.6 m -63.86 -37.91 89.13 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 114.277 1.214 . . . . 1.0 114.277 -176.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -61.77 -8.54 4.9 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.463 0.912 . . . . 1.0 113.463 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.404 ' CD1' ' HG2' ' A' ' 51' ' ' PRO . 23.3 m-85 -94.7 -0.24 54.49 Favored 'General case' 0 C--O 1.222 -0.379 0 O-C-N 120.184 -1.572 . . . . 1.0 113.398 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.9 m -137.76 159.01 34.19 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-O 121.606 0.717 . . . . 1.0 111.722 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.6 t -128.8 129.63 45.91 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 108.546 -0.909 . . . . 1.0 108.546 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -59.07 141.67 53.43 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.783 0.801 . . . . 1.0 111.073 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 5' ' ' THR . . . 72.54 -164.63 54.63 Favored Glycine 0 C--O 1.246 0.876 0 CA-C-N 115.354 -0.839 . . . . 1.0 113.453 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.255 1.352 0 CA-C-O 117.59 -1.195 . . . . 1.0 111.43 -176.984 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.34 0.114 . . . . 1.0 111.015 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.93 171.0 18.75 Favored 'Trans proline' 0 C--N 1.317 -1.109 1 C-N-CA 127.261 5.308 . . . . 1.0 109.673 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -114.38 165.38 12.78 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.788 0.804 . . . . 1.0 109.679 169.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.75 164.08 31.5 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.273 -0.876 . . . . 1.0 111.478 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.8 p -114.8 132.48 56.46 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.25 133.95 50.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.989 0.9 . . . . 1.0 110.402 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -99.24 -28.48 13.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.141 -0.936 . . . . 1.0 111.543 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -137.68 150.07 47.04 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 106.707 -1.59 . . . . 1.0 106.707 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -65.9 134.07 52.24 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -126.68 124.21 39.31 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 107.781 -1.192 . . . . 1.0 107.781 177.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -101.03 116.1 32.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.089 -0.96 . . . . 1.0 110.694 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.98 137.65 58.33 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.194 -1.003 . . . . 1.0 111.035 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -113.36 5.66 16.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.207 -0.906 . . . . 1.0 110.34 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -137.27 159.69 41.2 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.218 -1.03 . . . . 1.0 108.218 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -64.49 -33.92 77.02 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 113.866 1.062 . . . . 1.0 113.866 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -88.71 5.5 42.98 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.482 1.29 . . . . 1.0 114.482 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -100.7 136.9 39.84 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.313 0.578 . . . . 1.0 112.538 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.25 142.49 41.39 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.778 0.799 . . . . 1.0 110.336 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.2 m -110.0 131.2 55.28 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 105.969 -1.863 . . . . 1.0 105.969 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -155.68 169.26 24.74 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 120.402 -0.519 . . . . 1.0 110.129 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.4 m -120.37 160.77 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.694 0.621 . . . . 1.0 109.817 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.28 136.86 6.75 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 80.39 -8.92 1.44 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.757 2.132 . . . . 1.0 116.757 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.05 147.64 52.92 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.245 -0.982 . . . . 1.0 109.051 170.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.68 139.5 32.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.018 0.437 . . . . 1.0 111.627 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.412 HG21 ' CE1' ' A' ' 50' ' ' PHE . 4.5 mp -117.56 125.0 73.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 103.745 -2.687 . . . . 1.0 103.745 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 pt -115.7 165.88 10.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.667 0.746 . . . . 1.0 111.931 -172.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 51.1 50.94 18.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.978 0.894 . . . . 1.0 111.058 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.0 mt -68.02 128.8 31.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.934 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -113.0 121.74 45.53 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.051 -1.463 . . . . 1.0 107.051 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -76.19 72.21 2.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.57 0.7 . . . . 1.0 109.204 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.4 t -66.91 -43.82 89.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 113.94 1.089 . . . . 1.0 113.94 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -139.83 164.51 29.78 Favored 'General case' 0 C--O 1.22 -0.494 0 N-CA-C 106.716 -1.587 . . . . 1.0 106.716 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -64.93 -35.45 81.21 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 120.986 0.422 . . . . 1.0 111.648 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -97.49 -33.49 11.35 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 114.986 1.476 . . . . 1.0 114.986 -176.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.415 ' CH2' ' HG3' ' A' ' 51' ' ' PRO . 54.3 m95 -114.28 133.43 55.66 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.731 -1.211 . . . . 1.0 107.731 -178.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 53.0 m0 -116.52 151.0 37.03 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.09 -1.078 . . . . 1.0 108.09 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.9 tp -104.55 124.19 48.86 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.412 -0.958 . . . . 1.0 108.412 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.12 -165.77 11.09 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 119.609 -1.282 . . . . 1.0 111.834 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -140.15 139.7 35.82 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 123.73 0.812 . . . . 1.0 109.284 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.2 mt -76.15 132.25 39.88 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.096 -1.042 . . . . 1.0 112.256 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.76 -38.61 75.72 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.097 -0.641 . . . . 1.0 110.494 172.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.79 -21.6 59.23 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 115.929 1.825 . . . . 1.0 115.929 -168.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.83 -0.71 0.8 Allowed 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 116.084 1.883 . . . . 1.0 116.084 -174.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.87 1.76 79.64 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.673 -1.251 . . . . 1.0 115.43 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.0 p -70.06 150.86 46.15 Favored 'General case' 0 C--O 1.213 -0.851 0 CA-C-N 119.572 1.686 . . . . 1.0 108.577 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -130.23 149.96 51.69 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 109.276 -0.639 . . . . 1.0 109.276 -176.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.56 172.46 34.69 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.57 -0.824 . . . . 1.0 112.806 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.3 mt -75.54 140.36 42.69 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.586 -0.807 . . . . 1.0 111.62 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.412 ' CE1' HG21 ' A' ' 26' ' ' ILE . 50.3 p90 -144.12 139.55 16.01 Favored Pre-proline 0 C--O 1.246 0.875 0 N-CA-C 108.06 -1.089 . . . . 1.0 108.06 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.415 ' HG3' ' CH2' ' A' ' 36' ' ' TRP . 31.2 Cg_exo -62.9 133.83 43.54 Favored 'Trans proline' 0 CA--C 1.512 -0.6 0 N-CA-C 108.762 -1.284 . . . . 1.0 108.762 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 81.5 p -66.84 -17.95 65.14 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 114.368 1.247 . . . . 1.0 114.368 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -81.55 -1.26 45.62 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.435 0.902 . . . . 1.0 113.435 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -95.58 -0.99 51.33 Favored 'General case' 0 C--O 1.222 -0.375 0 O-C-N 120.171 -1.58 . . . . 1.0 113.5 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.8 m -136.54 162.13 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.582 0.706 . . . . 1.0 111.734 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 65.0 p -128.28 130.52 47.99 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 123.944 0.898 . . . . 1.0 108.589 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.5 mt -60.46 141.72 56.05 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.893 0.854 . . . . 1.0 111.017 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.44 -164.61 54.56 Favored Glycine 0 C--O 1.246 0.876 0 CA-C-N 115.34 -0.845 . . . . 1.0 113.549 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.329 0 CA-C-O 117.564 -1.208 . . . . 1.0 111.404 -176.966 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.348 0.118 . . . . 1.0 110.978 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -77.02 170.95 18.82 Favored 'Trans proline' 0 C--N 1.317 -1.122 1 C-N-CA 127.318 5.345 . . . . 1.0 109.574 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.28 165.45 12.68 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.816 0.817 . . . . 1.0 109.668 169.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.77 164.15 31.32 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.234 -0.893 . . . . 1.0 111.453 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 58' ' ' GLY . 25.5 p -115.35 132.9 56.47 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.161 -1.051 . . . . 1.0 108.161 178.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.482 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -67.46 136.72 55.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.987 0.899 . . . . 1.0 110.518 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -100.73 -26.34 13.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.204 -0.907 . . . . 1.0 111.533 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.402 ' HB2' ' CD2' ' A' ' 54' ' ' TYR . 91.5 m-85 -140.33 149.82 43.21 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 106.722 -1.585 . . . . 1.0 106.722 -178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -63.6 132.8 52.33 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.922 -0.769 . . . . 1.0 108.922 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -128.04 125.85 40.14 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.667 -1.234 . . . . 1.0 107.667 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -106.35 119.65 39.8 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 124.29 0.994 . . . . 1.0 110.789 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.459 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -60.39 136.33 58.01 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 119.195 -1.002 . . . . 1.0 111.114 178.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.25 2.8 27.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.229 -0.896 . . . . 1.0 110.298 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -142.53 163.85 31.72 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -65.85 -32.65 74.29 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 113.824 1.046 . . . . 1.0 113.824 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -85.99 5.92 31.09 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.544 1.313 . . . . 1.0 114.544 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 96.4 mt-10 -104.61 139.75 39.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.318 0.58 . . . . 1.0 112.537 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.6 mt -76.91 142.8 39.97 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.785 0.802 . . . . 1.0 110.321 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.2 m -111.06 129.13 56.01 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 105.953 -1.869 . . . . 1.0 105.953 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -156.17 169.28 24.89 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 120.288 -0.565 . . . . 1.0 110.056 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.31 160.79 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 O-C-N 123.628 0.58 . . . . 1.0 109.89 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -46.21 136.78 6.69 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.698 -0.853 . . . . 1.0 108.698 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 80.42 -8.92 1.44 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.757 2.132 . . . . 1.0 116.757 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -66.99 147.59 53.03 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.266 -0.974 . . . . 1.0 109.084 170.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.69 139.59 32.52 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.037 0.446 . . . . 1.0 111.582 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.61 124.98 73.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 103.756 -2.683 . . . . 1.0 103.756 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.1 pt -115.72 165.78 10.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-O 121.659 0.742 . . . . 1.0 111.958 -172.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.14 51.02 17.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.013 0.911 . . . . 1.0 111.042 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.1 mt -71.38 131.13 34.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.934 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -114.84 135.73 53.87 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.995 -1.483 . . . . 1.0 106.995 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -78.31 67.53 4.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.646 0.736 . . . . 1.0 109.164 -176.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.47 -40.86 89.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.885 1.068 . . . . 1.0 113.885 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -144.49 160.06 41.72 Favored 'General case' 0 C--O 1.219 -0.536 0 N-CA-C 106.763 -1.569 . . . . 1.0 106.763 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -63.68 -33.02 74.7 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 120.902 0.382 . . . . 1.0 111.612 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -100.29 -34.53 9.95 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 115.09 1.515 . . . . 1.0 115.09 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 52.2 m95 -111.24 135.29 51.98 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.598 -1.26 . . . . 1.0 107.598 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.425 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . 10.7 m0 -110.36 151.59 27.26 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.147 -1.057 . . . . 1.0 108.147 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.3 tp -108.58 125.95 52.4 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.419 -0.956 . . . . 1.0 108.419 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.99 -165.84 13.5 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 119.767 -1.206 . . . . 1.0 111.884 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.444 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 75.1 tt0 -135.59 141.94 45.22 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 123.75 0.82 . . . . 1.0 109.195 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.9 mt -75.16 132.21 41.0 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.159 -1.016 . . . . 1.0 112.282 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.82 -38.52 75.74 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.013 -0.675 . . . . 1.0 110.547 172.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.75 -21.58 59.27 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 115.912 1.819 . . . . 1.0 115.912 -168.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.94 -0.7 0.79 Allowed 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 116.091 1.886 . . . . 1.0 116.091 -174.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.82 1.79 79.45 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.658 -1.258 . . . . 1.0 115.51 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.0 p -70.04 150.92 46.12 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 119.541 1.67 . . . . 1.0 108.602 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.444 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.31 149.95 51.77 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 109.241 -0.652 . . . . 1.0 109.241 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.11 176.31 37.91 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.568 -0.825 . . . . 1.0 112.776 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -77.51 137.06 38.42 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.516 -0.842 . . . . 1.0 111.613 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.425 ' CE2' ' HB2' ' A' ' 37' ' ' TRP . 50.1 p90 -138.34 150.83 67.94 Favored Pre-proline 0 C--O 1.243 0.743 0 N-CA-C 107.943 -1.132 . . . . 1.0 107.943 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -80.36 129.19 7.46 Favored 'Trans proline' 0 CA--C 1.513 -0.54 0 N-CA-C 108.839 -1.254 . . . . 1.0 108.839 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.8 m -59.9 -34.84 73.72 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 114.344 1.239 . . . . 1.0 114.344 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -61.99 -9.23 6.59 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.489 0.922 . . . . 1.0 113.489 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.402 ' CD2' ' HB2' ' A' ' 8' ' ' TYR . 22.3 m-85 -94.74 1.15 55.45 Favored 'General case' 0 C--O 1.222 -0.356 0 O-C-N 120.243 -1.536 . . . . 1.0 113.405 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.482 HG12 ' HA ' ' A' ' 6' ' ' ALA . 33.7 m -138.01 162.28 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.482 0.658 . . . . 1.0 111.778 -178.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.2 p -133.34 131.59 40.28 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 176.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -60.63 141.72 56.4 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.836 0.827 . . . . 1.0 111.052 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 5' ' ' THR . . . 72.41 -164.67 54.54 Favored Glycine 0 C--O 1.247 0.933 0 CA-C-N 115.36 -0.836 . . . . 1.0 113.57 177.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.255 1.352 0 CA-C-O 117.59 -1.195 . . . . 1.0 111.43 -176.981 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.302 0.096 . . . . 1.0 110.998 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -76.79 170.98 18.82 Favored 'Trans proline' 0 C--N 1.316 -1.178 1 C-N-CA 127.307 5.338 . . . . 1.0 109.634 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.39 165.41 12.74 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.766 0.794 . . . . 1.0 109.74 169.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.7 164.05 31.54 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.348 -0.842 . . . . 1.0 111.549 -176.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.6 m -117.8 128.67 55.09 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.11 -1.07 . . . . 1.0 108.11 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.45 136.74 56.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.995 0.902 . . . . 1.0 110.49 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -101.71 -21.05 14.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.16 -0.927 . . . . 1.0 111.584 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -138.73 151.39 47.08 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 106.818 -1.549 . . . . 1.0 106.818 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -67.22 132.42 47.73 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.847 -0.797 . . . . 1.0 108.847 176.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.482 ' HB2' ' CD2' ' A' ' 54' ' ' TYR . 81.8 t80 -135.34 130.53 35.15 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 107.781 -1.192 . . . . 1.0 107.781 177.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -114.16 134.4 54.93 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.049 -0.978 . . . . 1.0 110.658 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.575 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -67.66 139.05 56.77 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.138 -1.025 . . . . 1.0 111.095 178.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.94 -4.87 18.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.254 -0.885 . . . . 1.0 110.273 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -131.14 166.78 20.36 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 108.26 -1.015 . . . . 1.0 108.26 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -66.81 -34.04 76.93 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 113.876 1.065 . . . . 1.0 113.876 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -87.95 7.56 30.42 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.458 1.281 . . . . 1.0 114.458 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.575 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 99.5 mt-10 -103.84 149.49 25.0 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.27 0.557 . . . . 1.0 112.448 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.457 HD22 ' HG ' ' A' ' 41' ' ' LEU . 75.6 mt -90.24 142.72 27.44 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.63 0.729 . . . . 1.0 110.349 177.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.1 t -109.86 132.19 54.38 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 105.882 -1.896 . . . . 1.0 105.882 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -156.12 169.19 25.07 Favored 'General case' 0 CA--C 1.503 -0.855 0 O-C-N 123.33 0.394 . . . . 1.0 110.13 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.8 m -120.31 160.85 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.683 0.614 . . . . 1.0 109.86 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -46.43 136.81 7.06 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.655 -0.869 . . . . 1.0 108.655 176.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 80.5 -8.92 1.43 Allowed 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 116.783 2.142 . . . . 1.0 116.783 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -66.97 147.6 53.02 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.266 -0.974 . . . . 1.0 109.103 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.7 139.51 32.66 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.996 0.427 . . . . 1.0 111.615 175.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.59 124.94 73.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.81 -2.663 . . . . 1.0 103.81 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 pt -115.68 165.91 10.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-O 121.673 0.749 . . . . 1.0 111.994 -172.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.08 51.02 17.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.013 0.911 . . . . 1.0 111.042 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.93 128.75 32.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.918 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -112.92 123.35 50.12 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.093 -1.447 . . . . 1.0 107.093 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -75.71 72.26 2.63 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.691 0.757 . . . . 1.0 109.127 -175.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.441 HG21 HD22 ' A' ' 38' ' ' LEU . 68.3 t -66.94 -44.64 88.52 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 N-CA-C 113.947 1.092 . . . . 1.0 113.947 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -141.22 163.09 33.9 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 106.745 -1.576 . . . . 1.0 106.745 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -66.1 -34.63 78.5 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.031 0.443 . . . . 1.0 111.508 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -93.2 -37.73 11.94 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 115.031 1.493 . . . . 1.0 115.031 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 33.3 m95 -114.29 135.23 54.29 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.705 -1.22 . . . . 1.0 107.705 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 50.7 m0 -114.19 148.72 36.85 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.233 -1.025 . . . . 1.0 108.233 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.441 HD22 HG21 ' A' ' 32' ' ' VAL . 38.0 tp -103.46 133.78 47.94 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.359 -0.978 . . . . 1.0 108.359 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.67 -166.64 17.42 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 119.746 -1.216 . . . . 1.0 111.884 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.469 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 77.4 tt0 -136.6 140.18 42.65 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.901 0.88 . . . . 1.0 109.327 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.457 ' HG ' HD22 ' A' ' 18' ' ' LEU . 52.6 mt -75.58 132.25 40.55 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.724 -0.791 . . . . 1.0 112.242 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.76 -38.62 75.72 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.097 -0.641 . . . . 1.0 110.494 172.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.74 -21.7 59.21 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 115.851 1.797 . . . . 1.0 115.851 -168.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 51.0 p30 -145.83 -0.71 0.8 Allowed 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 116.096 1.887 . . . . 1.0 116.096 -174.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.92 1.76 79.92 Favored Glycine 0 C--O 1.222 -0.631 0 C-N-CA 119.699 -1.239 . . . . 1.0 115.43 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.05 150.86 46.17 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 119.572 1.686 . . . . 1.0 108.584 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.469 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.2 149.87 51.71 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 -176.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.84 174.37 35.28 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.554 -0.831 . . . . 1.0 112.797 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.5 145.44 43.52 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.598 -0.801 . . . . 1.0 111.544 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -149.52 140.17 13.92 Favored Pre-proline 0 N--CA 1.443 -0.823 0 N-CA-C 108.025 -1.102 . . . . 1.0 108.025 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -63.47 133.65 40.99 Favored 'Trans proline' 0 CA--C 1.513 -0.529 0 N-CA-C 108.904 -1.229 . . . . 1.0 108.904 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.4 p -67.8 -18.22 64.78 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 114.274 1.212 . . . . 1.0 114.274 -176.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -80.18 -2.1 43.29 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.436 0.902 . . . . 1.0 113.436 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.482 ' CD2' ' HB2' ' A' ' 10' ' ' TYR . 32.2 m-85 -95.4 0.58 53.61 Favored 'General case' 0 C--O 1.223 -0.326 0 O-C-N 120.157 -1.589 . . . . 1.0 113.317 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 m -138.57 163.03 28.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 118.698 0.681 . . . . 1.0 111.813 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.3 p -129.92 130.76 45.54 Favored 'General case' 0 C--O 1.213 -0.818 0 C-N-CA 123.985 0.914 . . . . 1.0 108.562 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -59.33 141.67 53.94 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 119.628 -0.829 . . . . 1.0 111.073 -177.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.53 -164.68 54.62 Favored Glycine 0 C--O 1.247 0.914 0 CA-C-N 115.336 -0.847 . . . . 1.0 113.455 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.296 0 CA-C-O 117.563 -1.208 . . . . 1.0 111.342 -176.902 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.373 0.13 . . . . 1.0 111.002 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -76.82 171.02 18.75 Favored 'Trans proline' 0 C--N 1.317 -1.106 1 C-N-CA 127.285 5.323 . . . . 1.0 109.635 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.36 165.5 12.65 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.809 0.814 . . . . 1.0 109.712 169.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.77 164.08 31.52 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.292 -0.867 . . . . 1.0 111.487 -176.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.5 p -114.97 134.34 55.26 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.71 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -70.0 137.61 51.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.98 0.895 . . . . 1.0 110.532 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -104.25 -25.17 13.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.263 -0.88 . . . . 1.0 111.538 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -138.95 148.27 43.31 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 106.775 -1.565 . . . . 1.0 106.775 -178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -68.55 137.75 54.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -127.04 123.83 37.92 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.744 -1.206 . . . . 1.0 107.744 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -99.52 113.54 25.99 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 124.306 1.004 . . . . 1.0 110.651 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.482 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -60.34 136.97 58.2 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.226 -0.99 . . . . 1.0 111.001 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.95 -4.94 20.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.187 -0.915 . . . . 1.0 110.343 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -132.35 162.34 31.31 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.268 -1.012 . . . . 1.0 108.268 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -66.86 -31.76 72.59 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 113.885 1.068 . . . . 1.0 113.885 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -88.22 8.01 29.22 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.482 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 96.3 mt-10 -100.67 139.59 36.14 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 112.567 0.58 . . . . 1.0 112.567 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.845 HD11 ' HG ' ' A' ' 41' ' ' LEU . 12.7 tp -74.78 134.93 41.73 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.682 0.753 . . . . 1.0 110.403 177.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.5 m -110.5 128.63 55.71 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 105.939 -1.874 . . . . 1.0 105.939 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -155.78 169.32 24.64 Favored 'General case' 0 CA--C 1.503 -0.86 0 O-C-N 123.898 0.749 . . . . 1.0 110.112 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.5 m -120.4 160.82 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.687 0.617 . . . . 1.0 109.794 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.39 136.89 6.92 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.62 -0.881 . . . . 1.0 108.62 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 80.39 -8.92 1.44 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.757 2.132 . . . . 1.0 116.757 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.07 147.51 53.08 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.259 -0.976 . . . . 1.0 109.068 170.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.59 139.57 32.48 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.003 0.43 . . . . 1.0 111.642 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.524 HD13 HG11 ' A' ' 55' ' ' VAL . 4.5 mp -117.53 124.95 73.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.788 -2.671 . . . . 1.0 103.788 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 pt -115.65 165.86 10.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.648 0.737 . . . . 1.0 112.015 -172.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.1 50.94 18.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.947 0.879 . . . . 1.0 111.058 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.11 130.56 34.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.882 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -117.36 122.83 44.94 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.094 -1.447 . . . . 1.0 107.094 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -77.3 77.01 3.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.554 0.692 . . . . 1.0 109.152 -175.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.2 t -65.12 -45.27 94.64 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 N-CA-C 113.818 1.044 . . . . 1.0 113.818 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -135.35 177.1 8.08 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 106.759 -1.571 . . . . 1.0 106.759 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -71.05 -29.96 65.99 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 121.037 0.446 . . . . 1.0 111.626 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -111.23 -28.18 8.37 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 114.957 1.466 . . . . 1.0 114.957 -176.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 51.5 m95 -111.97 128.24 56.11 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.625 -1.25 . . . . 1.0 107.625 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -117.14 156.1 28.21 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.161 -1.051 . . . . 1.0 108.161 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.4 tp -106.2 128.22 53.78 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.361 -0.977 . . . . 1.0 108.361 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -150.24 172.51 30.05 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 119.788 -1.196 . . . . 1.0 111.904 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.43 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 77.7 tt0 -120.72 139.35 53.19 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.873 0.869 . . . . 1.0 109.302 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.845 ' HG ' HD11 ' A' ' 18' ' ' LEU . 52.6 mt -75.2 132.24 40.98 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.203 -0.999 . . . . 1.0 112.267 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.82 -38.56 75.82 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.013 -0.675 . . . . 1.0 110.547 172.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -74.73 -21.64 59.26 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 115.91 1.818 . . . . 1.0 115.91 -168.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.85 -0.62 0.81 Allowed 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 116.146 1.906 . . . . 1.0 116.146 -174.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.85 1.7 79.34 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.65 -1.262 . . . . 1.0 115.461 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.0 p -70.04 150.92 46.12 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 119.589 1.695 . . . . 1.0 108.602 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.43 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.31 149.95 51.77 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 109.241 -0.652 . . . . 1.0 109.241 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.43 172.69 34.02 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.559 -0.829 . . . . 1.0 112.749 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.0 mt -73.13 142.17 47.48 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 114.636 -0.782 . . . . 1.0 111.588 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -143.94 142.31 20.1 Favored Pre-proline 0 C--O 1.245 0.862 0 N-CA-C 108.015 -1.106 . . . . 1.0 108.015 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -65.14 133.65 36.29 Favored 'Trans proline' 0 CA--C 1.513 -0.564 0 N-CA-C 108.855 -1.248 . . . . 1.0 108.855 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.4 p -67.94 -14.81 63.26 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 114.264 1.209 . . . . 1.0 114.264 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -88.78 6.05 40.66 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.402 0.89 . . . . 1.0 113.402 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -101.53 -0.94 34.13 Favored 'General case' 0 C--O 1.221 -0.4 0 O-C-N 120.186 -1.571 . . . . 1.0 113.361 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.71 HG12 ' HA ' ' A' ' 6' ' ' ALA . 33.3 m -137.81 164.96 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.532 0.682 . . . . 1.0 111.733 -178.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.0 p -129.43 130.85 46.46 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 108.565 -0.902 . . . . 1.0 108.565 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -59.14 141.74 53.38 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.779 0.8 . . . . 1.0 111.13 -177.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.5 -164.7 54.6 Favored Glycine 0 C--O 1.246 0.904 0 CA-C-N 115.359 -0.837 . . . . 1.0 113.491 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.253 1.262 0 CA-C-O 117.581 -1.199 . . . . 1.0 111.43 -176.989 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 120.367 0.127 . . . . 1.0 111.02 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -76.94 171.0 18.75 Favored 'Trans proline' 0 C--N 1.317 -1.109 1 C-N-CA 127.273 5.316 . . . . 1.0 109.614 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.39 165.41 12.75 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.743 0.782 . . . . 1.0 109.724 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.77 164.06 31.57 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.354 -0.839 . . . . 1.0 111.526 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.4 m -115.93 128.03 55.44 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.262 -1.014 . . . . 1.0 108.262 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.575 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -65.17 135.69 55.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.992 0.901 . . . . 1.0 110.501 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -99.37 -24.87 14.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.185 -0.916 . . . . 1.0 111.531 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -140.29 149.81 43.26 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 106.787 -1.56 . . . . 1.0 106.787 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -66.11 136.21 55.65 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.904 -0.776 . . . . 1.0 108.904 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -128.85 123.47 32.83 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 107.757 -1.201 . . . . 1.0 107.757 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -102.28 119.47 38.86 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 124.279 0.987 . . . . 1.0 110.748 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -60.62 136.29 58.01 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.216 -0.994 . . . . 1.0 111.088 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.75 -3.37 22.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.269 -0.878 . . . . 1.0 110.307 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -136.11 164.6 27.65 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.212 -1.033 . . . . 1.0 108.212 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -65.02 -32.48 74.22 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 113.863 1.06 . . . . 1.0 113.863 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -87.34 4.88 41.2 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.556 1.317 . . . . 1.0 114.556 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.524 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 80.7 mm-40 -101.73 137.08 40.51 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 112.525 0.565 . . . . 1.0 112.525 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.0 mt -75.58 147.02 39.95 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.729 0.776 . . . . 1.0 110.39 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.5 m -115.43 129.47 56.58 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 105.853 -1.906 . . . . 1.0 105.853 175.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -153.9 169.29 23.8 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 123.353 0.408 . . . . 1.0 110.09 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.33 160.79 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.681 0.613 . . . . 1.0 109.86 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.24 136.81 6.73 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.605 -0.887 . . . . 1.0 108.605 176.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 80.43 -8.94 1.43 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.745 2.128 . . . . 1.0 116.745 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -67.07 147.63 52.92 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.245 -0.982 . . . . 1.0 109.038 170.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.7 139.54 32.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.06 0.457 . . . . 1.0 111.609 175.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.56 124.99 73.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.782 -2.673 . . . . 1.0 103.782 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.4 pt -115.69 165.9 10.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.642 0.734 . . . . 1.0 112.021 -172.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 51.03 50.97 18.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.928 0.87 . . . . 1.0 111.154 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 97.1 mt -69.22 130.19 34.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.48 -0.782 . . . . 1.0 110.865 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -113.86 128.2 56.31 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.114 -1.439 . . . . 1.0 107.114 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -77.68 70.45 4.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.651 0.739 . . . . 1.0 109.163 -175.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 65.2 t -68.1 -43.83 84.93 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 N-CA-C 113.889 1.07 . . . . 1.0 113.889 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -139.08 161.4 37.47 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.765 -1.569 . . . . 1.0 106.765 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -64.47 -34.51 78.38 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 121.101 0.477 . . . . 1.0 111.668 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -99.19 -33.18 10.87 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 114.991 1.478 . . . . 1.0 114.991 -176.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.495 ' CH2' ' HG3' ' A' ' 51' ' ' PRO . 30.2 m95 -119.4 132.7 55.88 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.655 -1.239 . . . . 1.0 107.655 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 30.7 m0 -115.99 155.59 27.78 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.105 -1.072 . . . . 1.0 108.105 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.82 128.2 53.58 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.398 -0.964 . . . . 1.0 108.398 178.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.1 -162.82 9.77 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 119.698 -1.239 . . . . 1.0 111.795 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.484 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 76.4 tt0 -140.41 139.35 35.25 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 123.847 0.859 . . . . 1.0 109.298 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.9 mt -75.73 132.25 40.37 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.62 -0.832 . . . . 1.0 112.256 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -57.82 -38.6 75.87 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 119.996 -0.682 . . . . 1.0 110.508 172.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.66 -21.62 59.33 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 115.911 1.819 . . . . 1.0 115.911 -168.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -145.91 -0.63 0.8 Allowed 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 116.105 1.891 . . . . 1.0 116.105 -174.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.93 1.74 79.87 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.649 -1.263 . . . . 1.0 115.428 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.1 150.86 46.12 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 119.589 1.694 . . . . 1.0 108.553 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.484 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.9 mttt -130.2 149.87 51.71 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 -176.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.88 175.97 36.81 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.64 -0.79 . . . . 1.0 112.826 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.7 mt -72.97 147.87 44.78 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.517 -0.841 . . . . 1.0 111.633 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.477 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 52.5 p90 -151.34 136.33 10.33 Favored Pre-proline 0 C--O 1.244 0.804 0 N-CA-C 107.952 -1.129 . . . . 1.0 107.952 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.495 ' HG3' ' CH2' ' A' ' 36' ' ' TRP . 30.2 Cg_exo -64.63 130.72 27.23 Favored 'Trans proline' 0 CA--C 1.512 -0.595 0 N-CA-C 108.837 -1.255 . . . . 1.0 108.837 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.2 p -67.35 -17.58 64.8 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.364 1.246 . . . . 1.0 114.364 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.3 p30 -77.51 -3.44 40.53 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.428 0.899 . . . . 1.0 113.428 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -100.85 6.01 43.6 Favored 'General case' 0 C--O 1.221 -0.446 0 O-C-N 120.204 -1.56 . . . . 1.0 113.416 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 6' ' ' ALA . 34.1 m -138.61 161.93 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.626 0.727 . . . . 1.0 111.681 -177.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.3 t -132.69 130.62 40.31 Favored 'General case' 0 C--O 1.215 -0.729 0 C-N-CA 123.92 0.888 . . . . 1.0 108.609 176.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.6 mt -59.78 141.65 54.85 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.855 0.836 . . . . 1.0 111.073 -177.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.62 -164.66 54.68 Favored Glycine 0 C--O 1.246 0.876 0 CA-C-N 115.332 -0.849 . . . . 1.0 113.512 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.255 1.352 0 CA-C-O 117.59 -1.195 . . . . 1.0 111.43 -177.03 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.316 0.103 . . . . 1.0 111.077 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.79 170.96 18.87 Favored 'Trans proline' 0 C--N 1.316 -1.165 1 C-N-CA 127.227 5.284 . . . . 1.0 109.717 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.3 165.38 12.76 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.757 0.789 . . . . 1.0 109.771 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.7 164.1 31.4 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.318 -0.856 . . . . 1.0 111.537 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.2 m -117.88 126.83 53.13 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.42 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -67.48 135.32 52.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 122.057 0.932 . . . . 1.0 110.45 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -102.11 -19.55 15.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.073 -0.967 . . . . 1.0 111.583 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -138.21 148.74 45.11 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 106.732 -1.581 . . . . 1.0 106.732 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.98 133.49 50.06 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -128.13 123.45 34.46 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.729 -1.211 . . . . 1.0 107.729 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -103.18 119.31 38.63 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 124.252 0.97 . . . . 1.0 110.841 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.455 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -62.67 135.98 57.65 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.215 -0.994 . . . . 1.0 110.983 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.09 -3.2 21.79 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.22 -0.9 . . . . 1.0 110.337 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -133.05 161.41 34.44 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 108.312 -0.996 . . . . 1.0 108.312 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -64.88 -34.05 77.46 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 113.889 1.07 . . . . 1.0 113.889 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 p30 -86.39 7.12 27.0 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.552 1.316 . . . . 1.0 114.552 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 97.8 mt-10 -103.74 138.48 40.3 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 112.542 0.571 . . . . 1.0 112.542 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.459 HD11 ' O ' ' A' ' 39' ' ' GLY . 97.2 mt -73.75 142.22 46.29 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.741 0.782 . . . . 1.0 110.411 176.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.7 m -111.7 128.3 56.03 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 105.942 -1.873 . . . . 1.0 105.942 175.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -155.57 169.32 24.57 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 120.156 -0.618 . . . . 1.0 110.056 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.1 m -120.34 160.75 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 O-C-N 123.606 0.566 . . . . 1.0 109.881 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.31 136.89 6.78 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.655 -0.868 . . . . 1.0 108.655 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 80.31 -8.85 1.46 Allowed 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 116.824 2.157 . . . . 1.0 116.824 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -67.12 147.63 52.88 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.238 -0.985 . . . . 1.0 109.038 170.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.65 139.56 32.55 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.01 0.433 . . . . 1.0 111.588 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.6 124.91 73.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 103.779 -2.674 . . . . 1.0 103.779 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 pt -115.58 165.84 10.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.685 0.755 . . . . 1.0 112.066 -172.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 51.07 51.01 17.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.973 0.892 . . . . 1.0 111.114 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.3 mt -68.0 128.4 31.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.902 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -113.36 120.03 39.71 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.166 -1.42 . . . . 1.0 107.166 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -75.05 72.35 2.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.654 0.74 . . . . 1.0 109.141 -175.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.56 -37.07 78.8 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.644 0 N-CA-C 113.864 1.061 . . . . 1.0 113.864 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -145.06 167.37 22.85 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.806 -1.553 . . . . 1.0 106.806 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -67.29 -34.23 76.96 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 121.005 0.431 . . . . 1.0 111.673 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -98.18 -39.41 8.89 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 115.03 1.492 . . . . 1.0 115.03 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -110.71 133.25 53.5 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.678 -1.231 . . . . 1.0 107.678 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 52.6 m0 -117.59 153.33 33.43 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 108.242 -1.021 . . . . 1.0 108.242 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.7 tp -100.28 133.27 44.93 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.42 -0.956 . . . . 1.0 108.42 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.459 ' O ' HD11 ' A' ' 18' ' ' LEU . . . -154.8 178.29 31.61 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 119.723 -1.227 . . . . 1.0 111.737 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.465 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 78.9 tt0 -125.62 140.27 52.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.512 -0.844 . . . . 1.0 109.375 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.6 mt -75.48 132.32 40.71 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 119.398 -0.921 . . . . 1.0 112.238 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.86 -38.61 76.01 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.093 -0.643 . . . . 1.0 110.473 172.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.82 -21.51 59.25 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 115.888 1.81 . . . . 1.0 115.888 -168.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.8 p30 -145.95 -0.72 0.79 Allowed 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 116.072 1.879 . . . . 1.0 116.072 -174.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.94 1.71 79.81 Favored Glycine 0 C--O 1.222 -0.636 0 C-N-CA 119.661 -1.257 . . . . 1.0 115.427 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.1 p -70.04 150.87 46.16 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-N 119.589 1.695 . . . . 1.0 108.59 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.26 149.95 51.72 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 -176.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.98 174.75 36.48 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.568 -0.825 . . . . 1.0 112.751 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.6 mt -73.65 139.36 45.38 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.463 -0.869 . . . . 1.0 111.721 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 51.3 p90 -140.31 150.14 60.27 Favored Pre-proline 0 C--O 1.245 0.854 0 N-CA-C 108.01 -1.108 . . . . 1.0 108.01 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.4 ' HG2' ' CD1' ' A' ' 54' ' ' TYR . 60.4 Cg_endo -79.75 133.86 10.55 Favored 'Trans proline' 0 CA--C 1.513 -0.571 0 N-CA-C 108.836 -1.255 . . . . 1.0 108.836 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.7 m -62.83 -34.95 78.4 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 114.409 1.263 . . . . 1.0 114.409 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -66.44 -7.36 18.97 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.403 0.89 . . . . 1.0 113.403 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.4 ' CD1' ' HG2' ' A' ' 51' ' ' PRO . 24.6 m-85 -93.53 -0.02 56.47 Favored 'General case' 0 C--O 1.222 -0.344 0 O-C-N 120.211 -1.556 . . . . 1.0 113.337 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 6' ' ' ALA . 33.3 m -138.15 163.29 29.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.613 0.721 . . . . 1.0 111.698 -178.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.9 p -132.77 131.17 40.83 Favored 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.6 mt -60.72 141.71 56.59 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.857 0.837 . . . . 1.0 111.039 -176.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.47 -164.65 54.58 Favored Glycine 0 C--O 1.246 0.904 0 CA-C-N 115.337 -0.847 . . . . 1.0 113.473 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.296 0 CA-C-O 117.593 -1.194 . . . . 1.0 111.44 -176.986 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.356 0.122 . . . . 1.0 110.986 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -76.88 171.02 18.74 Favored 'Trans proline' 0 C--N 1.317 -1.109 1 C-N-CA 127.302 5.335 . . . . 1.0 109.604 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.45 165.41 12.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.834 0.826 . . . . 1.0 109.704 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.71 164.09 31.46 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.323 -0.853 . . . . 1.0 111.543 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.5 p -114.64 129.26 56.66 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.159 -1.052 . . . . 1.0 108.159 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.64 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -65.76 134.04 52.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.03 0.919 . . . . 1.0 110.336 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -98.27 -25.46 14.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.144 -0.935 . . . . 1.0 111.525 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -140.19 151.72 45.45 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 106.719 -1.586 . . . . 1.0 106.719 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -67.42 134.87 52.22 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.89 -0.781 . . . . 1.0 108.89 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -127.32 121.87 32.23 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 107.884 -1.154 . . . . 1.0 107.884 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -100.97 116.34 32.6 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.099 -0.955 . . . . 1.0 110.642 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.476 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -59.84 136.82 58.12 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.222 -0.991 . . . . 1.0 111.018 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.74 -4.57 20.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.164 -0.925 . . . . 1.0 110.214 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -134.22 164.74 26.7 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.2 -1.037 . . . . 1.0 108.2 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -66.62 -29.44 69.48 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 113.884 1.068 . . . . 1.0 113.884 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -88.73 5.89 41.25 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.499 1.296 . . . . 1.0 114.499 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.476 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 98.4 mt-10 -104.45 136.61 43.69 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.321 0.581 . . . . 1.0 112.481 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.9 mt -74.83 145.13 43.1 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.642 0.734 . . . . 1.0 110.418 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.0 m -112.45 129.64 56.26 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 105.921 -1.881 . . . . 1.0 105.921 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -154.92 169.26 24.45 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 120.191 -0.603 . . . . 1.0 110.129 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.7 m -120.35 160.79 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.694 0.621 . . . . 1.0 109.845 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.3 136.85 6.79 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 80.38 -8.93 1.44 Allowed 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 116.82 2.156 . . . . 1.0 116.82 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -67.02 147.55 53.06 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.252 -0.979 . . . . 1.0 109.127 170.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.67 139.58 32.53 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.011 0.434 . . . . 1.0 111.603 175.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.52 124.86 73.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.876 -2.639 . . . . 1.0 103.876 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.1 pt -115.54 165.85 10.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.649 0.738 . . . . 1.0 112.027 -172.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.03 51.03 17.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.994 0.902 . . . . 1.0 111.103 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.6 mt -72.38 129.99 35.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.499 -0.773 . . . . 1.0 110.832 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -112.01 132.38 54.84 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.134 -1.432 . . . . 1.0 107.134 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.473 ' HA ' ' CD1' ' A' ' 37' ' ' TRP . 94.0 m-85 -78.88 69.1 4.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.598 0.713 . . . . 1.0 109.195 -176.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 80.2 t -65.86 -44.56 92.7 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 N-CA-C 113.97 1.1 . . . . 1.0 113.97 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -143.16 162.24 36.11 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 106.781 -1.562 . . . . 1.0 106.781 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -63.95 -34.69 78.54 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 120.942 0.401 . . . . 1.0 111.612 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -94.72 -40.28 9.87 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 115.048 1.499 . . . . 1.0 115.048 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -116.01 139.21 50.5 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.73 -1.211 . . . . 1.0 107.73 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.473 ' CD1' ' HA ' ' A' ' 31' ' ' PHE . 21.6 m0 -122.88 153.24 39.9 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.1 tp -99.21 131.59 45.13 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.78 -168.78 14.89 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 119.644 -1.265 . . . . 1.0 111.717 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.474 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 78.9 tt0 -138.47 139.2 38.72 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.839 0.856 . . . . 1.0 109.289 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.4 mt -76.04 132.26 40.01 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 119.237 -0.985 . . . . 1.0 112.297 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.76 -38.57 75.63 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 120.041 -0.664 . . . . 1.0 110.54 172.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.85 -21.54 59.21 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 115.884 1.809 . . . . 1.0 115.884 -168.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.8 p30 -145.82 -0.8 0.8 Allowed 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 116.119 1.896 . . . . 1.0 116.119 -174.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.87 1.79 79.74 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.715 -1.231 . . . . 1.0 115.445 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.7 p -70.05 150.91 46.12 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 119.572 1.686 . . . . 1.0 108.584 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.23 149.88 51.73 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.69 174.76 36.28 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.574 -0.822 . . . . 1.0 112.824 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.3 mt -73.09 139.24 46.35 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.579 -0.811 . . . . 1.0 111.554 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -139.16 149.12 59.91 Favored Pre-proline 0 N--CA 1.443 -0.778 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -79.85 129.66 8.2 Favored 'Trans proline' 0 CA--C 1.512 -0.606 0 N-CA-C 108.808 -1.266 . . . . 1.0 108.808 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.7 m -60.42 -34.74 74.4 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 -176.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -66.44 -6.57 15.07 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.54 0.941 . . . . 1.0 113.54 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -94.14 -0.12 55.46 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 120.078 -1.638 . . . . 1.0 113.4 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.64 HG12 ' HA ' ' A' ' 6' ' ' ALA . 35.0 m -138.4 162.97 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.7 0.762 . . . . 1.0 111.732 -178.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.5 t -131.42 130.81 43.02 Favored 'General case' 0 C--O 1.214 -0.782 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -60.28 141.62 55.86 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.816 0.817 . . . . 1.0 111.086 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.55 -164.63 54.64 Favored Glycine 0 C--O 1.248 0.988 0 CA-C-N 115.371 -0.831 . . . . 1.0 113.501 177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.255 1.363 0 CA-C-O 117.496 -1.24 . . . . 1.0 111.395 -176.977 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.329 0.109 . . . . 1.0 110.955 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -76.94 171.04 18.69 Favored 'Trans proline' 0 C--N 1.317 -1.109 1 C-N-CA 127.273 5.316 . . . . 1.0 109.614 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -114.42 165.36 12.81 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.788 0.804 . . . . 1.0 109.66 169.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.7 164.11 31.38 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.273 -0.876 . . . . 1.0 111.481 -176.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.9 m -119.59 128.61 54.06 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.205 -1.035 . . . . 1.0 108.205 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.537 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -71.39 140.27 50.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.069 0.937 . . . . 1.0 110.431 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.405 ' C ' ' HG3' ' A' ' 22' ' ' GLU . 97.2 mt-10 -102.89 -16.68 15.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.053 -0.976 . . . . 1.0 111.539 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -141.54 151.53 43.31 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 106.732 -1.581 . . . . 1.0 106.732 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -68.81 137.43 53.95 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -129.02 125.03 36.46 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.723 -1.214 . . . . 1.0 107.723 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -104.1 117.13 33.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.059 -0.973 . . . . 1.0 110.64 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -58.17 134.54 56.58 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 119.181 -1.008 . . . . 1.0 110.984 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.07 -5.05 26.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.079 -0.964 . . . . 1.0 110.313 176.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -137.2 165.2 26.67 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.266 -1.013 . . . . 1.0 108.266 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -65.95 -32.39 73.85 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 113.884 1.068 . . . . 1.0 113.884 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -84.98 7.1 22.45 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 114.481 1.289 . . . . 1.0 114.481 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.501 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 98.8 mt-10 -106.42 138.9 41.77 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.376 0.608 . . . . 1.0 112.495 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.61 140.49 42.65 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.687 0.756 . . . . 1.0 110.411 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.0 m -107.51 128.39 54.46 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 105.859 -1.904 . . . . 1.0 105.859 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -154.63 169.27 24.28 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.074 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.1 m -120.28 160.78 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 O-C-N 123.626 0.579 . . . . 1.0 109.874 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.405 ' HG3' ' C ' ' A' ' 7' ' ' GLU . 74.5 tt0 -46.39 136.85 6.95 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.62 -0.881 . . . . 1.0 108.62 176.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 80.45 -8.92 1.43 Allowed 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 116.783 2.142 . . . . 1.0 116.783 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.04 147.61 52.97 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.259 -0.976 . . . . 1.0 109.038 170.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.65 139.59 32.5 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.047 0.451 . . . . 1.0 111.594 175.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.433 HD13 HG11 ' A' ' 55' ' ' VAL . 4.5 mp -117.59 124.94 73.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 103.841 -2.651 . . . . 1.0 103.841 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 pt -115.64 165.81 10.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-O 121.625 0.726 . . . . 1.0 112.027 -172.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 51.14 50.97 17.96 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.982 0.896 . . . . 1.0 111.022 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.8 mt -71.75 131.07 35.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.96 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -112.65 133.53 54.63 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.065 -1.457 . . . . 1.0 107.065 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -79.34 68.67 5.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.66 0.743 . . . . 1.0 109.145 -176.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.507 HG21 ' HB2' ' A' ' 38' ' ' LEU . 66.9 t -64.86 -44.3 96.28 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 N-CA-C 113.873 1.064 . . . . 1.0 113.873 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -143.49 163.84 32.02 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.762 -1.57 . . . . 1.0 106.762 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -64.34 -32.57 74.23 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 120.976 0.417 . . . . 1.0 111.585 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -102.11 -36.28 8.61 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 114.946 1.462 . . . . 1.0 114.946 -177.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -111.76 133.56 53.91 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 16.3 m0 -117.95 158.05 25.61 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.199 -1.037 . . . . 1.0 108.199 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.507 ' HB2' HG21 ' A' ' 32' ' ' VAL . 47.1 tp -110.44 126.5 54.38 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.51 -170.0 14.7 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 119.694 -1.241 . . . . 1.0 111.853 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.402 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 80.9 tt0 -133.05 139.26 47.09 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 123.733 0.813 . . . . 1.0 109.345 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.9 mt -74.87 132.28 41.38 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 118.801 -1.159 . . . . 1.0 112.308 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -57.82 -38.59 75.84 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 120.081 -0.648 . . . . 1.0 110.543 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.84 -21.53 59.21 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 115.849 1.796 . . . . 1.0 115.849 -168.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.86 -0.75 0.8 Allowed 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 116.023 1.86 . . . . 1.0 116.023 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.91 1.77 79.84 Favored Glycine 0 C--O 1.223 -0.566 0 C-N-CA 119.657 -1.259 . . . . 1.0 115.449 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.07 150.87 46.13 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 119.598 1.699 . . . . 1.0 108.602 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.402 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.21 149.97 51.67 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.37 175.22 36.48 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.607 -0.806 . . . . 1.0 112.789 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.29 137.39 46.68 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.52 -0.84 . . . . 1.0 111.599 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.522 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 39.3 p90 -138.41 146.8 52.73 Favored Pre-proline 0 C--O 1.244 0.804 0 N-CA-C 108.088 -1.079 . . . . 1.0 108.088 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.536 ' HG2' ' CD1' ' A' ' 54' ' ' TYR . 57.8 Cg_endo -77.78 129.26 9.83 Favored 'Trans proline' 0 CA--C 1.512 -0.597 0 N-CA-C 108.83 -1.258 . . . . 1.0 108.83 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.5 m -61.8 -36.18 80.37 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 114.36 1.244 . . . . 1.0 114.36 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -64.3 -7.51 9.73 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.477 0.917 . . . . 1.0 113.477 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.536 ' CD1' ' HG2' ' A' ' 51' ' ' PRO . 15.5 m-85 -94.12 -0.14 55.48 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 120.198 -1.563 . . . . 1.0 113.316 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 6' ' ' ALA . 27.7 m -137.36 161.66 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.605 0.717 . . . . 1.0 111.847 -178.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.7 t -129.4 129.82 45.21 Favored 'General case' 0 C--O 1.214 -0.806 0 C-N-CA 124.054 0.941 . . . . 1.0 108.553 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.8 mt -58.85 141.71 52.52 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.762 0.791 . . . . 1.0 111.108 -177.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.53 -164.64 54.62 Favored Glycine 0 C--O 1.246 0.876 0 CA-C-N 115.377 -0.828 . . . . 1.0 113.547 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.318 0 CA-C-O 117.624 -1.179 . . . . 1.0 111.411 -176.998 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.329 0.109 . . . . 1.0 110.979 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -76.86 170.97 18.83 Favored 'Trans proline' 0 C--N 1.316 -1.144 1 C-N-CA 127.302 5.334 . . . . 1.0 109.637 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.38 165.38 12.78 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.788 0.804 . . . . 1.0 109.679 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.73 164.09 31.45 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.273 -0.876 . . . . 1.0 111.515 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.4 p -115.37 131.1 57.04 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.132 -1.062 . . . . 1.0 108.132 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.69 136.83 56.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.947 0.88 . . . . 1.0 110.49 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -101.19 -25.38 14.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.167 -0.924 . . . . 1.0 111.578 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.405 ' HB2' ' CD2' ' A' ' 54' ' ' TYR . 85.6 m-85 -139.77 153.21 47.1 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 106.741 -1.578 . . . . 1.0 106.741 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -69.17 133.72 48.34 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.928 -0.768 . . . . 1.0 108.928 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -129.14 121.0 26.84 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -101.08 119.96 39.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.048 -0.978 . . . . 1.0 110.62 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.25 135.65 57.79 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 119.204 -0.999 . . . . 1.0 110.929 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.87 -2.58 19.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.135 -0.939 . . . . 1.0 110.277 176.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -136.58 164.66 27.67 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.295 -1.002 . . . . 1.0 108.295 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -65.24 -33.97 77.24 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 113.904 1.075 . . . . 1.0 113.904 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.6 p-10 -85.86 2.35 46.22 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 114.496 1.295 . . . . 1.0 114.496 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -100.12 137.68 38.24 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.331 0.586 . . . . 1.0 112.466 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.8 mt -76.29 147.22 38.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.715 0.769 . . . . 1.0 110.423 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.0 m -114.91 127.47 55.72 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 105.924 -1.88 . . . . 1.0 105.924 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -154.09 169.28 23.93 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 123.477 0.485 . . . . 1.0 110.056 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.8 m -120.31 160.85 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 O-C-N 123.67 0.606 . . . . 1.0 109.89 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -46.39 136.92 6.9 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 80.41 -8.96 1.43 Allowed 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 116.783 2.142 . . . . 1.0 116.783 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -67.04 147.64 52.93 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.258 -0.977 . . . . 1.0 109.051 170.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.66 139.61 32.49 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.019 0.438 . . . . 1.0 111.588 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.64 124.96 73.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 103.792 -2.67 . . . . 1.0 103.792 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 pt -115.64 165.86 10.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.655 0.741 . . . . 1.0 112.031 -172.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 51.08 51.02 17.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.013 0.911 . . . . 1.0 111.042 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.5 mt -72.75 131.29 35.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.873 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -112.8 134.29 54.39 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.036 -1.468 . . . . 1.0 107.036 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.437 ' HA ' ' CD1' ' A' ' 37' ' ' TRP . 94.0 m-85 -78.68 68.04 4.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.701 0.762 . . . . 1.0 109.246 -176.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.423 HG21 ' HB2' ' A' ' 38' ' ' LEU . 92.6 t -65.27 -44.32 95.01 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.703 0 N-CA-C 113.946 1.091 . . . . 1.0 113.946 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -143.42 162.99 34.32 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.702 -1.592 . . . . 1.0 106.702 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -64.56 -35.68 81.77 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 120.922 0.391 . . . . 1.0 111.594 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -96.28 -42.02 8.37 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.959 1.466 . . . . 1.0 114.959 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -113.26 136.89 52.25 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.633 -1.247 . . . . 1.0 107.633 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 17.6 m0 -120.52 160.02 24.01 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.139 -1.06 . . . . 1.0 108.139 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.439 HD12 ' C ' ' A' ' 48' ' ' GLY . 53.0 tp -107.68 131.06 54.81 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.72 -170.8 16.87 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 119.65 -1.262 . . . . 1.0 111.836 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.455 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 78.3 tt0 -133.67 139.3 46.36 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 123.797 0.839 . . . . 1.0 109.374 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.7 mt -75.81 132.22 40.26 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 119.311 -0.956 . . . . 1.0 112.266 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -57.77 -38.62 75.74 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 120.072 -0.651 . . . . 1.0 110.556 172.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.81 -21.55 59.23 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 115.898 1.814 . . . . 1.0 115.898 -168.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.9 -0.66 0.8 Allowed 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 116.082 1.882 . . . . 1.0 116.082 -174.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.93 1.71 79.81 Favored Glycine 0 C--O 1.223 -0.566 0 C-N-CA 119.588 -1.292 . . . . 1.0 115.446 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.05 150.84 46.19 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 119.615 1.708 . . . . 1.0 108.546 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.455 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.22 149.9 51.71 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 109.373 -0.602 . . . . 1.0 109.373 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.439 ' C ' HD12 ' A' ' 38' ' ' LEU . . . 166.47 178.99 39.5 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.582 -0.818 . . . . 1.0 112.772 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.9 mp -73.33 146.03 45.55 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.551 -0.825 . . . . 1.0 111.608 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.533 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 44.0 p90 -146.57 150.48 40.37 Favored Pre-proline 0 C--O 1.245 0.827 0 N-CA-C 108.053 -1.091 . . . . 1.0 108.053 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.432 ' HG2' ' CD1' ' A' ' 54' ' ' TYR . 61.4 Cg_endo -82.62 127.08 4.86 Favored 'Trans proline' 0 CA--C 1.513 -0.572 0 N-CA-C 108.784 -1.275 . . . . 1.0 108.784 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.6 m -59.05 -36.9 75.83 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 114.383 1.253 . . . . 1.0 114.383 -177.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -65.32 -6.5 10.08 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.403 0.89 . . . . 1.0 113.403 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.432 ' CD1' ' HG2' ' A' ' 51' ' ' PRO . 16.3 m-85 -92.63 -2.83 55.8 Favored 'General case' 0 C--O 1.222 -0.374 0 O-C-N 120.275 -1.516 . . . . 1.0 113.434 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.1 m -138.3 162.11 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.617 0.722 . . . . 1.0 111.774 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 56.3 m -127.63 130.36 48.83 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 123.995 0.918 . . . . 1.0 108.596 177.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.8 mt -58.36 141.76 50.27 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.836 0.827 . . . . 1.0 111.074 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.42 -164.61 54.55 Favored Glycine 0 C--O 1.246 0.904 0 CA-C-N 115.401 -0.818 . . . . 1.0 113.546 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.318 0 CA-C-O 117.619 -1.181 . . . . 1.0 111.44 -177.023 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo . . . . . 0 CA--C 1.515 -0.431 0 N-CA-C 109.614 -0.956 . . . . 1.0 109.614 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.37 165.44 12.71 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.795 0.807 . . . . 1.0 109.696 169.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.74 164.12 31.37 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.256 -0.884 . . . . 1.0 111.537 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 58' ' ' GLY . 4.5 p -104.05 162.2 13.36 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 177.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.511 ' HB3' ' N ' ' A' ' 23' ' ' ASN . . . -92.77 109.77 21.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.103 0.954 . . . . 1.0 110.459 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -70.84 -42.3 70.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.192 -0.913 . . . . 1.0 111.6 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -137.72 155.89 48.59 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 106.744 -1.576 . . . . 1.0 106.744 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -67.03 133.58 50.2 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 175.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -127.45 124.42 38.37 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.777 -1.194 . . . . 1.0 107.777 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -103.25 118.78 37.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.04 -0.982 . . . . 1.0 110.647 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -62.31 136.5 57.95 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.146 -1.022 . . . . 1.0 111.012 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.28 5.96 22.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.361 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -140.29 159.96 41.04 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -63.36 -33.84 76.41 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 113.849 1.055 . . . . 1.0 113.849 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -88.08 6.63 35.37 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.415 1.265 . . . . 1.0 114.415 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 99.2 mt-10 -103.27 139.57 38.54 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.328 0.585 . . . . 1.0 112.51 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.07 145.1 36.03 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.697 0.76 . . . . 1.0 110.367 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.9 m -112.83 130.37 56.11 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 105.92 -1.882 . . . . 1.0 105.92 175.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -156.21 169.3 24.85 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.112 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.7 m -120.34 160.8 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 O-C-N 123.694 0.621 . . . . 1.0 109.874 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.36 136.88 6.87 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.511 ' N ' ' HB3' ' A' ' 6' ' ' ALA . 90.6 m-20 80.39 -8.92 1.44 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.757 2.132 . . . . 1.0 116.757 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.04 147.62 52.96 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.259 -0.976 . . . . 1.0 109.038 170.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.72 139.54 32.63 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.048 0.451 . . . . 1.0 111.596 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.53 125.0 73.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 103.83 -2.656 . . . . 1.0 103.83 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 pt -115.66 165.84 10.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-O 121.618 0.723 . . . . 1.0 111.972 -172.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.08 50.99 17.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.982 0.896 . . . . 1.0 111.042 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.4 mt -70.69 131.25 34.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.868 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -112.51 132.84 54.89 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 107.092 -1.447 . . . . 1.0 107.092 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.487 ' HA ' ' CD1' ' A' ' 37' ' ' TRP . 90.1 m-85 -78.85 68.68 4.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.632 0.73 . . . . 1.0 109.174 -176.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.5 t -66.56 -43.85 90.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 113.872 1.064 . . . . 1.0 113.872 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -143.24 162.03 36.72 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.799 -1.556 . . . . 1.0 106.799 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -64.64 -33.13 75.22 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 120.948 0.404 . . . . 1.0 111.575 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -96.56 -39.61 9.45 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 115.076 1.51 . . . . 1.0 115.076 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 43.5 m95 -117.76 141.3 48.56 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.668 -1.234 . . . . 1.0 107.668 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.487 ' CD1' ' HA ' ' A' ' 31' ' ' PHE . 17.5 m0 -126.57 154.88 43.3 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.165 -1.05 . . . . 1.0 108.165 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.5 tp -99.43 128.83 45.57 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.374 -0.973 . . . . 1.0 108.374 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.59 -162.54 9.55 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 119.78 -1.2 . . . . 1.0 111.819 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.456 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 77.1 tt0 -141.92 138.52 32.07 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 123.837 0.855 . . . . 1.0 109.251 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.4 mt -75.3 132.25 40.87 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.287 -0.965 . . . . 1.0 112.256 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.82 -38.52 75.74 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.013 -0.675 . . . . 1.0 110.547 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.84 -21.54 59.21 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 115.884 1.809 . . . . 1.0 115.884 -168.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.87 -0.72 0.8 Allowed 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 116.155 1.909 . . . . 1.0 116.155 -174.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.9 1.76 79.77 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.65 -1.262 . . . . 1.0 115.495 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.04 150.87 46.17 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 119.541 1.67 . . . . 1.0 108.602 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.456 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.25 149.94 51.72 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 109.276 -0.639 . . . . 1.0 109.276 -176.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.42 175.17 36.47 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.579 -0.82 . . . . 1.0 112.825 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.3 mt -72.49 139.45 47.65 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.535 -0.832 . . . . 1.0 111.595 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 49.5 p90 -139.86 149.41 58.99 Favored Pre-proline 0 C--O 1.245 0.837 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.404 ' HG2' ' CD1' ' A' ' 54' ' ' TYR . 61.5 Cg_endo -82.11 134.11 7.97 Favored 'Trans proline' 0 CA--C 1.512 -0.589 0 N-CA-C 108.857 -1.247 . . . . 1.0 108.857 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.6 m -63.86 -37.91 89.13 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 114.277 1.214 . . . . 1.0 114.277 -176.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -61.77 -8.54 4.9 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.463 0.912 . . . . 1.0 113.463 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.404 ' CD1' ' HG2' ' A' ' 51' ' ' PRO . 23.3 m-85 -94.7 -0.24 54.49 Favored 'General case' 0 C--O 1.222 -0.379 0 O-C-N 120.184 -1.572 . . . . 1.0 113.398 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.9 m -137.76 159.01 34.19 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-O 121.606 0.717 . . . . 1.0 111.722 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.6 t -128.8 129.63 45.91 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 108.546 -0.909 . . . . 1.0 108.546 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -59.07 141.67 53.43 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.783 0.801 . . . . 1.0 111.073 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 5' ' ' THR . . . 72.54 -164.63 54.63 Favored Glycine 0 C--O 1.246 0.876 0 CA-C-N 115.354 -0.839 . . . . 1.0 113.453 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.255 1.352 0 CA-C-O 117.59 -1.195 . . . . 1.0 111.43 -176.984 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 CA--C 1.515 -0.447 0 N-CA-C 109.673 -0.933 . . . . 1.0 109.673 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -114.38 165.38 12.78 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.788 0.804 . . . . 1.0 109.679 169.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.75 164.08 31.5 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.273 -0.876 . . . . 1.0 111.478 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.8 p -114.8 132.48 56.46 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.25 133.95 50.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.989 0.9 . . . . 1.0 110.402 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -99.24 -28.48 13.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.141 -0.936 . . . . 1.0 111.543 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -137.68 150.07 47.04 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 106.707 -1.59 . . . . 1.0 106.707 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -65.9 134.07 52.24 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -126.68 124.21 39.31 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 107.781 -1.192 . . . . 1.0 107.781 177.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -101.03 116.1 32.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.089 -0.96 . . . . 1.0 110.694 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.98 137.65 58.33 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.194 -1.003 . . . . 1.0 111.035 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -113.36 5.66 16.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.207 -0.906 . . . . 1.0 110.34 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -137.27 159.69 41.2 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.218 -1.03 . . . . 1.0 108.218 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -64.49 -33.92 77.02 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 113.866 1.062 . . . . 1.0 113.866 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -88.71 5.5 42.98 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.482 1.29 . . . . 1.0 114.482 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -100.7 136.9 39.84 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.313 0.578 . . . . 1.0 112.538 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.25 142.49 41.39 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.778 0.799 . . . . 1.0 110.336 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.2 m -110.0 131.2 55.28 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 105.969 -1.863 . . . . 1.0 105.969 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -155.68 169.26 24.74 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 120.402 -0.519 . . . . 1.0 110.129 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.4 m -120.37 160.77 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.694 0.621 . . . . 1.0 109.817 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.28 136.86 6.75 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 80.39 -8.92 1.44 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.757 2.132 . . . . 1.0 116.757 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.05 147.64 52.92 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.245 -0.982 . . . . 1.0 109.051 170.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.68 139.5 32.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.018 0.437 . . . . 1.0 111.627 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.412 HG21 ' CE1' ' A' ' 50' ' ' PHE . 4.5 mp -117.56 125.0 73.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 103.745 -2.687 . . . . 1.0 103.745 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 pt -115.7 165.88 10.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.667 0.746 . . . . 1.0 111.931 -172.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 51.1 50.94 18.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.978 0.894 . . . . 1.0 111.058 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.0 mt -68.02 128.8 31.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.934 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -113.0 121.74 45.53 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.051 -1.463 . . . . 1.0 107.051 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -76.19 72.21 2.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.57 0.7 . . . . 1.0 109.204 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.4 t -66.91 -43.82 89.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 113.94 1.089 . . . . 1.0 113.94 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -139.83 164.51 29.78 Favored 'General case' 0 C--O 1.22 -0.494 0 N-CA-C 106.716 -1.587 . . . . 1.0 106.716 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -64.93 -35.45 81.21 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 120.986 0.422 . . . . 1.0 111.648 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -97.49 -33.49 11.35 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 114.986 1.476 . . . . 1.0 114.986 -176.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.415 ' CH2' ' HG3' ' A' ' 51' ' ' PRO . 54.3 m95 -114.28 133.43 55.66 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.731 -1.211 . . . . 1.0 107.731 -178.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 53.0 m0 -116.52 151.0 37.03 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.09 -1.078 . . . . 1.0 108.09 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.9 tp -104.55 124.19 48.86 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.412 -0.958 . . . . 1.0 108.412 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.12 -165.77 11.09 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 119.609 -1.282 . . . . 1.0 111.834 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -140.15 139.7 35.82 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 123.73 0.812 . . . . 1.0 109.284 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.2 mt -76.15 132.25 39.88 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.096 -1.042 . . . . 1.0 112.256 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.76 -38.61 75.72 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.097 -0.641 . . . . 1.0 110.494 172.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.79 -21.6 59.23 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 115.929 1.825 . . . . 1.0 115.929 -168.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.83 -0.71 0.8 Allowed 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 116.084 1.883 . . . . 1.0 116.084 -174.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.87 1.76 79.64 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.673 -1.251 . . . . 1.0 115.43 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.0 p -70.06 150.86 46.15 Favored 'General case' 0 C--O 1.213 -0.851 0 CA-C-N 119.572 1.686 . . . . 1.0 108.577 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -130.23 149.96 51.69 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 109.276 -0.639 . . . . 1.0 109.276 -176.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.56 172.46 34.69 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.57 -0.824 . . . . 1.0 112.806 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.3 mt -75.54 140.36 42.69 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.586 -0.807 . . . . 1.0 111.62 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.412 ' CE1' HG21 ' A' ' 26' ' ' ILE . 50.3 p90 -144.12 139.55 16.01 Favored Pre-proline 0 C--O 1.246 0.875 0 N-CA-C 108.06 -1.089 . . . . 1.0 108.06 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.415 ' HG3' ' CH2' ' A' ' 36' ' ' TRP . 31.2 Cg_exo -62.9 133.83 43.54 Favored 'Trans proline' 0 CA--C 1.512 -0.6 0 N-CA-C 108.762 -1.284 . . . . 1.0 108.762 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 81.5 p -66.84 -17.95 65.14 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 114.368 1.247 . . . . 1.0 114.368 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -81.55 -1.26 45.62 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.435 0.902 . . . . 1.0 113.435 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -95.58 -0.99 51.33 Favored 'General case' 0 C--O 1.222 -0.375 0 O-C-N 120.171 -1.58 . . . . 1.0 113.5 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.8 m -136.54 162.13 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.582 0.706 . . . . 1.0 111.734 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 65.0 p -128.28 130.52 47.99 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 123.944 0.898 . . . . 1.0 108.589 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.5 mt -60.46 141.72 56.05 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.893 0.854 . . . . 1.0 111.017 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.44 -164.61 54.56 Favored Glycine 0 C--O 1.246 0.876 0 CA-C-N 115.34 -0.845 . . . . 1.0 113.549 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.329 0 CA-C-O 117.564 -1.208 . . . . 1.0 111.404 -176.966 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 CA--C 1.516 -0.398 0 N-CA-C 109.574 -0.971 . . . . 1.0 109.574 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.28 165.45 12.68 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.816 0.817 . . . . 1.0 109.668 169.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.77 164.15 31.32 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.234 -0.893 . . . . 1.0 111.453 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 58' ' ' GLY . 25.5 p -115.35 132.9 56.47 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.161 -1.051 . . . . 1.0 108.161 178.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.482 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -67.46 136.72 55.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.987 0.899 . . . . 1.0 110.518 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -100.73 -26.34 13.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.204 -0.907 . . . . 1.0 111.533 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.402 ' HB2' ' CD2' ' A' ' 54' ' ' TYR . 91.5 m-85 -140.33 149.82 43.21 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 106.722 -1.585 . . . . 1.0 106.722 -178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -63.6 132.8 52.33 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.922 -0.769 . . . . 1.0 108.922 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -128.04 125.85 40.14 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.667 -1.234 . . . . 1.0 107.667 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -106.35 119.65 39.8 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 124.29 0.994 . . . . 1.0 110.789 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.459 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -60.39 136.33 58.01 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 119.195 -1.002 . . . . 1.0 111.114 178.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.25 2.8 27.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.229 -0.896 . . . . 1.0 110.298 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -142.53 163.85 31.72 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -65.85 -32.65 74.29 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 113.824 1.046 . . . . 1.0 113.824 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -85.99 5.92 31.09 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.544 1.313 . . . . 1.0 114.544 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 96.4 mt-10 -104.61 139.75 39.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.318 0.58 . . . . 1.0 112.537 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.6 mt -76.91 142.8 39.97 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.785 0.802 . . . . 1.0 110.321 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.2 m -111.06 129.13 56.01 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 105.953 -1.869 . . . . 1.0 105.953 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -156.17 169.28 24.89 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 120.288 -0.565 . . . . 1.0 110.056 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.31 160.79 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 O-C-N 123.628 0.58 . . . . 1.0 109.89 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -46.21 136.78 6.69 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.698 -0.853 . . . . 1.0 108.698 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 80.42 -8.92 1.44 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.757 2.132 . . . . 1.0 116.757 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -66.99 147.59 53.03 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.266 -0.974 . . . . 1.0 109.084 170.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.69 139.59 32.52 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.037 0.446 . . . . 1.0 111.582 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.61 124.98 73.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 103.756 -2.683 . . . . 1.0 103.756 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.1 pt -115.72 165.78 10.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-O 121.659 0.742 . . . . 1.0 111.958 -172.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.14 51.02 17.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.013 0.911 . . . . 1.0 111.042 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.1 mt -71.38 131.13 34.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.934 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -114.84 135.73 53.87 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.995 -1.483 . . . . 1.0 106.995 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -78.31 67.53 4.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.646 0.736 . . . . 1.0 109.164 -176.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.47 -40.86 89.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.885 1.068 . . . . 1.0 113.885 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -144.49 160.06 41.72 Favored 'General case' 0 C--O 1.219 -0.536 0 N-CA-C 106.763 -1.569 . . . . 1.0 106.763 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -63.68 -33.02 74.7 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 120.902 0.382 . . . . 1.0 111.612 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -100.29 -34.53 9.95 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 115.09 1.515 . . . . 1.0 115.09 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 52.2 m95 -111.24 135.29 51.98 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.598 -1.26 . . . . 1.0 107.598 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.425 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . 10.7 m0 -110.36 151.59 27.26 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.147 -1.057 . . . . 1.0 108.147 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.3 tp -108.58 125.95 52.4 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.419 -0.956 . . . . 1.0 108.419 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.99 -165.84 13.5 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 119.767 -1.206 . . . . 1.0 111.884 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.444 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 75.1 tt0 -135.59 141.94 45.22 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 123.75 0.82 . . . . 1.0 109.195 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.9 mt -75.16 132.21 41.0 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.159 -1.016 . . . . 1.0 112.282 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.82 -38.52 75.74 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.013 -0.675 . . . . 1.0 110.547 172.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.75 -21.58 59.27 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 115.912 1.819 . . . . 1.0 115.912 -168.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.94 -0.7 0.79 Allowed 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 116.091 1.886 . . . . 1.0 116.091 -174.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.82 1.79 79.45 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.658 -1.258 . . . . 1.0 115.51 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.0 p -70.04 150.92 46.12 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 119.541 1.67 . . . . 1.0 108.602 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.444 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.31 149.95 51.77 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 109.241 -0.652 . . . . 1.0 109.241 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.11 176.31 37.91 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.568 -0.825 . . . . 1.0 112.776 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -77.51 137.06 38.42 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.516 -0.842 . . . . 1.0 111.613 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.425 ' CE2' ' HB2' ' A' ' 37' ' ' TRP . 50.1 p90 -138.34 150.83 67.94 Favored Pre-proline 0 C--O 1.243 0.743 0 N-CA-C 107.943 -1.132 . . . . 1.0 107.943 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -80.36 129.19 7.46 Favored 'Trans proline' 0 CA--C 1.513 -0.54 0 N-CA-C 108.839 -1.254 . . . . 1.0 108.839 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.8 m -59.9 -34.84 73.72 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 114.344 1.239 . . . . 1.0 114.344 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -61.99 -9.23 6.59 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.489 0.922 . . . . 1.0 113.489 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.402 ' CD2' ' HB2' ' A' ' 8' ' ' TYR . 22.3 m-85 -94.74 1.15 55.45 Favored 'General case' 0 C--O 1.222 -0.356 0 O-C-N 120.243 -1.536 . . . . 1.0 113.405 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.482 HG12 ' HA ' ' A' ' 6' ' ' ALA . 33.7 m -138.01 162.28 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.482 0.658 . . . . 1.0 111.778 -178.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.2 p -133.34 131.59 40.28 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 176.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -60.63 141.72 56.4 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.836 0.827 . . . . 1.0 111.052 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 5' ' ' THR . . . 72.41 -164.67 54.54 Favored Glycine 0 C--O 1.247 0.933 0 CA-C-N 115.36 -0.836 . . . . 1.0 113.57 177.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.255 1.352 0 CA-C-O 117.59 -1.195 . . . . 1.0 111.43 -176.981 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 CA--C 1.515 -0.464 0 N-CA-C 109.634 -0.948 . . . . 1.0 109.634 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.39 165.41 12.74 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.766 0.794 . . . . 1.0 109.74 169.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.7 164.05 31.54 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.348 -0.842 . . . . 1.0 111.549 -176.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.6 m -117.8 128.67 55.09 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.11 -1.07 . . . . 1.0 108.11 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.45 136.74 56.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.995 0.902 . . . . 1.0 110.49 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -101.71 -21.05 14.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.16 -0.927 . . . . 1.0 111.584 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -138.73 151.39 47.08 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 106.818 -1.549 . . . . 1.0 106.818 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -67.22 132.42 47.73 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.847 -0.797 . . . . 1.0 108.847 176.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.482 ' HB2' ' CD2' ' A' ' 54' ' ' TYR . 81.8 t80 -135.34 130.53 35.15 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 107.781 -1.192 . . . . 1.0 107.781 177.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -114.16 134.4 54.93 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.049 -0.978 . . . . 1.0 110.658 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.575 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -67.66 139.05 56.77 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.138 -1.025 . . . . 1.0 111.095 178.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.94 -4.87 18.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.254 -0.885 . . . . 1.0 110.273 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -131.14 166.78 20.36 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 108.26 -1.015 . . . . 1.0 108.26 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -66.81 -34.04 76.93 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 113.876 1.065 . . . . 1.0 113.876 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -87.95 7.56 30.42 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.458 1.281 . . . . 1.0 114.458 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.575 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 99.5 mt-10 -103.84 149.49 25.0 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.27 0.557 . . . . 1.0 112.448 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.457 HD22 ' HG ' ' A' ' 41' ' ' LEU . 75.6 mt -90.24 142.72 27.44 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.63 0.729 . . . . 1.0 110.349 177.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.1 t -109.86 132.19 54.38 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 105.882 -1.896 . . . . 1.0 105.882 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -156.12 169.19 25.07 Favored 'General case' 0 CA--C 1.503 -0.855 0 O-C-N 123.33 0.394 . . . . 1.0 110.13 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.8 m -120.31 160.85 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.683 0.614 . . . . 1.0 109.86 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -46.43 136.81 7.06 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.655 -0.869 . . . . 1.0 108.655 176.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 80.5 -8.92 1.43 Allowed 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 116.783 2.142 . . . . 1.0 116.783 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -66.97 147.6 53.02 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.266 -0.974 . . . . 1.0 109.103 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.7 139.51 32.66 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.996 0.427 . . . . 1.0 111.615 175.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.59 124.94 73.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.81 -2.663 . . . . 1.0 103.81 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 pt -115.68 165.91 10.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-O 121.673 0.749 . . . . 1.0 111.994 -172.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.08 51.02 17.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.013 0.911 . . . . 1.0 111.042 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.93 128.75 32.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.918 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -112.92 123.35 50.12 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.093 -1.447 . . . . 1.0 107.093 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -75.71 72.26 2.63 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.691 0.757 . . . . 1.0 109.127 -175.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.441 HG21 HD22 ' A' ' 38' ' ' LEU . 68.3 t -66.94 -44.64 88.52 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 N-CA-C 113.947 1.092 . . . . 1.0 113.947 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -141.22 163.09 33.9 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 106.745 -1.576 . . . . 1.0 106.745 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -66.1 -34.63 78.5 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.031 0.443 . . . . 1.0 111.508 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -93.2 -37.73 11.94 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 115.031 1.493 . . . . 1.0 115.031 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 33.3 m95 -114.29 135.23 54.29 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.705 -1.22 . . . . 1.0 107.705 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 50.7 m0 -114.19 148.72 36.85 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.233 -1.025 . . . . 1.0 108.233 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.441 HD22 HG21 ' A' ' 32' ' ' VAL . 38.0 tp -103.46 133.78 47.94 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.359 -0.978 . . . . 1.0 108.359 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.67 -166.64 17.42 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 119.746 -1.216 . . . . 1.0 111.884 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.469 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 77.4 tt0 -136.6 140.18 42.65 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.901 0.88 . . . . 1.0 109.327 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.457 ' HG ' HD22 ' A' ' 18' ' ' LEU . 52.6 mt -75.58 132.25 40.55 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.724 -0.791 . . . . 1.0 112.242 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.76 -38.62 75.72 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.097 -0.641 . . . . 1.0 110.494 172.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.74 -21.7 59.21 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 115.851 1.797 . . . . 1.0 115.851 -168.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 51.0 p30 -145.83 -0.71 0.8 Allowed 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 116.096 1.887 . . . . 1.0 116.096 -174.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.92 1.76 79.92 Favored Glycine 0 C--O 1.222 -0.631 0 C-N-CA 119.699 -1.239 . . . . 1.0 115.43 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.05 150.86 46.17 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 119.572 1.686 . . . . 1.0 108.584 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.469 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.2 149.87 51.71 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 -176.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.84 174.37 35.28 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.554 -0.831 . . . . 1.0 112.797 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.5 145.44 43.52 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.598 -0.801 . . . . 1.0 111.544 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -149.52 140.17 13.92 Favored Pre-proline 0 N--CA 1.443 -0.823 0 N-CA-C 108.025 -1.102 . . . . 1.0 108.025 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -63.47 133.65 40.99 Favored 'Trans proline' 0 CA--C 1.513 -0.529 0 N-CA-C 108.904 -1.229 . . . . 1.0 108.904 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.4 p -67.8 -18.22 64.78 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 114.274 1.212 . . . . 1.0 114.274 -176.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -80.18 -2.1 43.29 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.436 0.902 . . . . 1.0 113.436 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.482 ' CD2' ' HB2' ' A' ' 10' ' ' TYR . 32.2 m-85 -95.4 0.58 53.61 Favored 'General case' 0 C--O 1.223 -0.326 0 O-C-N 120.157 -1.589 . . . . 1.0 113.317 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 m -138.57 163.03 28.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 118.698 0.681 . . . . 1.0 111.813 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.3 p -129.92 130.76 45.54 Favored 'General case' 0 C--O 1.213 -0.818 0 C-N-CA 123.985 0.914 . . . . 1.0 108.562 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -59.33 141.67 53.94 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 119.628 -0.829 . . . . 1.0 111.073 -177.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.53 -164.68 54.62 Favored Glycine 0 C--O 1.247 0.914 0 CA-C-N 115.336 -0.847 . . . . 1.0 113.455 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.296 0 CA-C-O 117.563 -1.208 . . . . 1.0 111.342 -176.902 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 CA--C 1.515 -0.464 0 N-CA-C 109.635 -0.948 . . . . 1.0 109.635 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.36 165.5 12.65 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.809 0.814 . . . . 1.0 109.712 169.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.77 164.08 31.52 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.292 -0.867 . . . . 1.0 111.487 -176.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.5 p -114.97 134.34 55.26 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.71 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -70.0 137.61 51.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.98 0.895 . . . . 1.0 110.532 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -104.25 -25.17 13.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.263 -0.88 . . . . 1.0 111.538 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -138.95 148.27 43.31 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 106.775 -1.565 . . . . 1.0 106.775 -178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -68.55 137.75 54.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -127.04 123.83 37.92 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.744 -1.206 . . . . 1.0 107.744 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -99.52 113.54 25.99 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 124.306 1.004 . . . . 1.0 110.651 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.482 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -60.34 136.97 58.2 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.226 -0.99 . . . . 1.0 111.001 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.95 -4.94 20.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.187 -0.915 . . . . 1.0 110.343 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -132.35 162.34 31.31 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.268 -1.012 . . . . 1.0 108.268 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -66.86 -31.76 72.59 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 113.885 1.068 . . . . 1.0 113.885 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -88.22 8.01 29.22 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.482 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 96.3 mt-10 -100.67 139.59 36.14 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 112.567 0.58 . . . . 1.0 112.567 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.845 HD11 ' HG ' ' A' ' 41' ' ' LEU . 12.7 tp -74.78 134.93 41.73 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.682 0.753 . . . . 1.0 110.403 177.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.5 m -110.5 128.63 55.71 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 105.939 -1.874 . . . . 1.0 105.939 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -155.78 169.32 24.64 Favored 'General case' 0 CA--C 1.503 -0.86 0 O-C-N 123.898 0.749 . . . . 1.0 110.112 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.5 m -120.4 160.82 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.687 0.617 . . . . 1.0 109.794 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.39 136.89 6.92 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.62 -0.881 . . . . 1.0 108.62 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 80.39 -8.92 1.44 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.757 2.132 . . . . 1.0 116.757 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.07 147.51 53.08 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.259 -0.976 . . . . 1.0 109.068 170.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.59 139.57 32.48 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.003 0.43 . . . . 1.0 111.642 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.524 HD13 HG11 ' A' ' 55' ' ' VAL . 4.5 mp -117.53 124.95 73.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.788 -2.671 . . . . 1.0 103.788 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 pt -115.65 165.86 10.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.648 0.737 . . . . 1.0 112.015 -172.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.1 50.94 18.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.947 0.879 . . . . 1.0 111.058 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.11 130.56 34.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.882 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -117.36 122.83 44.94 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.094 -1.447 . . . . 1.0 107.094 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -77.3 77.01 3.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.554 0.692 . . . . 1.0 109.152 -175.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.2 t -65.12 -45.27 94.64 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 N-CA-C 113.818 1.044 . . . . 1.0 113.818 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -135.35 177.1 8.08 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 106.759 -1.571 . . . . 1.0 106.759 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -71.05 -29.96 65.99 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 121.037 0.446 . . . . 1.0 111.626 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -111.23 -28.18 8.37 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 114.957 1.466 . . . . 1.0 114.957 -176.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 51.5 m95 -111.97 128.24 56.11 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.625 -1.25 . . . . 1.0 107.625 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -117.14 156.1 28.21 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.161 -1.051 . . . . 1.0 108.161 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.4 tp -106.2 128.22 53.78 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.361 -0.977 . . . . 1.0 108.361 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -150.24 172.51 30.05 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 119.788 -1.196 . . . . 1.0 111.904 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.43 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 77.7 tt0 -120.72 139.35 53.19 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.873 0.869 . . . . 1.0 109.302 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.845 ' HG ' HD11 ' A' ' 18' ' ' LEU . 52.6 mt -75.2 132.24 40.98 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.203 -0.999 . . . . 1.0 112.267 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.82 -38.56 75.82 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.013 -0.675 . . . . 1.0 110.547 172.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -74.73 -21.64 59.26 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 115.91 1.818 . . . . 1.0 115.91 -168.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.85 -0.62 0.81 Allowed 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 116.146 1.906 . . . . 1.0 116.146 -174.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.85 1.7 79.34 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.65 -1.262 . . . . 1.0 115.461 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.0 p -70.04 150.92 46.12 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 119.589 1.695 . . . . 1.0 108.602 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.43 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.31 149.95 51.77 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 109.241 -0.652 . . . . 1.0 109.241 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.43 172.69 34.02 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.559 -0.829 . . . . 1.0 112.749 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.0 mt -73.13 142.17 47.48 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 114.636 -0.782 . . . . 1.0 111.588 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -143.94 142.31 20.1 Favored Pre-proline 0 C--O 1.245 0.862 0 N-CA-C 108.015 -1.106 . . . . 1.0 108.015 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -65.14 133.65 36.29 Favored 'Trans proline' 0 CA--C 1.513 -0.564 0 N-CA-C 108.855 -1.248 . . . . 1.0 108.855 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.4 p -67.94 -14.81 63.26 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 114.264 1.209 . . . . 1.0 114.264 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -88.78 6.05 40.66 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.402 0.89 . . . . 1.0 113.402 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -101.53 -0.94 34.13 Favored 'General case' 0 C--O 1.221 -0.4 0 O-C-N 120.186 -1.571 . . . . 1.0 113.361 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.71 HG12 ' HA ' ' A' ' 6' ' ' ALA . 33.3 m -137.81 164.96 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.532 0.682 . . . . 1.0 111.733 -178.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.0 p -129.43 130.85 46.46 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 108.565 -0.902 . . . . 1.0 108.565 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -59.14 141.74 53.38 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.779 0.8 . . . . 1.0 111.13 -177.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.5 -164.7 54.6 Favored Glycine 0 C--O 1.246 0.904 0 CA-C-N 115.359 -0.837 . . . . 1.0 113.491 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.253 1.262 0 CA-C-O 117.581 -1.199 . . . . 1.0 111.43 -176.989 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo . . . . . 0 CA--C 1.515 -0.431 0 N-CA-C 109.614 -0.956 . . . . 1.0 109.614 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.39 165.41 12.75 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.743 0.782 . . . . 1.0 109.724 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.77 164.06 31.57 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.354 -0.839 . . . . 1.0 111.526 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.4 m -115.93 128.03 55.44 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.262 -1.014 . . . . 1.0 108.262 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.575 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -65.17 135.69 55.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.992 0.901 . . . . 1.0 110.501 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -99.37 -24.87 14.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.185 -0.916 . . . . 1.0 111.531 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -140.29 149.81 43.26 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 106.787 -1.56 . . . . 1.0 106.787 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -66.11 136.21 55.65 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.904 -0.776 . . . . 1.0 108.904 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -128.85 123.47 32.83 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 107.757 -1.201 . . . . 1.0 107.757 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -102.28 119.47 38.86 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 124.279 0.987 . . . . 1.0 110.748 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -60.62 136.29 58.01 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.216 -0.994 . . . . 1.0 111.088 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.75 -3.37 22.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.269 -0.878 . . . . 1.0 110.307 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -136.11 164.6 27.65 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.212 -1.033 . . . . 1.0 108.212 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -65.02 -32.48 74.22 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 113.863 1.06 . . . . 1.0 113.863 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -87.34 4.88 41.2 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.556 1.317 . . . . 1.0 114.556 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.524 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 80.7 mm-40 -101.73 137.08 40.51 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 112.525 0.565 . . . . 1.0 112.525 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.0 mt -75.58 147.02 39.95 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.729 0.776 . . . . 1.0 110.39 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.5 m -115.43 129.47 56.58 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 105.853 -1.906 . . . . 1.0 105.853 175.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -153.9 169.29 23.8 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 123.353 0.408 . . . . 1.0 110.09 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.33 160.79 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.681 0.613 . . . . 1.0 109.86 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.24 136.81 6.73 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.605 -0.887 . . . . 1.0 108.605 176.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 80.43 -8.94 1.43 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.745 2.128 . . . . 1.0 116.745 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -67.07 147.63 52.92 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.245 -0.982 . . . . 1.0 109.038 170.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.7 139.54 32.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.06 0.457 . . . . 1.0 111.609 175.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.56 124.99 73.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.782 -2.673 . . . . 1.0 103.782 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.4 pt -115.69 165.9 10.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.642 0.734 . . . . 1.0 112.021 -172.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 51.03 50.97 18.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.928 0.87 . . . . 1.0 111.154 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 97.1 mt -69.22 130.19 34.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.48 -0.782 . . . . 1.0 110.865 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -113.86 128.2 56.31 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.114 -1.439 . . . . 1.0 107.114 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -77.68 70.45 4.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.651 0.739 . . . . 1.0 109.163 -175.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 65.2 t -68.1 -43.83 84.93 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 N-CA-C 113.889 1.07 . . . . 1.0 113.889 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -139.08 161.4 37.47 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.765 -1.569 . . . . 1.0 106.765 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -64.47 -34.51 78.38 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 121.101 0.477 . . . . 1.0 111.668 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -99.19 -33.18 10.87 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 114.991 1.478 . . . . 1.0 114.991 -176.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.495 ' CH2' ' HG3' ' A' ' 51' ' ' PRO . 30.2 m95 -119.4 132.7 55.88 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.655 -1.239 . . . . 1.0 107.655 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 30.7 m0 -115.99 155.59 27.78 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.105 -1.072 . . . . 1.0 108.105 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.82 128.2 53.58 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.398 -0.964 . . . . 1.0 108.398 178.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.1 -162.82 9.77 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 119.698 -1.239 . . . . 1.0 111.795 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.484 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 76.4 tt0 -140.41 139.35 35.25 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 123.847 0.859 . . . . 1.0 109.298 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.9 mt -75.73 132.25 40.37 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.62 -0.832 . . . . 1.0 112.256 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -57.82 -38.6 75.87 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 119.996 -0.682 . . . . 1.0 110.508 172.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.66 -21.62 59.33 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 115.911 1.819 . . . . 1.0 115.911 -168.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -145.91 -0.63 0.8 Allowed 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 116.105 1.891 . . . . 1.0 116.105 -174.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.93 1.74 79.87 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.649 -1.263 . . . . 1.0 115.428 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.1 150.86 46.12 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 119.589 1.694 . . . . 1.0 108.553 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.484 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.9 mttt -130.2 149.87 51.71 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 -176.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.88 175.97 36.81 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.64 -0.79 . . . . 1.0 112.826 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.7 mt -72.97 147.87 44.78 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.517 -0.841 . . . . 1.0 111.633 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.477 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 52.5 p90 -151.34 136.33 10.33 Favored Pre-proline 0 C--O 1.244 0.804 0 N-CA-C 107.952 -1.129 . . . . 1.0 107.952 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.495 ' HG3' ' CH2' ' A' ' 36' ' ' TRP . 30.2 Cg_exo -64.63 130.72 27.23 Favored 'Trans proline' 0 CA--C 1.512 -0.595 0 N-CA-C 108.837 -1.255 . . . . 1.0 108.837 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.2 p -67.35 -17.58 64.8 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.364 1.246 . . . . 1.0 114.364 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.3 p30 -77.51 -3.44 40.53 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.428 0.899 . . . . 1.0 113.428 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -100.85 6.01 43.6 Favored 'General case' 0 C--O 1.221 -0.446 0 O-C-N 120.204 -1.56 . . . . 1.0 113.416 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 6' ' ' ALA . 34.1 m -138.61 161.93 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.626 0.727 . . . . 1.0 111.681 -177.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.3 t -132.69 130.62 40.31 Favored 'General case' 0 C--O 1.215 -0.729 0 C-N-CA 123.92 0.888 . . . . 1.0 108.609 176.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.6 mt -59.78 141.65 54.85 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.855 0.836 . . . . 1.0 111.073 -177.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.62 -164.66 54.68 Favored Glycine 0 C--O 1.246 0.876 0 CA-C-N 115.332 -0.849 . . . . 1.0 113.512 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.255 1.352 0 CA-C-O 117.59 -1.195 . . . . 1.0 111.43 -177.03 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 CA--C 1.515 -0.447 0 N-CA-C 109.717 -0.917 . . . . 1.0 109.717 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.3 165.38 12.76 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.757 0.789 . . . . 1.0 109.771 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.7 164.1 31.4 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.318 -0.856 . . . . 1.0 111.537 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.2 m -117.88 126.83 53.13 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.42 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -67.48 135.32 52.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 122.057 0.932 . . . . 1.0 110.45 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -102.11 -19.55 15.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.073 -0.967 . . . . 1.0 111.583 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -138.21 148.74 45.11 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 106.732 -1.581 . . . . 1.0 106.732 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.98 133.49 50.06 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -128.13 123.45 34.46 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.729 -1.211 . . . . 1.0 107.729 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -103.18 119.31 38.63 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 124.252 0.97 . . . . 1.0 110.841 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.455 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -62.67 135.98 57.65 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.215 -0.994 . . . . 1.0 110.983 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.09 -3.2 21.79 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.22 -0.9 . . . . 1.0 110.337 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -133.05 161.41 34.44 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 108.312 -0.996 . . . . 1.0 108.312 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -64.88 -34.05 77.46 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 113.889 1.07 . . . . 1.0 113.889 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 p30 -86.39 7.12 27.0 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.552 1.316 . . . . 1.0 114.552 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 97.8 mt-10 -103.74 138.48 40.3 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 112.542 0.571 . . . . 1.0 112.542 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.459 HD11 ' O ' ' A' ' 39' ' ' GLY . 97.2 mt -73.75 142.22 46.29 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.741 0.782 . . . . 1.0 110.411 176.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.7 m -111.7 128.3 56.03 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 105.942 -1.873 . . . . 1.0 105.942 175.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -155.57 169.32 24.57 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 120.156 -0.618 . . . . 1.0 110.056 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.1 m -120.34 160.75 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 O-C-N 123.606 0.566 . . . . 1.0 109.881 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.31 136.89 6.78 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.655 -0.868 . . . . 1.0 108.655 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 80.31 -8.85 1.46 Allowed 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 116.824 2.157 . . . . 1.0 116.824 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -67.12 147.63 52.88 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.238 -0.985 . . . . 1.0 109.038 170.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.65 139.56 32.55 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.01 0.433 . . . . 1.0 111.588 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.6 124.91 73.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 103.779 -2.674 . . . . 1.0 103.779 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 pt -115.58 165.84 10.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.685 0.755 . . . . 1.0 112.066 -172.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 51.07 51.01 17.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.973 0.892 . . . . 1.0 111.114 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.3 mt -68.0 128.4 31.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.902 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -113.36 120.03 39.71 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.166 -1.42 . . . . 1.0 107.166 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -75.05 72.35 2.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.654 0.74 . . . . 1.0 109.141 -175.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.56 -37.07 78.8 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.644 0 N-CA-C 113.864 1.061 . . . . 1.0 113.864 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -145.06 167.37 22.85 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.806 -1.553 . . . . 1.0 106.806 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -67.29 -34.23 76.96 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 121.005 0.431 . . . . 1.0 111.673 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -98.18 -39.41 8.89 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 115.03 1.492 . . . . 1.0 115.03 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -110.71 133.25 53.5 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.678 -1.231 . . . . 1.0 107.678 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 52.6 m0 -117.59 153.33 33.43 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 108.242 -1.021 . . . . 1.0 108.242 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.7 tp -100.28 133.27 44.93 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.42 -0.956 . . . . 1.0 108.42 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.459 ' O ' HD11 ' A' ' 18' ' ' LEU . . . -154.8 178.29 31.61 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 119.723 -1.227 . . . . 1.0 111.737 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.465 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 78.9 tt0 -125.62 140.27 52.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.512 -0.844 . . . . 1.0 109.375 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.6 mt -75.48 132.32 40.71 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 119.398 -0.921 . . . . 1.0 112.238 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.86 -38.61 76.01 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.093 -0.643 . . . . 1.0 110.473 172.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.82 -21.51 59.25 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 115.888 1.81 . . . . 1.0 115.888 -168.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.8 p30 -145.95 -0.72 0.79 Allowed 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 116.072 1.879 . . . . 1.0 116.072 -174.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.94 1.71 79.81 Favored Glycine 0 C--O 1.222 -0.636 0 C-N-CA 119.661 -1.257 . . . . 1.0 115.427 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.1 p -70.04 150.87 46.16 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-N 119.589 1.695 . . . . 1.0 108.59 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.26 149.95 51.72 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 -176.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.98 174.75 36.48 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.568 -0.825 . . . . 1.0 112.751 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.6 mt -73.65 139.36 45.38 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.463 -0.869 . . . . 1.0 111.721 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 51.3 p90 -140.31 150.14 60.27 Favored Pre-proline 0 C--O 1.245 0.854 0 N-CA-C 108.01 -1.108 . . . . 1.0 108.01 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.4 ' HG2' ' CD1' ' A' ' 54' ' ' TYR . 60.4 Cg_endo -79.75 133.86 10.55 Favored 'Trans proline' 0 CA--C 1.513 -0.571 0 N-CA-C 108.836 -1.255 . . . . 1.0 108.836 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.7 m -62.83 -34.95 78.4 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 114.409 1.263 . . . . 1.0 114.409 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -66.44 -7.36 18.97 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.403 0.89 . . . . 1.0 113.403 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.4 ' CD1' ' HG2' ' A' ' 51' ' ' PRO . 24.6 m-85 -93.53 -0.02 56.47 Favored 'General case' 0 C--O 1.222 -0.344 0 O-C-N 120.211 -1.556 . . . . 1.0 113.337 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 6' ' ' ALA . 33.3 m -138.15 163.29 29.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.613 0.721 . . . . 1.0 111.698 -178.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.9 p -132.77 131.17 40.83 Favored 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.6 mt -60.72 141.71 56.59 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.857 0.837 . . . . 1.0 111.039 -176.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.47 -164.65 54.58 Favored Glycine 0 C--O 1.246 0.904 0 CA-C-N 115.337 -0.847 . . . . 1.0 113.473 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.296 0 CA-C-O 117.593 -1.194 . . . . 1.0 111.44 -176.986 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 CA--C 1.515 -0.43 0 N-CA-C 109.604 -0.96 . . . . 1.0 109.604 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.45 165.41 12.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.834 0.826 . . . . 1.0 109.704 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.71 164.09 31.46 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.323 -0.853 . . . . 1.0 111.543 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.5 p -114.64 129.26 56.66 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.159 -1.052 . . . . 1.0 108.159 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.64 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -65.76 134.04 52.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.03 0.919 . . . . 1.0 110.336 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -98.27 -25.46 14.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.144 -0.935 . . . . 1.0 111.525 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -140.19 151.72 45.45 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 106.719 -1.586 . . . . 1.0 106.719 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -67.42 134.87 52.22 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.89 -0.781 . . . . 1.0 108.89 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -127.32 121.87 32.23 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 107.884 -1.154 . . . . 1.0 107.884 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -100.97 116.34 32.6 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.099 -0.955 . . . . 1.0 110.642 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.476 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -59.84 136.82 58.12 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.222 -0.991 . . . . 1.0 111.018 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.74 -4.57 20.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.164 -0.925 . . . . 1.0 110.214 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -134.22 164.74 26.7 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.2 -1.037 . . . . 1.0 108.2 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -66.62 -29.44 69.48 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 113.884 1.068 . . . . 1.0 113.884 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -88.73 5.89 41.25 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.499 1.296 . . . . 1.0 114.499 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.476 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 98.4 mt-10 -104.45 136.61 43.69 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.321 0.581 . . . . 1.0 112.481 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.9 mt -74.83 145.13 43.1 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.642 0.734 . . . . 1.0 110.418 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.0 m -112.45 129.64 56.26 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 105.921 -1.881 . . . . 1.0 105.921 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -154.92 169.26 24.45 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 120.191 -0.603 . . . . 1.0 110.129 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.7 m -120.35 160.79 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.694 0.621 . . . . 1.0 109.845 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.3 136.85 6.79 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 80.38 -8.93 1.44 Allowed 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 116.82 2.156 . . . . 1.0 116.82 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -67.02 147.55 53.06 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.252 -0.979 . . . . 1.0 109.127 170.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.67 139.58 32.53 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.011 0.434 . . . . 1.0 111.603 175.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.52 124.86 73.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.876 -2.639 . . . . 1.0 103.876 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.1 pt -115.54 165.85 10.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.649 0.738 . . . . 1.0 112.027 -172.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.03 51.03 17.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.994 0.902 . . . . 1.0 111.103 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.6 mt -72.38 129.99 35.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.499 -0.773 . . . . 1.0 110.832 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -112.01 132.38 54.84 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.134 -1.432 . . . . 1.0 107.134 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.473 ' HA ' ' CD1' ' A' ' 37' ' ' TRP . 94.0 m-85 -78.88 69.1 4.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.598 0.713 . . . . 1.0 109.195 -176.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 80.2 t -65.86 -44.56 92.7 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 N-CA-C 113.97 1.1 . . . . 1.0 113.97 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -143.16 162.24 36.11 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 106.781 -1.562 . . . . 1.0 106.781 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -63.95 -34.69 78.54 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 120.942 0.401 . . . . 1.0 111.612 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -94.72 -40.28 9.87 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 115.048 1.499 . . . . 1.0 115.048 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -116.01 139.21 50.5 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.73 -1.211 . . . . 1.0 107.73 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.473 ' CD1' ' HA ' ' A' ' 31' ' ' PHE . 21.6 m0 -122.88 153.24 39.9 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.1 tp -99.21 131.59 45.13 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.78 -168.78 14.89 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 119.644 -1.265 . . . . 1.0 111.717 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.474 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 78.9 tt0 -138.47 139.2 38.72 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.839 0.856 . . . . 1.0 109.289 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.4 mt -76.04 132.26 40.01 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 119.237 -0.985 . . . . 1.0 112.297 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.76 -38.57 75.63 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 120.041 -0.664 . . . . 1.0 110.54 172.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.85 -21.54 59.21 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 115.884 1.809 . . . . 1.0 115.884 -168.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.8 p30 -145.82 -0.8 0.8 Allowed 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 116.119 1.896 . . . . 1.0 116.119 -174.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.87 1.79 79.74 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.715 -1.231 . . . . 1.0 115.445 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.7 p -70.05 150.91 46.12 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 119.572 1.686 . . . . 1.0 108.584 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.23 149.88 51.73 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.69 174.76 36.28 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.574 -0.822 . . . . 1.0 112.824 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.3 mt -73.09 139.24 46.35 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.579 -0.811 . . . . 1.0 111.554 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -139.16 149.12 59.91 Favored Pre-proline 0 N--CA 1.443 -0.778 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -79.85 129.66 8.2 Favored 'Trans proline' 0 CA--C 1.512 -0.606 0 N-CA-C 108.808 -1.266 . . . . 1.0 108.808 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.7 m -60.42 -34.74 74.4 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 -176.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -66.44 -6.57 15.07 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.54 0.941 . . . . 1.0 113.54 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -94.14 -0.12 55.46 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 120.078 -1.638 . . . . 1.0 113.4 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.64 HG12 ' HA ' ' A' ' 6' ' ' ALA . 35.0 m -138.4 162.97 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.7 0.762 . . . . 1.0 111.732 -178.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.5 t -131.42 130.81 43.02 Favored 'General case' 0 C--O 1.214 -0.782 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -60.28 141.62 55.86 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.816 0.817 . . . . 1.0 111.086 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.55 -164.63 54.64 Favored Glycine 0 C--O 1.248 0.988 0 CA-C-N 115.371 -0.831 . . . . 1.0 113.501 177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.255 1.363 0 CA-C-O 117.496 -1.24 . . . . 1.0 111.395 -176.977 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 CA--C 1.515 -0.431 0 N-CA-C 109.614 -0.956 . . . . 1.0 109.614 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -114.42 165.36 12.81 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.788 0.804 . . . . 1.0 109.66 169.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.7 164.11 31.38 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.273 -0.876 . . . . 1.0 111.481 -176.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.9 m -119.59 128.61 54.06 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.205 -1.035 . . . . 1.0 108.205 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.537 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -71.39 140.27 50.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.069 0.937 . . . . 1.0 110.431 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.405 ' C ' ' HG3' ' A' ' 22' ' ' GLU . 97.2 mt-10 -102.89 -16.68 15.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.053 -0.976 . . . . 1.0 111.539 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -141.54 151.53 43.31 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 106.732 -1.581 . . . . 1.0 106.732 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -68.81 137.43 53.95 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -129.02 125.03 36.46 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.723 -1.214 . . . . 1.0 107.723 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -104.1 117.13 33.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.059 -0.973 . . . . 1.0 110.64 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -58.17 134.54 56.58 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 119.181 -1.008 . . . . 1.0 110.984 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.07 -5.05 26.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.079 -0.964 . . . . 1.0 110.313 176.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -137.2 165.2 26.67 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.266 -1.013 . . . . 1.0 108.266 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -65.95 -32.39 73.85 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 113.884 1.068 . . . . 1.0 113.884 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -84.98 7.1 22.45 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 114.481 1.289 . . . . 1.0 114.481 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.501 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 98.8 mt-10 -106.42 138.9 41.77 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.376 0.608 . . . . 1.0 112.495 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.61 140.49 42.65 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.687 0.756 . . . . 1.0 110.411 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.0 m -107.51 128.39 54.46 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 105.859 -1.904 . . . . 1.0 105.859 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -154.63 169.27 24.28 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.074 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.1 m -120.28 160.78 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 O-C-N 123.626 0.579 . . . . 1.0 109.874 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.405 ' HG3' ' C ' ' A' ' 7' ' ' GLU . 74.5 tt0 -46.39 136.85 6.95 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.62 -0.881 . . . . 1.0 108.62 176.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 80.45 -8.92 1.43 Allowed 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 116.783 2.142 . . . . 1.0 116.783 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.04 147.61 52.97 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.259 -0.976 . . . . 1.0 109.038 170.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.65 139.59 32.5 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.047 0.451 . . . . 1.0 111.594 175.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.433 HD13 HG11 ' A' ' 55' ' ' VAL . 4.5 mp -117.59 124.94 73.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 103.841 -2.651 . . . . 1.0 103.841 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 pt -115.64 165.81 10.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-O 121.625 0.726 . . . . 1.0 112.027 -172.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 51.14 50.97 17.96 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.982 0.896 . . . . 1.0 111.022 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.8 mt -71.75 131.07 35.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.96 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -112.65 133.53 54.63 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.065 -1.457 . . . . 1.0 107.065 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -79.34 68.67 5.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.66 0.743 . . . . 1.0 109.145 -176.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.507 HG21 ' HB2' ' A' ' 38' ' ' LEU . 66.9 t -64.86 -44.3 96.28 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 N-CA-C 113.873 1.064 . . . . 1.0 113.873 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -143.49 163.84 32.02 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.762 -1.57 . . . . 1.0 106.762 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -64.34 -32.57 74.23 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 120.976 0.417 . . . . 1.0 111.585 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -102.11 -36.28 8.61 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 114.946 1.462 . . . . 1.0 114.946 -177.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -111.76 133.56 53.91 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 16.3 m0 -117.95 158.05 25.61 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.199 -1.037 . . . . 1.0 108.199 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.507 ' HB2' HG21 ' A' ' 32' ' ' VAL . 47.1 tp -110.44 126.5 54.38 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.51 -170.0 14.7 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 119.694 -1.241 . . . . 1.0 111.853 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.402 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 80.9 tt0 -133.05 139.26 47.09 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 123.733 0.813 . . . . 1.0 109.345 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.9 mt -74.87 132.28 41.38 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 118.801 -1.159 . . . . 1.0 112.308 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -57.82 -38.59 75.84 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 120.081 -0.648 . . . . 1.0 110.543 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.84 -21.53 59.21 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 115.849 1.796 . . . . 1.0 115.849 -168.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.86 -0.75 0.8 Allowed 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 116.023 1.86 . . . . 1.0 116.023 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.91 1.77 79.84 Favored Glycine 0 C--O 1.223 -0.566 0 C-N-CA 119.657 -1.259 . . . . 1.0 115.449 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.07 150.87 46.13 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 119.598 1.699 . . . . 1.0 108.602 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.402 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.21 149.97 51.67 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.37 175.22 36.48 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.607 -0.806 . . . . 1.0 112.789 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.29 137.39 46.68 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.52 -0.84 . . . . 1.0 111.599 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.522 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 39.3 p90 -138.41 146.8 52.73 Favored Pre-proline 0 C--O 1.244 0.804 0 N-CA-C 108.088 -1.079 . . . . 1.0 108.088 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.536 ' HG2' ' CD1' ' A' ' 54' ' ' TYR . 57.8 Cg_endo -77.78 129.26 9.83 Favored 'Trans proline' 0 CA--C 1.512 -0.597 0 N-CA-C 108.83 -1.258 . . . . 1.0 108.83 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.5 m -61.8 -36.18 80.37 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 114.36 1.244 . . . . 1.0 114.36 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -64.3 -7.51 9.73 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.477 0.917 . . . . 1.0 113.477 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.536 ' CD1' ' HG2' ' A' ' 51' ' ' PRO . 15.5 m-85 -94.12 -0.14 55.48 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 120.198 -1.563 . . . . 1.0 113.316 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 6' ' ' ALA . 27.7 m -137.36 161.66 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.605 0.717 . . . . 1.0 111.847 -178.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.7 t -129.4 129.82 45.21 Favored 'General case' 0 C--O 1.214 -0.806 0 C-N-CA 124.054 0.941 . . . . 1.0 108.553 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.8 mt -58.85 141.71 52.52 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.762 0.791 . . . . 1.0 111.108 -177.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.53 -164.64 54.62 Favored Glycine 0 C--O 1.246 0.876 0 CA-C-N 115.377 -0.828 . . . . 1.0 113.547 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.318 0 CA-C-O 117.624 -1.179 . . . . 1.0 111.411 -176.998 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 CA--C 1.515 -0.431 0 N-CA-C 109.637 -0.947 . . . . 1.0 109.637 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.38 165.38 12.78 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.788 0.804 . . . . 1.0 109.679 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.73 164.09 31.45 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.273 -0.876 . . . . 1.0 111.515 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.4 p -115.37 131.1 57.04 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.132 -1.062 . . . . 1.0 108.132 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.69 136.83 56.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.947 0.88 . . . . 1.0 110.49 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -101.19 -25.38 14.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.167 -0.924 . . . . 1.0 111.578 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.405 ' HB2' ' CD2' ' A' ' 54' ' ' TYR . 85.6 m-85 -139.77 153.21 47.1 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 106.741 -1.578 . . . . 1.0 106.741 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -69.17 133.72 48.34 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.928 -0.768 . . . . 1.0 108.928 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -129.14 121.0 26.84 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -101.08 119.96 39.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.048 -0.978 . . . . 1.0 110.62 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.25 135.65 57.79 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 119.204 -0.999 . . . . 1.0 110.929 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.87 -2.58 19.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.135 -0.939 . . . . 1.0 110.277 176.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -136.58 164.66 27.67 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.295 -1.002 . . . . 1.0 108.295 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -65.24 -33.97 77.24 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 113.904 1.075 . . . . 1.0 113.904 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.6 p-10 -85.86 2.35 46.22 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 114.496 1.295 . . . . 1.0 114.496 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -100.12 137.68 38.24 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.331 0.586 . . . . 1.0 112.466 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.8 mt -76.29 147.22 38.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.715 0.769 . . . . 1.0 110.423 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.0 m -114.91 127.47 55.72 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 105.924 -1.88 . . . . 1.0 105.924 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -154.09 169.28 23.93 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 123.477 0.485 . . . . 1.0 110.056 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.8 m -120.31 160.85 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 O-C-N 123.67 0.606 . . . . 1.0 109.89 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -46.39 136.92 6.9 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 80.41 -8.96 1.43 Allowed 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 116.783 2.142 . . . . 1.0 116.783 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -67.04 147.64 52.93 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.258 -0.977 . . . . 1.0 109.051 170.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.66 139.61 32.49 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.019 0.438 . . . . 1.0 111.588 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.64 124.96 73.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 103.792 -2.67 . . . . 1.0 103.792 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 pt -115.64 165.86 10.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.655 0.741 . . . . 1.0 112.031 -172.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 51.08 51.02 17.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.013 0.911 . . . . 1.0 111.042 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.5 mt -72.75 131.29 35.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.873 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -112.8 134.29 54.39 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.036 -1.468 . . . . 1.0 107.036 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.437 ' HA ' ' CD1' ' A' ' 37' ' ' TRP . 94.0 m-85 -78.68 68.04 4.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.701 0.762 . . . . 1.0 109.246 -176.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.423 HG21 ' HB2' ' A' ' 38' ' ' LEU . 92.6 t -65.27 -44.32 95.01 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.703 0 N-CA-C 113.946 1.091 . . . . 1.0 113.946 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -143.42 162.99 34.32 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.702 -1.592 . . . . 1.0 106.702 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -64.56 -35.68 81.77 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 120.922 0.391 . . . . 1.0 111.594 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -96.28 -42.02 8.37 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.959 1.466 . . . . 1.0 114.959 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -113.26 136.89 52.25 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.633 -1.247 . . . . 1.0 107.633 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 17.6 m0 -120.52 160.02 24.01 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.139 -1.06 . . . . 1.0 108.139 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.439 HD12 ' C ' ' A' ' 48' ' ' GLY . 53.0 tp -107.68 131.06 54.81 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.72 -170.8 16.87 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 119.65 -1.262 . . . . 1.0 111.836 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.455 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 78.3 tt0 -133.67 139.3 46.36 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 123.797 0.839 . . . . 1.0 109.374 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.7 mt -75.81 132.22 40.26 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 119.311 -0.956 . . . . 1.0 112.266 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -57.77 -38.62 75.74 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 120.072 -0.651 . . . . 1.0 110.556 172.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.81 -21.55 59.23 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 115.898 1.814 . . . . 1.0 115.898 -168.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.9 -0.66 0.8 Allowed 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 116.082 1.882 . . . . 1.0 116.082 -174.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.93 1.71 79.81 Favored Glycine 0 C--O 1.223 -0.566 0 C-N-CA 119.588 -1.292 . . . . 1.0 115.446 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.05 150.84 46.19 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 119.615 1.708 . . . . 1.0 108.546 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.455 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.22 149.9 51.71 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 109.373 -0.602 . . . . 1.0 109.373 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.439 ' C ' HD12 ' A' ' 38' ' ' LEU . . . 166.47 178.99 39.5 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.582 -0.818 . . . . 1.0 112.772 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.9 mp -73.33 146.03 45.55 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.551 -0.825 . . . . 1.0 111.608 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.533 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 44.0 p90 -146.57 150.48 40.37 Favored Pre-proline 0 C--O 1.245 0.827 0 N-CA-C 108.053 -1.091 . . . . 1.0 108.053 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.432 ' HG2' ' CD1' ' A' ' 54' ' ' TYR . 61.4 Cg_endo -82.62 127.08 4.86 Favored 'Trans proline' 0 CA--C 1.513 -0.572 0 N-CA-C 108.784 -1.275 . . . . 1.0 108.784 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.6 m -59.05 -36.9 75.83 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 114.383 1.253 . . . . 1.0 114.383 -177.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -65.32 -6.5 10.08 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.403 0.89 . . . . 1.0 113.403 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.432 ' CD1' ' HG2' ' A' ' 51' ' ' PRO . 16.3 m-85 -92.63 -2.83 55.8 Favored 'General case' 0 C--O 1.222 -0.374 0 O-C-N 120.275 -1.516 . . . . 1.0 113.434 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.1 m -138.3 162.11 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.617 0.722 . . . . 1.0 111.774 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 56.3 m -127.63 130.36 48.83 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 123.995 0.918 . . . . 1.0 108.596 177.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.8 mt -58.36 141.76 50.27 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.836 0.827 . . . . 1.0 111.074 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.42 -164.61 54.55 Favored Glycine 0 C--O 1.246 0.904 0 CA-C-N 115.401 -0.818 . . . . 1.0 113.546 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.318 0 CA-C-O 117.619 -1.181 . . . . 1.0 111.44 -177.023 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.366 0.127 . . . . 1.0 111.05 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -76.94 171.0 18.75 Favored 'Trans proline' 0 C--N 1.317 -1.109 1 C-N-CA 127.273 5.316 . . . . 1.0 109.614 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.37 165.44 12.71 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.795 0.807 . . . . 1.0 109.696 169.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.74 164.12 31.37 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.256 -0.884 . . . . 1.0 111.537 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 58' ' ' GLY . 4.5 p -104.05 162.2 13.36 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 177.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.511 ' HB3' ' N ' ' A' ' 23' ' ' ASN . . . -92.77 109.77 21.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.103 0.954 . . . . 1.0 110.459 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -70.84 -42.3 70.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.192 -0.913 . . . . 1.0 111.6 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -137.72 155.89 48.59 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 106.744 -1.576 . . . . 1.0 106.744 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -67.03 133.58 50.2 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 175.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -127.45 124.42 38.37 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.777 -1.194 . . . . 1.0 107.777 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -103.25 118.78 37.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.04 -0.982 . . . . 1.0 110.647 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -62.31 136.5 57.95 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.146 -1.022 . . . . 1.0 111.012 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.28 5.96 22.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.361 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -140.29 159.96 41.04 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -63.36 -33.84 76.41 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 113.849 1.055 . . . . 1.0 113.849 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -88.08 6.63 35.37 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.415 1.265 . . . . 1.0 114.415 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 99.2 mt-10 -103.27 139.57 38.54 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.328 0.585 . . . . 1.0 112.51 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.07 145.1 36.03 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.697 0.76 . . . . 1.0 110.367 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.9 m -112.83 130.37 56.11 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 105.92 -1.882 . . . . 1.0 105.92 175.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -156.21 169.3 24.85 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.112 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.7 m -120.34 160.8 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 O-C-N 123.694 0.621 . . . . 1.0 109.874 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.36 136.88 6.87 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.511 ' N ' ' HB3' ' A' ' 6' ' ' ALA . 90.6 m-20 80.39 -8.92 1.44 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.757 2.132 . . . . 1.0 116.757 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.04 147.62 52.96 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.259 -0.976 . . . . 1.0 109.038 170.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.72 139.54 32.63 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.048 0.451 . . . . 1.0 111.596 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.53 125.0 73.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 103.83 -2.656 . . . . 1.0 103.83 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 pt -115.66 165.84 10.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-O 121.618 0.723 . . . . 1.0 111.972 -172.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.08 50.99 17.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.982 0.896 . . . . 1.0 111.042 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.4 mt -70.69 131.25 34.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.868 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -112.51 132.84 54.89 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 107.092 -1.447 . . . . 1.0 107.092 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.487 ' HA ' ' CD1' ' A' ' 37' ' ' TRP . 90.1 m-85 -78.85 68.68 4.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.632 0.73 . . . . 1.0 109.174 -176.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.5 t -66.56 -43.85 90.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 113.872 1.064 . . . . 1.0 113.872 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -143.24 162.03 36.72 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.799 -1.556 . . . . 1.0 106.799 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -64.64 -33.13 75.22 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 120.948 0.404 . . . . 1.0 111.575 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -96.56 -39.61 9.45 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 115.076 1.51 . . . . 1.0 115.076 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 43.5 m95 -117.76 141.3 48.56 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.668 -1.234 . . . . 1.0 107.668 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.487 ' CD1' ' HA ' ' A' ' 31' ' ' PHE . 17.5 m0 -126.57 154.88 43.3 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.165 -1.05 . . . . 1.0 108.165 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.5 tp -99.43 128.83 45.57 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.374 -0.973 . . . . 1.0 108.374 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.59 -162.54 9.55 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 119.78 -1.2 . . . . 1.0 111.819 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.456 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 77.1 tt0 -141.92 138.52 32.07 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 123.837 0.855 . . . . 1.0 109.251 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.4 mt -75.3 132.25 40.87 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.287 -0.965 . . . . 1.0 112.256 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.82 -38.52 75.74 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.013 -0.675 . . . . 1.0 110.547 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.84 -21.54 59.21 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 115.884 1.809 . . . . 1.0 115.884 -168.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.87 -0.72 0.8 Allowed 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 116.155 1.909 . . . . 1.0 116.155 -174.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.9 1.76 79.77 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.65 -1.262 . . . . 1.0 115.495 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.04 150.87 46.17 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 119.541 1.67 . . . . 1.0 108.602 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.456 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.25 149.94 51.72 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 109.276 -0.639 . . . . 1.0 109.276 -176.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.42 175.17 36.47 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.579 -0.82 . . . . 1.0 112.825 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.3 mt -72.49 139.45 47.65 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.535 -0.832 . . . . 1.0 111.595 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 49.5 p90 -139.86 149.41 58.99 Favored Pre-proline 0 C--O 1.245 0.837 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.404 ' HG2' ' CD1' ' A' ' 54' ' ' TYR . 61.5 Cg_endo -82.11 134.11 7.97 Favored 'Trans proline' 0 CA--C 1.512 -0.589 0 N-CA-C 108.857 -1.247 . . . . 1.0 108.857 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.6 m -63.86 -37.91 89.13 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 114.277 1.214 . . . . 1.0 114.277 -176.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -61.77 -8.54 4.9 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.463 0.912 . . . . 1.0 113.463 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.404 ' CD1' ' HG2' ' A' ' 51' ' ' PRO . 23.3 m-85 -94.7 -0.24 54.49 Favored 'General case' 0 C--O 1.222 -0.379 0 O-C-N 120.184 -1.572 . . . . 1.0 113.398 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.9 m -137.76 159.01 34.19 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-O 121.606 0.717 . . . . 1.0 111.722 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.6 t -128.8 129.63 45.91 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 108.546 -0.909 . . . . 1.0 108.546 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -59.07 141.67 53.43 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.783 0.801 . . . . 1.0 111.073 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 5' ' ' THR . . . 72.54 -164.63 54.63 Favored Glycine 0 C--O 1.246 0.876 0 CA-C-N 115.354 -0.839 . . . . 1.0 113.453 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.255 1.352 0 CA-C-O 117.59 -1.195 . . . . 1.0 111.43 -176.984 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.34 0.114 . . . . 1.0 111.015 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.93 171.0 18.75 Favored 'Trans proline' 0 C--N 1.317 -1.109 1 C-N-CA 127.261 5.308 . . . . 1.0 109.673 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -114.38 165.38 12.78 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.788 0.804 . . . . 1.0 109.679 169.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.75 164.08 31.5 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.273 -0.876 . . . . 1.0 111.478 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.8 p -114.8 132.48 56.46 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.25 133.95 50.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.989 0.9 . . . . 1.0 110.402 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -99.24 -28.48 13.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.141 -0.936 . . . . 1.0 111.543 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -137.68 150.07 47.04 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 106.707 -1.59 . . . . 1.0 106.707 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -65.9 134.07 52.24 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -126.68 124.21 39.31 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 107.781 -1.192 . . . . 1.0 107.781 177.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -101.03 116.1 32.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.089 -0.96 . . . . 1.0 110.694 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.98 137.65 58.33 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.194 -1.003 . . . . 1.0 111.035 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -113.36 5.66 16.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.207 -0.906 . . . . 1.0 110.34 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -137.27 159.69 41.2 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.218 -1.03 . . . . 1.0 108.218 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -64.49 -33.92 77.02 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 113.866 1.062 . . . . 1.0 113.866 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -88.71 5.5 42.98 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.482 1.29 . . . . 1.0 114.482 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -100.7 136.9 39.84 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.313 0.578 . . . . 1.0 112.538 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.25 142.49 41.39 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.778 0.799 . . . . 1.0 110.336 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.2 m -110.0 131.2 55.28 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 105.969 -1.863 . . . . 1.0 105.969 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -155.68 169.26 24.74 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 120.402 -0.519 . . . . 1.0 110.129 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.4 m -120.37 160.77 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.694 0.621 . . . . 1.0 109.817 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.28 136.86 6.75 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 80.39 -8.92 1.44 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.757 2.132 . . . . 1.0 116.757 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.05 147.64 52.92 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.245 -0.982 . . . . 1.0 109.051 170.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.68 139.5 32.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.018 0.437 . . . . 1.0 111.627 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.412 HG21 ' CE1' ' A' ' 50' ' ' PHE . 4.5 mp -117.56 125.0 73.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 103.745 -2.687 . . . . 1.0 103.745 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 pt -115.7 165.88 10.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.667 0.746 . . . . 1.0 111.931 -172.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 51.1 50.94 18.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.978 0.894 . . . . 1.0 111.058 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.0 mt -68.02 128.8 31.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.934 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -113.0 121.74 45.53 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.051 -1.463 . . . . 1.0 107.051 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -76.19 72.21 2.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.57 0.7 . . . . 1.0 109.204 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.4 t -66.91 -43.82 89.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 113.94 1.089 . . . . 1.0 113.94 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -139.83 164.51 29.78 Favored 'General case' 0 C--O 1.22 -0.494 0 N-CA-C 106.716 -1.587 . . . . 1.0 106.716 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -64.93 -35.45 81.21 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 120.986 0.422 . . . . 1.0 111.648 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -97.49 -33.49 11.35 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 114.986 1.476 . . . . 1.0 114.986 -176.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.415 ' CH2' ' HG3' ' A' ' 51' ' ' PRO . 54.3 m95 -114.28 133.43 55.66 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.731 -1.211 . . . . 1.0 107.731 -178.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 53.0 m0 -116.52 151.0 37.03 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.09 -1.078 . . . . 1.0 108.09 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.9 tp -104.55 124.19 48.86 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.412 -0.958 . . . . 1.0 108.412 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -144.12 -165.77 11.09 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 119.609 -1.282 . . . . 1.0 111.834 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -140.15 139.7 35.82 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 123.73 0.812 . . . . 1.0 109.284 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.2 mt -76.15 132.25 39.88 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.096 -1.042 . . . . 1.0 112.256 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.76 -38.61 75.72 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.097 -0.641 . . . . 1.0 110.494 172.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.79 -21.6 59.23 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 115.929 1.825 . . . . 1.0 115.929 -168.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.83 -0.71 0.8 Allowed 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 116.084 1.883 . . . . 1.0 116.084 -174.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.87 1.76 79.64 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.673 -1.251 . . . . 1.0 115.43 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.0 p -70.06 150.86 46.15 Favored 'General case' 0 C--O 1.213 -0.851 0 CA-C-N 119.572 1.686 . . . . 1.0 108.577 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -130.23 149.96 51.69 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 109.276 -0.639 . . . . 1.0 109.276 -176.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.56 172.46 34.69 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.57 -0.824 . . . . 1.0 112.806 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.3 mt -75.54 140.36 42.69 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.586 -0.807 . . . . 1.0 111.62 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.412 ' CE1' HG21 ' A' ' 26' ' ' ILE . 50.3 p90 -144.12 139.55 16.01 Favored Pre-proline 0 C--O 1.246 0.875 0 N-CA-C 108.06 -1.089 . . . . 1.0 108.06 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.415 ' HG3' ' CH2' ' A' ' 36' ' ' TRP . 31.2 Cg_exo -62.9 133.83 43.54 Favored 'Trans proline' 0 CA--C 1.512 -0.6 0 N-CA-C 108.762 -1.284 . . . . 1.0 108.762 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 81.5 p -66.84 -17.95 65.14 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 114.368 1.247 . . . . 1.0 114.368 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -81.55 -1.26 45.62 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.435 0.902 . . . . 1.0 113.435 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -95.58 -0.99 51.33 Favored 'General case' 0 C--O 1.222 -0.375 0 O-C-N 120.171 -1.58 . . . . 1.0 113.5 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.8 m -136.54 162.13 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.582 0.706 . . . . 1.0 111.734 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 65.0 p -128.28 130.52 47.99 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 123.944 0.898 . . . . 1.0 108.589 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.5 mt -60.46 141.72 56.05 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.893 0.854 . . . . 1.0 111.017 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.44 -164.61 54.56 Favored Glycine 0 C--O 1.246 0.876 0 CA-C-N 115.34 -0.845 . . . . 1.0 113.549 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.329 0 CA-C-O 117.564 -1.208 . . . . 1.0 111.404 -176.966 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.348 0.118 . . . . 1.0 110.978 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -77.02 170.95 18.82 Favored 'Trans proline' 0 C--N 1.317 -1.122 1 C-N-CA 127.318 5.345 . . . . 1.0 109.574 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.28 165.45 12.68 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.816 0.817 . . . . 1.0 109.668 169.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.77 164.15 31.32 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.234 -0.893 . . . . 1.0 111.453 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 58' ' ' GLY . 25.5 p -115.35 132.9 56.47 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.161 -1.051 . . . . 1.0 108.161 178.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.482 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -67.46 136.72 55.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.987 0.899 . . . . 1.0 110.518 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -100.73 -26.34 13.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.204 -0.907 . . . . 1.0 111.533 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.402 ' HB2' ' CD2' ' A' ' 54' ' ' TYR . 91.5 m-85 -140.33 149.82 43.21 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 106.722 -1.585 . . . . 1.0 106.722 -178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -63.6 132.8 52.33 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.922 -0.769 . . . . 1.0 108.922 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -128.04 125.85 40.14 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.667 -1.234 . . . . 1.0 107.667 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -106.35 119.65 39.8 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 124.29 0.994 . . . . 1.0 110.789 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.459 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -60.39 136.33 58.01 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 119.195 -1.002 . . . . 1.0 111.114 178.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.25 2.8 27.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.229 -0.896 . . . . 1.0 110.298 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -142.53 163.85 31.72 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -65.85 -32.65 74.29 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 113.824 1.046 . . . . 1.0 113.824 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -85.99 5.92 31.09 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.544 1.313 . . . . 1.0 114.544 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 96.4 mt-10 -104.61 139.75 39.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.318 0.58 . . . . 1.0 112.537 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.6 mt -76.91 142.8 39.97 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.785 0.802 . . . . 1.0 110.321 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.2 m -111.06 129.13 56.01 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 105.953 -1.869 . . . . 1.0 105.953 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -156.17 169.28 24.89 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 120.288 -0.565 . . . . 1.0 110.056 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.31 160.79 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 O-C-N 123.628 0.58 . . . . 1.0 109.89 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -46.21 136.78 6.69 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.698 -0.853 . . . . 1.0 108.698 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 80.42 -8.92 1.44 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.757 2.132 . . . . 1.0 116.757 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -66.99 147.59 53.03 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.266 -0.974 . . . . 1.0 109.084 170.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.69 139.59 32.52 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.037 0.446 . . . . 1.0 111.582 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.61 124.98 73.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 103.756 -2.683 . . . . 1.0 103.756 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.1 pt -115.72 165.78 10.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-O 121.659 0.742 . . . . 1.0 111.958 -172.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.14 51.02 17.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.013 0.911 . . . . 1.0 111.042 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.1 mt -71.38 131.13 34.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.934 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -114.84 135.73 53.87 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.995 -1.483 . . . . 1.0 106.995 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -78.31 67.53 4.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.646 0.736 . . . . 1.0 109.164 -176.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.47 -40.86 89.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.885 1.068 . . . . 1.0 113.885 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -144.49 160.06 41.72 Favored 'General case' 0 C--O 1.219 -0.536 0 N-CA-C 106.763 -1.569 . . . . 1.0 106.763 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -63.68 -33.02 74.7 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 120.902 0.382 . . . . 1.0 111.612 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -100.29 -34.53 9.95 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 115.09 1.515 . . . . 1.0 115.09 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 52.2 m95 -111.24 135.29 51.98 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.598 -1.26 . . . . 1.0 107.598 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.425 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . 10.7 m0 -110.36 151.59 27.26 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.147 -1.057 . . . . 1.0 108.147 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.3 tp -108.58 125.95 52.4 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.419 -0.956 . . . . 1.0 108.419 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.99 -165.84 13.5 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 119.767 -1.206 . . . . 1.0 111.884 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.444 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 75.1 tt0 -135.59 141.94 45.22 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 123.75 0.82 . . . . 1.0 109.195 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.9 mt -75.16 132.21 41.0 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.159 -1.016 . . . . 1.0 112.282 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.82 -38.52 75.74 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.013 -0.675 . . . . 1.0 110.547 172.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.75 -21.58 59.27 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 115.912 1.819 . . . . 1.0 115.912 -168.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.94 -0.7 0.79 Allowed 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 116.091 1.886 . . . . 1.0 116.091 -174.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.82 1.79 79.45 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.658 -1.258 . . . . 1.0 115.51 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.0 p -70.04 150.92 46.12 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 119.541 1.67 . . . . 1.0 108.602 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.444 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.31 149.95 51.77 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 109.241 -0.652 . . . . 1.0 109.241 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.11 176.31 37.91 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.568 -0.825 . . . . 1.0 112.776 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -77.51 137.06 38.42 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.516 -0.842 . . . . 1.0 111.613 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.425 ' CE2' ' HB2' ' A' ' 37' ' ' TRP . 50.1 p90 -138.34 150.83 67.94 Favored Pre-proline 0 C--O 1.243 0.743 0 N-CA-C 107.943 -1.132 . . . . 1.0 107.943 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -80.36 129.19 7.46 Favored 'Trans proline' 0 CA--C 1.513 -0.54 0 N-CA-C 108.839 -1.254 . . . . 1.0 108.839 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.8 m -59.9 -34.84 73.72 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 114.344 1.239 . . . . 1.0 114.344 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -61.99 -9.23 6.59 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.489 0.922 . . . . 1.0 113.489 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.402 ' CD2' ' HB2' ' A' ' 8' ' ' TYR . 22.3 m-85 -94.74 1.15 55.45 Favored 'General case' 0 C--O 1.222 -0.356 0 O-C-N 120.243 -1.536 . . . . 1.0 113.405 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.482 HG12 ' HA ' ' A' ' 6' ' ' ALA . 33.7 m -138.01 162.28 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.482 0.658 . . . . 1.0 111.778 -178.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.2 p -133.34 131.59 40.28 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 176.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -60.63 141.72 56.4 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.836 0.827 . . . . 1.0 111.052 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 5' ' ' THR . . . 72.41 -164.67 54.54 Favored Glycine 0 C--O 1.247 0.933 0 CA-C-N 115.36 -0.836 . . . . 1.0 113.57 177.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.255 1.352 0 CA-C-O 117.59 -1.195 . . . . 1.0 111.43 -176.981 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.302 0.096 . . . . 1.0 110.998 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -76.79 170.98 18.82 Favored 'Trans proline' 0 C--N 1.316 -1.178 1 C-N-CA 127.307 5.338 . . . . 1.0 109.634 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.39 165.41 12.74 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.766 0.794 . . . . 1.0 109.74 169.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.7 164.05 31.54 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.348 -0.842 . . . . 1.0 111.549 -176.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.6 m -117.8 128.67 55.09 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.11 -1.07 . . . . 1.0 108.11 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.45 136.74 56.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.995 0.902 . . . . 1.0 110.49 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -101.71 -21.05 14.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.16 -0.927 . . . . 1.0 111.584 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -138.73 151.39 47.08 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 106.818 -1.549 . . . . 1.0 106.818 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -67.22 132.42 47.73 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.847 -0.797 . . . . 1.0 108.847 176.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.482 ' HB2' ' CD2' ' A' ' 54' ' ' TYR . 81.8 t80 -135.34 130.53 35.15 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 107.781 -1.192 . . . . 1.0 107.781 177.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -114.16 134.4 54.93 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.049 -0.978 . . . . 1.0 110.658 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.575 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -67.66 139.05 56.77 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.138 -1.025 . . . . 1.0 111.095 178.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.94 -4.87 18.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.254 -0.885 . . . . 1.0 110.273 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -131.14 166.78 20.36 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 108.26 -1.015 . . . . 1.0 108.26 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -66.81 -34.04 76.93 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 113.876 1.065 . . . . 1.0 113.876 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -87.95 7.56 30.42 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.458 1.281 . . . . 1.0 114.458 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.575 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 99.5 mt-10 -103.84 149.49 25.0 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.27 0.557 . . . . 1.0 112.448 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.457 HD22 ' HG ' ' A' ' 41' ' ' LEU . 75.6 mt -90.24 142.72 27.44 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.63 0.729 . . . . 1.0 110.349 177.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.1 t -109.86 132.19 54.38 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 105.882 -1.896 . . . . 1.0 105.882 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -156.12 169.19 25.07 Favored 'General case' 0 CA--C 1.503 -0.855 0 O-C-N 123.33 0.394 . . . . 1.0 110.13 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.8 m -120.31 160.85 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.683 0.614 . . . . 1.0 109.86 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -46.43 136.81 7.06 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.655 -0.869 . . . . 1.0 108.655 176.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 80.5 -8.92 1.43 Allowed 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 116.783 2.142 . . . . 1.0 116.783 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -66.97 147.6 53.02 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.266 -0.974 . . . . 1.0 109.103 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.7 139.51 32.66 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.996 0.427 . . . . 1.0 111.615 175.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.59 124.94 73.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.81 -2.663 . . . . 1.0 103.81 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 pt -115.68 165.91 10.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-O 121.673 0.749 . . . . 1.0 111.994 -172.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.08 51.02 17.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.013 0.911 . . . . 1.0 111.042 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.93 128.75 32.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.918 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -112.92 123.35 50.12 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.093 -1.447 . . . . 1.0 107.093 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -75.71 72.26 2.63 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.691 0.757 . . . . 1.0 109.127 -175.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.441 HG21 HD22 ' A' ' 38' ' ' LEU . 68.3 t -66.94 -44.64 88.52 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 N-CA-C 113.947 1.092 . . . . 1.0 113.947 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -141.22 163.09 33.9 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 106.745 -1.576 . . . . 1.0 106.745 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -66.1 -34.63 78.5 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.031 0.443 . . . . 1.0 111.508 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -93.2 -37.73 11.94 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 115.031 1.493 . . . . 1.0 115.031 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 33.3 m95 -114.29 135.23 54.29 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.705 -1.22 . . . . 1.0 107.705 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 50.7 m0 -114.19 148.72 36.85 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.233 -1.025 . . . . 1.0 108.233 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.441 HD22 HG21 ' A' ' 32' ' ' VAL . 38.0 tp -103.46 133.78 47.94 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.359 -0.978 . . . . 1.0 108.359 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.67 -166.64 17.42 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 119.746 -1.216 . . . . 1.0 111.884 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.469 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 77.4 tt0 -136.6 140.18 42.65 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.901 0.88 . . . . 1.0 109.327 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.457 ' HG ' HD22 ' A' ' 18' ' ' LEU . 52.6 mt -75.58 132.25 40.55 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.724 -0.791 . . . . 1.0 112.242 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.76 -38.62 75.72 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.097 -0.641 . . . . 1.0 110.494 172.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.74 -21.7 59.21 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 115.851 1.797 . . . . 1.0 115.851 -168.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 51.0 p30 -145.83 -0.71 0.8 Allowed 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 116.096 1.887 . . . . 1.0 116.096 -174.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.92 1.76 79.92 Favored Glycine 0 C--O 1.222 -0.631 0 C-N-CA 119.699 -1.239 . . . . 1.0 115.43 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.05 150.86 46.17 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 119.572 1.686 . . . . 1.0 108.584 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.469 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.2 149.87 51.71 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 -176.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.84 174.37 35.28 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.554 -0.831 . . . . 1.0 112.797 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.5 145.44 43.52 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.598 -0.801 . . . . 1.0 111.544 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -149.52 140.17 13.92 Favored Pre-proline 0 N--CA 1.443 -0.823 0 N-CA-C 108.025 -1.102 . . . . 1.0 108.025 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -63.47 133.65 40.99 Favored 'Trans proline' 0 CA--C 1.513 -0.529 0 N-CA-C 108.904 -1.229 . . . . 1.0 108.904 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.4 p -67.8 -18.22 64.78 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 114.274 1.212 . . . . 1.0 114.274 -176.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -80.18 -2.1 43.29 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.436 0.902 . . . . 1.0 113.436 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.482 ' CD2' ' HB2' ' A' ' 10' ' ' TYR . 32.2 m-85 -95.4 0.58 53.61 Favored 'General case' 0 C--O 1.223 -0.326 0 O-C-N 120.157 -1.589 . . . . 1.0 113.317 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 m -138.57 163.03 28.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 118.698 0.681 . . . . 1.0 111.813 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.3 p -129.92 130.76 45.54 Favored 'General case' 0 C--O 1.213 -0.818 0 C-N-CA 123.985 0.914 . . . . 1.0 108.562 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -59.33 141.67 53.94 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 119.628 -0.829 . . . . 1.0 111.073 -177.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.53 -164.68 54.62 Favored Glycine 0 C--O 1.247 0.914 0 CA-C-N 115.336 -0.847 . . . . 1.0 113.455 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.296 0 CA-C-O 117.563 -1.208 . . . . 1.0 111.342 -176.902 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.373 0.13 . . . . 1.0 111.002 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -76.82 171.02 18.75 Favored 'Trans proline' 0 C--N 1.317 -1.106 1 C-N-CA 127.285 5.323 . . . . 1.0 109.635 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.36 165.5 12.65 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.809 0.814 . . . . 1.0 109.712 169.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.77 164.08 31.52 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.292 -0.867 . . . . 1.0 111.487 -176.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.5 p -114.97 134.34 55.26 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.71 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -70.0 137.61 51.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.98 0.895 . . . . 1.0 110.532 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -104.25 -25.17 13.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.263 -0.88 . . . . 1.0 111.538 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -138.95 148.27 43.31 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 106.775 -1.565 . . . . 1.0 106.775 -178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -68.55 137.75 54.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -127.04 123.83 37.92 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.744 -1.206 . . . . 1.0 107.744 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -99.52 113.54 25.99 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 124.306 1.004 . . . . 1.0 110.651 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.482 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -60.34 136.97 58.2 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.226 -0.99 . . . . 1.0 111.001 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.95 -4.94 20.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.187 -0.915 . . . . 1.0 110.343 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -132.35 162.34 31.31 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.268 -1.012 . . . . 1.0 108.268 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -66.86 -31.76 72.59 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 113.885 1.068 . . . . 1.0 113.885 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -88.22 8.01 29.22 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.482 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 96.3 mt-10 -100.67 139.59 36.14 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 112.567 0.58 . . . . 1.0 112.567 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.845 HD11 ' HG ' ' A' ' 41' ' ' LEU . 12.7 tp -74.78 134.93 41.73 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.682 0.753 . . . . 1.0 110.403 177.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.5 m -110.5 128.63 55.71 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 105.939 -1.874 . . . . 1.0 105.939 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -155.78 169.32 24.64 Favored 'General case' 0 CA--C 1.503 -0.86 0 O-C-N 123.898 0.749 . . . . 1.0 110.112 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.5 m -120.4 160.82 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.687 0.617 . . . . 1.0 109.794 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.39 136.89 6.92 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.62 -0.881 . . . . 1.0 108.62 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 80.39 -8.92 1.44 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.757 2.132 . . . . 1.0 116.757 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.07 147.51 53.08 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.259 -0.976 . . . . 1.0 109.068 170.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.59 139.57 32.48 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.003 0.43 . . . . 1.0 111.642 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.524 HD13 HG11 ' A' ' 55' ' ' VAL . 4.5 mp -117.53 124.95 73.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.788 -2.671 . . . . 1.0 103.788 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 pt -115.65 165.86 10.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.648 0.737 . . . . 1.0 112.015 -172.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.1 50.94 18.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.947 0.879 . . . . 1.0 111.058 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.11 130.56 34.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.882 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -117.36 122.83 44.94 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.094 -1.447 . . . . 1.0 107.094 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -77.3 77.01 3.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.554 0.692 . . . . 1.0 109.152 -175.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.2 t -65.12 -45.27 94.64 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 N-CA-C 113.818 1.044 . . . . 1.0 113.818 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -135.35 177.1 8.08 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 106.759 -1.571 . . . . 1.0 106.759 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -71.05 -29.96 65.99 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 121.037 0.446 . . . . 1.0 111.626 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -111.23 -28.18 8.37 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 114.957 1.466 . . . . 1.0 114.957 -176.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 51.5 m95 -111.97 128.24 56.11 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.625 -1.25 . . . . 1.0 107.625 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -117.14 156.1 28.21 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.161 -1.051 . . . . 1.0 108.161 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.4 tp -106.2 128.22 53.78 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.361 -0.977 . . . . 1.0 108.361 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -150.24 172.51 30.05 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 119.788 -1.196 . . . . 1.0 111.904 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.43 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 77.7 tt0 -120.72 139.35 53.19 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.873 0.869 . . . . 1.0 109.302 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.845 ' HG ' HD11 ' A' ' 18' ' ' LEU . 52.6 mt -75.2 132.24 40.98 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.203 -0.999 . . . . 1.0 112.267 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.82 -38.56 75.82 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.013 -0.675 . . . . 1.0 110.547 172.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -74.73 -21.64 59.26 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 115.91 1.818 . . . . 1.0 115.91 -168.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.85 -0.62 0.81 Allowed 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 116.146 1.906 . . . . 1.0 116.146 -174.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.85 1.7 79.34 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.65 -1.262 . . . . 1.0 115.461 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.0 p -70.04 150.92 46.12 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 119.589 1.695 . . . . 1.0 108.602 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.43 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.31 149.95 51.77 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 109.241 -0.652 . . . . 1.0 109.241 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.43 172.69 34.02 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.559 -0.829 . . . . 1.0 112.749 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.0 mt -73.13 142.17 47.48 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 114.636 -0.782 . . . . 1.0 111.588 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -143.94 142.31 20.1 Favored Pre-proline 0 C--O 1.245 0.862 0 N-CA-C 108.015 -1.106 . . . . 1.0 108.015 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -65.14 133.65 36.29 Favored 'Trans proline' 0 CA--C 1.513 -0.564 0 N-CA-C 108.855 -1.248 . . . . 1.0 108.855 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.4 p -67.94 -14.81 63.26 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 114.264 1.209 . . . . 1.0 114.264 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -88.78 6.05 40.66 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.402 0.89 . . . . 1.0 113.402 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -101.53 -0.94 34.13 Favored 'General case' 0 C--O 1.221 -0.4 0 O-C-N 120.186 -1.571 . . . . 1.0 113.361 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.71 HG12 ' HA ' ' A' ' 6' ' ' ALA . 33.3 m -137.81 164.96 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.532 0.682 . . . . 1.0 111.733 -178.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.0 p -129.43 130.85 46.46 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 108.565 -0.902 . . . . 1.0 108.565 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -59.14 141.74 53.38 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.779 0.8 . . . . 1.0 111.13 -177.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.5 -164.7 54.6 Favored Glycine 0 C--O 1.246 0.904 0 CA-C-N 115.359 -0.837 . . . . 1.0 113.491 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.253 1.262 0 CA-C-O 117.581 -1.199 . . . . 1.0 111.43 -176.989 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 120.367 0.127 . . . . 1.0 111.02 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -76.94 171.0 18.75 Favored 'Trans proline' 0 C--N 1.317 -1.109 1 C-N-CA 127.273 5.316 . . . . 1.0 109.614 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.39 165.41 12.75 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.743 0.782 . . . . 1.0 109.724 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.77 164.06 31.57 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.354 -0.839 . . . . 1.0 111.526 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.4 m -115.93 128.03 55.44 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.262 -1.014 . . . . 1.0 108.262 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.575 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -65.17 135.69 55.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.992 0.901 . . . . 1.0 110.501 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -99.37 -24.87 14.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.185 -0.916 . . . . 1.0 111.531 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -140.29 149.81 43.26 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 106.787 -1.56 . . . . 1.0 106.787 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -66.11 136.21 55.65 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.904 -0.776 . . . . 1.0 108.904 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -128.85 123.47 32.83 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 107.757 -1.201 . . . . 1.0 107.757 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -102.28 119.47 38.86 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 124.279 0.987 . . . . 1.0 110.748 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -60.62 136.29 58.01 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.216 -0.994 . . . . 1.0 111.088 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.75 -3.37 22.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.269 -0.878 . . . . 1.0 110.307 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -136.11 164.6 27.65 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.212 -1.033 . . . . 1.0 108.212 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -65.02 -32.48 74.22 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 113.863 1.06 . . . . 1.0 113.863 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -87.34 4.88 41.2 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.556 1.317 . . . . 1.0 114.556 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.524 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 80.7 mm-40 -101.73 137.08 40.51 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 112.525 0.565 . . . . 1.0 112.525 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.0 mt -75.58 147.02 39.95 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.729 0.776 . . . . 1.0 110.39 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.5 m -115.43 129.47 56.58 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 105.853 -1.906 . . . . 1.0 105.853 175.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -153.9 169.29 23.8 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 123.353 0.408 . . . . 1.0 110.09 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.33 160.79 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.681 0.613 . . . . 1.0 109.86 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.24 136.81 6.73 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.605 -0.887 . . . . 1.0 108.605 176.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 80.43 -8.94 1.43 Allowed 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 116.745 2.128 . . . . 1.0 116.745 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -67.07 147.63 52.92 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.245 -0.982 . . . . 1.0 109.038 170.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.7 139.54 32.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.06 0.457 . . . . 1.0 111.609 175.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.56 124.99 73.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.782 -2.673 . . . . 1.0 103.782 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.4 pt -115.69 165.9 10.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.642 0.734 . . . . 1.0 112.021 -172.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 51.03 50.97 18.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.928 0.87 . . . . 1.0 111.154 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 97.1 mt -69.22 130.19 34.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.48 -0.782 . . . . 1.0 110.865 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -113.86 128.2 56.31 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.114 -1.439 . . . . 1.0 107.114 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -77.68 70.45 4.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.651 0.739 . . . . 1.0 109.163 -175.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 65.2 t -68.1 -43.83 84.93 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 N-CA-C 113.889 1.07 . . . . 1.0 113.889 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -139.08 161.4 37.47 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.765 -1.569 . . . . 1.0 106.765 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -64.47 -34.51 78.38 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 121.101 0.477 . . . . 1.0 111.668 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -99.19 -33.18 10.87 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 114.991 1.478 . . . . 1.0 114.991 -176.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.495 ' CH2' ' HG3' ' A' ' 51' ' ' PRO . 30.2 m95 -119.4 132.7 55.88 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.655 -1.239 . . . . 1.0 107.655 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 30.7 m0 -115.99 155.59 27.78 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.105 -1.072 . . . . 1.0 108.105 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.82 128.2 53.58 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.398 -0.964 . . . . 1.0 108.398 178.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.1 -162.82 9.77 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 119.698 -1.239 . . . . 1.0 111.795 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.484 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 76.4 tt0 -140.41 139.35 35.25 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 123.847 0.859 . . . . 1.0 109.298 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.9 mt -75.73 132.25 40.37 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.62 -0.832 . . . . 1.0 112.256 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -57.82 -38.6 75.87 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 119.996 -0.682 . . . . 1.0 110.508 172.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.66 -21.62 59.33 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 115.911 1.819 . . . . 1.0 115.911 -168.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -145.91 -0.63 0.8 Allowed 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 116.105 1.891 . . . . 1.0 116.105 -174.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.93 1.74 79.87 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.649 -1.263 . . . . 1.0 115.428 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.1 150.86 46.12 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 119.589 1.694 . . . . 1.0 108.553 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.484 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.9 mttt -130.2 149.87 51.71 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 -176.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.88 175.97 36.81 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.64 -0.79 . . . . 1.0 112.826 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.7 mt -72.97 147.87 44.78 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.517 -0.841 . . . . 1.0 111.633 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.477 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 52.5 p90 -151.34 136.33 10.33 Favored Pre-proline 0 C--O 1.244 0.804 0 N-CA-C 107.952 -1.129 . . . . 1.0 107.952 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.495 ' HG3' ' CH2' ' A' ' 36' ' ' TRP . 30.2 Cg_exo -64.63 130.72 27.23 Favored 'Trans proline' 0 CA--C 1.512 -0.595 0 N-CA-C 108.837 -1.255 . . . . 1.0 108.837 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.2 p -67.35 -17.58 64.8 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.364 1.246 . . . . 1.0 114.364 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.3 p30 -77.51 -3.44 40.53 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.428 0.899 . . . . 1.0 113.428 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -100.85 6.01 43.6 Favored 'General case' 0 C--O 1.221 -0.446 0 O-C-N 120.204 -1.56 . . . . 1.0 113.416 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 6' ' ' ALA . 34.1 m -138.61 161.93 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.626 0.727 . . . . 1.0 111.681 -177.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.3 t -132.69 130.62 40.31 Favored 'General case' 0 C--O 1.215 -0.729 0 C-N-CA 123.92 0.888 . . . . 1.0 108.609 176.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.6 mt -59.78 141.65 54.85 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.855 0.836 . . . . 1.0 111.073 -177.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.62 -164.66 54.68 Favored Glycine 0 C--O 1.246 0.876 0 CA-C-N 115.332 -0.849 . . . . 1.0 113.512 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.255 1.352 0 CA-C-O 117.59 -1.195 . . . . 1.0 111.43 -177.03 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.316 0.103 . . . . 1.0 111.077 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -76.79 170.96 18.87 Favored 'Trans proline' 0 C--N 1.316 -1.165 1 C-N-CA 127.227 5.284 . . . . 1.0 109.717 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.3 165.38 12.76 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.757 0.789 . . . . 1.0 109.771 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.7 164.1 31.4 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.318 -0.856 . . . . 1.0 111.537 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.2 m -117.88 126.83 53.13 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.42 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -67.48 135.32 52.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 122.057 0.932 . . . . 1.0 110.45 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -102.11 -19.55 15.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.073 -0.967 . . . . 1.0 111.583 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -138.21 148.74 45.11 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 106.732 -1.581 . . . . 1.0 106.732 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -66.98 133.49 50.06 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -128.13 123.45 34.46 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.729 -1.211 . . . . 1.0 107.729 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -103.18 119.31 38.63 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 124.252 0.97 . . . . 1.0 110.841 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.455 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -62.67 135.98 57.65 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.215 -0.994 . . . . 1.0 110.983 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.09 -3.2 21.79 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.22 -0.9 . . . . 1.0 110.337 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -133.05 161.41 34.44 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 108.312 -0.996 . . . . 1.0 108.312 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -64.88 -34.05 77.46 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 113.889 1.07 . . . . 1.0 113.889 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 p30 -86.39 7.12 27.0 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.552 1.316 . . . . 1.0 114.552 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 97.8 mt-10 -103.74 138.48 40.3 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 112.542 0.571 . . . . 1.0 112.542 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.459 HD11 ' O ' ' A' ' 39' ' ' GLY . 97.2 mt -73.75 142.22 46.29 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.741 0.782 . . . . 1.0 110.411 176.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.7 m -111.7 128.3 56.03 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 105.942 -1.873 . . . . 1.0 105.942 175.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -155.57 169.32 24.57 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 120.156 -0.618 . . . . 1.0 110.056 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.1 m -120.34 160.75 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 O-C-N 123.606 0.566 . . . . 1.0 109.881 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.31 136.89 6.78 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.655 -0.868 . . . . 1.0 108.655 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 80.31 -8.85 1.46 Allowed 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 116.824 2.157 . . . . 1.0 116.824 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -67.12 147.63 52.88 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.238 -0.985 . . . . 1.0 109.038 170.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.65 139.56 32.55 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.01 0.433 . . . . 1.0 111.588 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.6 124.91 73.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 103.779 -2.674 . . . . 1.0 103.779 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 pt -115.58 165.84 10.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.685 0.755 . . . . 1.0 112.066 -172.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 51.07 51.01 17.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.973 0.892 . . . . 1.0 111.114 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.3 mt -68.0 128.4 31.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.902 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -113.36 120.03 39.71 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.166 -1.42 . . . . 1.0 107.166 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -75.05 72.35 2.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.654 0.74 . . . . 1.0 109.141 -175.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.56 -37.07 78.8 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.644 0 N-CA-C 113.864 1.061 . . . . 1.0 113.864 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -145.06 167.37 22.85 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.806 -1.553 . . . . 1.0 106.806 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -67.29 -34.23 76.96 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 121.005 0.431 . . . . 1.0 111.673 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -98.18 -39.41 8.89 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 115.03 1.492 . . . . 1.0 115.03 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -110.71 133.25 53.5 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.678 -1.231 . . . . 1.0 107.678 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 52.6 m0 -117.59 153.33 33.43 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 108.242 -1.021 . . . . 1.0 108.242 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.7 tp -100.28 133.27 44.93 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.42 -0.956 . . . . 1.0 108.42 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.459 ' O ' HD11 ' A' ' 18' ' ' LEU . . . -154.8 178.29 31.61 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 119.723 -1.227 . . . . 1.0 111.737 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.465 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 78.9 tt0 -125.62 140.27 52.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.512 -0.844 . . . . 1.0 109.375 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.6 mt -75.48 132.32 40.71 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 119.398 -0.921 . . . . 1.0 112.238 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.86 -38.61 76.01 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.093 -0.643 . . . . 1.0 110.473 172.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.82 -21.51 59.25 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 115.888 1.81 . . . . 1.0 115.888 -168.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.8 p30 -145.95 -0.72 0.79 Allowed 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 116.072 1.879 . . . . 1.0 116.072 -174.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.94 1.71 79.81 Favored Glycine 0 C--O 1.222 -0.636 0 C-N-CA 119.661 -1.257 . . . . 1.0 115.427 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.1 p -70.04 150.87 46.16 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-N 119.589 1.695 . . . . 1.0 108.59 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.26 149.95 51.72 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 -176.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.98 174.75 36.48 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.568 -0.825 . . . . 1.0 112.751 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.6 mt -73.65 139.36 45.38 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.463 -0.869 . . . . 1.0 111.721 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 51.3 p90 -140.31 150.14 60.27 Favored Pre-proline 0 C--O 1.245 0.854 0 N-CA-C 108.01 -1.108 . . . . 1.0 108.01 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.4 ' HG2' ' CD1' ' A' ' 54' ' ' TYR . 60.4 Cg_endo -79.75 133.86 10.55 Favored 'Trans proline' 0 CA--C 1.513 -0.571 0 N-CA-C 108.836 -1.255 . . . . 1.0 108.836 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.7 m -62.83 -34.95 78.4 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 114.409 1.263 . . . . 1.0 114.409 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -66.44 -7.36 18.97 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.403 0.89 . . . . 1.0 113.403 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.4 ' CD1' ' HG2' ' A' ' 51' ' ' PRO . 24.6 m-85 -93.53 -0.02 56.47 Favored 'General case' 0 C--O 1.222 -0.344 0 O-C-N 120.211 -1.556 . . . . 1.0 113.337 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 6' ' ' ALA . 33.3 m -138.15 163.29 29.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.613 0.721 . . . . 1.0 111.698 -178.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.9 p -132.77 131.17 40.83 Favored 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.6 mt -60.72 141.71 56.59 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.857 0.837 . . . . 1.0 111.039 -176.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.47 -164.65 54.58 Favored Glycine 0 C--O 1.246 0.904 0 CA-C-N 115.337 -0.847 . . . . 1.0 113.473 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.296 0 CA-C-O 117.593 -1.194 . . . . 1.0 111.44 -176.986 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.356 0.122 . . . . 1.0 110.986 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -76.88 171.02 18.74 Favored 'Trans proline' 0 C--N 1.317 -1.109 1 C-N-CA 127.302 5.335 . . . . 1.0 109.604 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.45 165.41 12.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.834 0.826 . . . . 1.0 109.704 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.71 164.09 31.46 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.323 -0.853 . . . . 1.0 111.543 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.5 p -114.64 129.26 56.66 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.159 -1.052 . . . . 1.0 108.159 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.64 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -65.76 134.04 52.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.03 0.919 . . . . 1.0 110.336 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -98.27 -25.46 14.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.144 -0.935 . . . . 1.0 111.525 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -140.19 151.72 45.45 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 106.719 -1.586 . . . . 1.0 106.719 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -67.42 134.87 52.22 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.89 -0.781 . . . . 1.0 108.89 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -127.32 121.87 32.23 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 107.884 -1.154 . . . . 1.0 107.884 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -100.97 116.34 32.6 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.099 -0.955 . . . . 1.0 110.642 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.476 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -59.84 136.82 58.12 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.222 -0.991 . . . . 1.0 111.018 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.74 -4.57 20.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.164 -0.925 . . . . 1.0 110.214 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -134.22 164.74 26.7 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.2 -1.037 . . . . 1.0 108.2 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -66.62 -29.44 69.48 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 113.884 1.068 . . . . 1.0 113.884 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -88.73 5.89 41.25 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.499 1.296 . . . . 1.0 114.499 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.476 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 98.4 mt-10 -104.45 136.61 43.69 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.321 0.581 . . . . 1.0 112.481 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.9 mt -74.83 145.13 43.1 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.642 0.734 . . . . 1.0 110.418 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.0 m -112.45 129.64 56.26 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 105.921 -1.881 . . . . 1.0 105.921 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -154.92 169.26 24.45 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 120.191 -0.603 . . . . 1.0 110.129 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.7 m -120.35 160.79 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 O-C-N 123.694 0.621 . . . . 1.0 109.845 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -46.3 136.85 6.79 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 80.38 -8.93 1.44 Allowed 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 116.82 2.156 . . . . 1.0 116.82 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -67.02 147.55 53.06 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.252 -0.979 . . . . 1.0 109.127 170.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.67 139.58 32.53 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.011 0.434 . . . . 1.0 111.603 175.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.52 124.86 73.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.876 -2.639 . . . . 1.0 103.876 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.1 pt -115.54 165.85 10.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.649 0.738 . . . . 1.0 112.027 -172.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.03 51.03 17.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.994 0.902 . . . . 1.0 111.103 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.6 mt -72.38 129.99 35.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.499 -0.773 . . . . 1.0 110.832 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -112.01 132.38 54.84 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.134 -1.432 . . . . 1.0 107.134 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.473 ' HA ' ' CD1' ' A' ' 37' ' ' TRP . 94.0 m-85 -78.88 69.1 4.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.598 0.713 . . . . 1.0 109.195 -176.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 80.2 t -65.86 -44.56 92.7 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 N-CA-C 113.97 1.1 . . . . 1.0 113.97 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -143.16 162.24 36.11 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 106.781 -1.562 . . . . 1.0 106.781 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -63.95 -34.69 78.54 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 120.942 0.401 . . . . 1.0 111.612 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -94.72 -40.28 9.87 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 115.048 1.499 . . . . 1.0 115.048 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -116.01 139.21 50.5 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.73 -1.211 . . . . 1.0 107.73 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.473 ' CD1' ' HA ' ' A' ' 31' ' ' PHE . 21.6 m0 -122.88 153.24 39.9 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.1 tp -99.21 131.59 45.13 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.78 -168.78 14.89 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 119.644 -1.265 . . . . 1.0 111.717 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.474 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 78.9 tt0 -138.47 139.2 38.72 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.839 0.856 . . . . 1.0 109.289 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.4 mt -76.04 132.26 40.01 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 119.237 -0.985 . . . . 1.0 112.297 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.76 -38.57 75.63 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 120.041 -0.664 . . . . 1.0 110.54 172.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.85 -21.54 59.21 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 115.884 1.809 . . . . 1.0 115.884 -168.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.8 p30 -145.82 -0.8 0.8 Allowed 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 116.119 1.896 . . . . 1.0 116.119 -174.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.87 1.79 79.74 Favored Glycine 0 C--O 1.221 -0.673 0 C-N-CA 119.715 -1.231 . . . . 1.0 115.445 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.7 p -70.05 150.91 46.12 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 119.572 1.686 . . . . 1.0 108.584 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.23 149.88 51.73 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.69 174.76 36.28 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.574 -0.822 . . . . 1.0 112.824 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.3 mt -73.09 139.24 46.35 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.579 -0.811 . . . . 1.0 111.554 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -139.16 149.12 59.91 Favored Pre-proline 0 N--CA 1.443 -0.778 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -79.85 129.66 8.2 Favored 'Trans proline' 0 CA--C 1.512 -0.606 0 N-CA-C 108.808 -1.266 . . . . 1.0 108.808 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.7 m -60.42 -34.74 74.4 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 114.404 1.261 . . . . 1.0 114.404 -176.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -66.44 -6.57 15.07 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.54 0.941 . . . . 1.0 113.54 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -94.14 -0.12 55.46 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 120.078 -1.638 . . . . 1.0 113.4 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.64 HG12 ' HA ' ' A' ' 6' ' ' ALA . 35.0 m -138.4 162.97 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.7 0.762 . . . . 1.0 111.732 -178.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.5 t -131.42 130.81 43.02 Favored 'General case' 0 C--O 1.214 -0.782 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.7 mt -60.28 141.62 55.86 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.816 0.817 . . . . 1.0 111.086 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.55 -164.63 54.64 Favored Glycine 0 C--O 1.248 0.988 0 CA-C-N 115.371 -0.831 . . . . 1.0 113.501 177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.255 1.363 0 CA-C-O 117.496 -1.24 . . . . 1.0 111.395 -176.977 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.329 0.109 . . . . 1.0 110.955 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -76.94 171.04 18.69 Favored 'Trans proline' 0 C--N 1.317 -1.109 1 C-N-CA 127.273 5.316 . . . . 1.0 109.614 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -114.42 165.36 12.81 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.788 0.804 . . . . 1.0 109.66 169.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.7 164.11 31.38 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.273 -0.876 . . . . 1.0 111.481 -176.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.9 m -119.59 128.61 54.06 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.205 -1.035 . . . . 1.0 108.205 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.537 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -71.39 140.27 50.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.069 0.937 . . . . 1.0 110.431 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.405 ' C ' ' HG3' ' A' ' 22' ' ' GLU . 97.2 mt-10 -102.89 -16.68 15.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.053 -0.976 . . . . 1.0 111.539 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -141.54 151.53 43.31 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 106.732 -1.581 . . . . 1.0 106.732 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -68.81 137.43 53.95 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -129.02 125.03 36.46 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.723 -1.214 . . . . 1.0 107.723 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -104.1 117.13 33.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.059 -0.973 . . . . 1.0 110.64 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 17' ' ' GLU . . . -58.17 134.54 56.58 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 119.181 -1.008 . . . . 1.0 110.984 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.07 -5.05 26.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.079 -0.964 . . . . 1.0 110.313 176.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -137.2 165.2 26.67 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.266 -1.013 . . . . 1.0 108.266 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -65.95 -32.39 73.85 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 113.884 1.068 . . . . 1.0 113.884 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -84.98 7.1 22.45 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 114.481 1.289 . . . . 1.0 114.481 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.501 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 98.8 mt-10 -106.42 138.9 41.77 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.376 0.608 . . . . 1.0 112.495 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.61 140.49 42.65 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.687 0.756 . . . . 1.0 110.411 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.0 m -107.51 128.39 54.46 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 105.859 -1.904 . . . . 1.0 105.859 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -154.63 169.27 24.28 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.074 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.1 m -120.28 160.78 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 O-C-N 123.626 0.579 . . . . 1.0 109.874 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.405 ' HG3' ' C ' ' A' ' 7' ' ' GLU . 74.5 tt0 -46.39 136.85 6.95 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.62 -0.881 . . . . 1.0 108.62 176.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 80.45 -8.92 1.43 Allowed 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 116.783 2.142 . . . . 1.0 116.783 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.04 147.61 52.97 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.259 -0.976 . . . . 1.0 109.038 170.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.65 139.59 32.5 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.047 0.451 . . . . 1.0 111.594 175.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.433 HD13 HG11 ' A' ' 55' ' ' VAL . 4.5 mp -117.59 124.94 73.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 103.841 -2.651 . . . . 1.0 103.841 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 pt -115.64 165.81 10.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-O 121.625 0.726 . . . . 1.0 112.027 -172.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 51.14 50.97 17.96 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.982 0.896 . . . . 1.0 111.022 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.8 mt -71.75 131.07 35.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.96 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -112.65 133.53 54.63 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.065 -1.457 . . . . 1.0 107.065 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -79.34 68.67 5.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.66 0.743 . . . . 1.0 109.145 -176.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.507 HG21 ' HB2' ' A' ' 38' ' ' LEU . 66.9 t -64.86 -44.3 96.28 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 N-CA-C 113.873 1.064 . . . . 1.0 113.873 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -143.49 163.84 32.02 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.762 -1.57 . . . . 1.0 106.762 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -64.34 -32.57 74.23 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 120.976 0.417 . . . . 1.0 111.585 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -102.11 -36.28 8.61 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 114.946 1.462 . . . . 1.0 114.946 -177.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -111.76 133.56 53.91 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 16.3 m0 -117.95 158.05 25.61 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.199 -1.037 . . . . 1.0 108.199 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.507 ' HB2' HG21 ' A' ' 32' ' ' VAL . 47.1 tp -110.44 126.5 54.38 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.51 -170.0 14.7 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 119.694 -1.241 . . . . 1.0 111.853 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.402 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 80.9 tt0 -133.05 139.26 47.09 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 123.733 0.813 . . . . 1.0 109.345 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.9 mt -74.87 132.28 41.38 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 118.801 -1.159 . . . . 1.0 112.308 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -57.82 -38.59 75.84 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 120.081 -0.648 . . . . 1.0 110.543 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.84 -21.53 59.21 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 115.849 1.796 . . . . 1.0 115.849 -168.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.86 -0.75 0.8 Allowed 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 116.023 1.86 . . . . 1.0 116.023 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.91 1.77 79.84 Favored Glycine 0 C--O 1.223 -0.566 0 C-N-CA 119.657 -1.259 . . . . 1.0 115.449 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.07 150.87 46.13 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 119.598 1.699 . . . . 1.0 108.602 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.402 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.21 149.97 51.67 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.37 175.22 36.48 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.607 -0.806 . . . . 1.0 112.789 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.29 137.39 46.68 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.52 -0.84 . . . . 1.0 111.599 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.522 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 39.3 p90 -138.41 146.8 52.73 Favored Pre-proline 0 C--O 1.244 0.804 0 N-CA-C 108.088 -1.079 . . . . 1.0 108.088 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.536 ' HG2' ' CD1' ' A' ' 54' ' ' TYR . 57.8 Cg_endo -77.78 129.26 9.83 Favored 'Trans proline' 0 CA--C 1.512 -0.597 0 N-CA-C 108.83 -1.258 . . . . 1.0 108.83 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.5 m -61.8 -36.18 80.37 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 114.36 1.244 . . . . 1.0 114.36 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -64.3 -7.51 9.73 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.477 0.917 . . . . 1.0 113.477 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.536 ' CD1' ' HG2' ' A' ' 51' ' ' PRO . 15.5 m-85 -94.12 -0.14 55.48 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 120.198 -1.563 . . . . 1.0 113.316 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 6' ' ' ALA . 27.7 m -137.36 161.66 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.605 0.717 . . . . 1.0 111.847 -178.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.7 t -129.4 129.82 45.21 Favored 'General case' 0 C--O 1.214 -0.806 0 C-N-CA 124.054 0.941 . . . . 1.0 108.553 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.8 mt -58.85 141.71 52.52 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.762 0.791 . . . . 1.0 111.108 -177.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.53 -164.64 54.62 Favored Glycine 0 C--O 1.246 0.876 0 CA-C-N 115.377 -0.828 . . . . 1.0 113.547 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.318 0 CA-C-O 117.624 -1.179 . . . . 1.0 111.411 -176.998 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.329 0.109 . . . . 1.0 110.979 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -76.86 170.97 18.83 Favored 'Trans proline' 0 C--N 1.316 -1.144 1 C-N-CA 127.302 5.334 . . . . 1.0 109.637 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -114.38 165.38 12.78 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.788 0.804 . . . . 1.0 109.679 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.73 164.09 31.45 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.273 -0.876 . . . . 1.0 111.515 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.4 p -115.37 131.1 57.04 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.132 -1.062 . . . . 1.0 108.132 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.69 136.83 56.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.947 0.88 . . . . 1.0 110.49 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -101.19 -25.38 14.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.167 -0.924 . . . . 1.0 111.578 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.405 ' HB2' ' CD2' ' A' ' 54' ' ' TYR . 85.6 m-85 -139.77 153.21 47.1 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 106.741 -1.578 . . . . 1.0 106.741 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -69.17 133.72 48.34 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.928 -0.768 . . . . 1.0 108.928 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -129.14 121.0 26.84 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -101.08 119.96 39.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.048 -0.978 . . . . 1.0 110.62 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.25 135.65 57.79 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 119.204 -0.999 . . . . 1.0 110.929 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.87 -2.58 19.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.135 -0.939 . . . . 1.0 110.277 176.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -136.58 164.66 27.67 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.295 -1.002 . . . . 1.0 108.295 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -65.24 -33.97 77.24 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 113.904 1.075 . . . . 1.0 113.904 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.6 p-10 -85.86 2.35 46.22 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 114.496 1.295 . . . . 1.0 114.496 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -100.12 137.68 38.24 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.331 0.586 . . . . 1.0 112.466 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.8 mt -76.29 147.22 38.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.715 0.769 . . . . 1.0 110.423 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.0 m -114.91 127.47 55.72 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 105.924 -1.88 . . . . 1.0 105.924 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -154.09 169.28 23.93 Favored 'General case' 0 CA--C 1.502 -0.889 0 O-C-N 123.477 0.485 . . . . 1.0 110.056 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.8 m -120.31 160.85 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 O-C-N 123.67 0.606 . . . . 1.0 109.89 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -46.39 136.92 6.9 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 80.41 -8.96 1.43 Allowed 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 116.783 2.142 . . . . 1.0 116.783 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -67.04 147.64 52.93 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.258 -0.977 . . . . 1.0 109.051 170.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.66 139.61 32.49 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.019 0.438 . . . . 1.0 111.588 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.64 124.96 73.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 103.792 -2.67 . . . . 1.0 103.792 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 pt -115.64 165.86 10.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.655 0.741 . . . . 1.0 112.031 -172.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 51.08 51.02 17.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.013 0.911 . . . . 1.0 111.042 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.5 mt -72.75 131.29 35.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.873 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -112.8 134.29 54.39 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.036 -1.468 . . . . 1.0 107.036 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.437 ' HA ' ' CD1' ' A' ' 37' ' ' TRP . 94.0 m-85 -78.68 68.04 4.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.701 0.762 . . . . 1.0 109.246 -176.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.423 HG21 ' HB2' ' A' ' 38' ' ' LEU . 92.6 t -65.27 -44.32 95.01 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.703 0 N-CA-C 113.946 1.091 . . . . 1.0 113.946 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -143.42 162.99 34.32 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.702 -1.592 . . . . 1.0 106.702 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -64.56 -35.68 81.77 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 120.922 0.391 . . . . 1.0 111.594 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -96.28 -42.02 8.37 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.959 1.466 . . . . 1.0 114.959 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -113.26 136.89 52.25 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.633 -1.247 . . . . 1.0 107.633 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 17.6 m0 -120.52 160.02 24.01 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.139 -1.06 . . . . 1.0 108.139 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.439 HD12 ' C ' ' A' ' 48' ' ' GLY . 53.0 tp -107.68 131.06 54.81 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.72 -170.8 16.87 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 119.65 -1.262 . . . . 1.0 111.836 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.455 ' CD ' ' HE2' ' A' ' 47' ' ' LYS . 78.3 tt0 -133.67 139.3 46.36 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 123.797 0.839 . . . . 1.0 109.374 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.7 mt -75.81 132.22 40.26 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 119.311 -0.956 . . . . 1.0 112.266 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -57.77 -38.62 75.74 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 120.072 -0.651 . . . . 1.0 110.556 172.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -74.81 -21.55 59.23 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 115.898 1.814 . . . . 1.0 115.898 -168.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -145.9 -0.66 0.8 Allowed 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 116.082 1.882 . . . . 1.0 116.082 -174.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.93 1.71 79.81 Favored Glycine 0 C--O 1.223 -0.566 0 C-N-CA 119.588 -1.292 . . . . 1.0 115.446 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.8 p -70.05 150.84 46.19 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 119.615 1.708 . . . . 1.0 108.546 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.455 ' HE2' ' CD ' ' A' ' 40' ' ' GLU . 76.8 mttt -130.22 149.9 51.71 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 109.373 -0.602 . . . . 1.0 109.373 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.439 ' C ' HD12 ' A' ' 38' ' ' LEU . . . 166.47 178.99 39.5 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.582 -0.818 . . . . 1.0 112.772 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.9 mp -73.33 146.03 45.55 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.551 -0.825 . . . . 1.0 111.608 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.533 ' CZ ' ' HB2' ' A' ' 37' ' ' TRP . 44.0 p90 -146.57 150.48 40.37 Favored Pre-proline 0 C--O 1.245 0.827 0 N-CA-C 108.053 -1.091 . . . . 1.0 108.053 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.432 ' HG2' ' CD1' ' A' ' 54' ' ' TYR . 61.4 Cg_endo -82.62 127.08 4.86 Favored 'Trans proline' 0 CA--C 1.513 -0.572 0 N-CA-C 108.784 -1.275 . . . . 1.0 108.784 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.6 m -59.05 -36.9 75.83 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 114.383 1.253 . . . . 1.0 114.383 -177.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -65.32 -6.5 10.08 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.403 0.89 . . . . 1.0 113.403 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.432 ' CD1' ' HG2' ' A' ' 51' ' ' PRO . 16.3 m-85 -92.63 -2.83 55.8 Favored 'General case' 0 C--O 1.222 -0.374 0 O-C-N 120.275 -1.516 . . . . 1.0 113.434 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.1 m -138.3 162.11 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.617 0.722 . . . . 1.0 111.774 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 56.3 m -127.63 130.36 48.83 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 123.995 0.918 . . . . 1.0 108.596 177.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.8 mt -58.36 141.76 50.27 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.836 0.827 . . . . 1.0 111.074 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.42 -164.61 54.55 Favored Glycine 0 C--O 1.246 0.904 0 CA-C-N 115.401 -0.818 . . . . 1.0 113.546 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.254 1.318 0 CA-C-O 117.619 -1.181 . . . . 1.0 111.44 -177.023 . . . . . . . . 0 0 . 1 stop_ save_